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Abstract
In recent years the possibility to engineer cells in vitro has encountered significant
progress. This engineering of cellular states, which is tightly coupled to the field of stem
cell research, is considered to be a very useful technology for the generation of specialised
cells for drug development, disease modelling, or regenerative medicine. One important
part of this process is the quality control, i.e. the detailed characterisation of the end
products, to ensure that the transformed cells are similar to their in vivo counterparts.
Many markers and functional assays exist that can be used for quality control of these
cells. However, most of them focus on specific, relatively narrow properties of the cells,
neglecting a global overall comparison to the desired cell type.
Here, we present a genome-wide gene expression microarray based approach to cell char-
acterisation, providing complementary information to the commonly used single gene or
morphological markers. We use a dimension reduction approach to localise newly gener-
ated microarray data in the high dimensional expression space. Using a combination of
unsupervised and supervised dimension reduction methods, we establish a two-scale map
of global gene expression with phenotypic interpretation of the coordinates.
This two-scale map is used to characterise several different samples. It is first validated
on a dataset of 24 different tissues and cell lines as well as on two datasets of artificially
mixed tissues. Using these datasets, it is shown that the developed method outperforms
three existing methods for RNA based global cell characterisation and that it provides in-
creased information compared to the purely unsupervised or purely supervised dimension
reduction methods.
Application of the two-scale map to characterise in vitro transformed cells prooves to be
useful in providing complementary information to the typical marker based or morpholog-
ical criteria. In this respect, we could identify two examples of in vitro transformed cells
where the transformation process is incomplete on a global expression level. Furthermore,
we can show that in vitro differentiation of pluripotent stem cells results in immature cells
that are similar to embryonic of fetal tissues of the respective type.
Using microarray data from artificial mixtures of different tissues, we can observe clear
non-linear effects in the data that fit well to the current understanding of the relation-
ship between the RNA content of cells and the measurement signal of microarrays. Such
non-linear effects are currently not captured by the proposed linear dimension reduction
approach and give important hints for further improvements of the method.
In addition to quality control of in vitro transformed cells, the two-scale decomposition
approach developed in this thesis may also be useful for a number of other applications,
such as the analysis of drug response profiles or disease progression.
Zusammenfassung
Die gezielte Modifizierung von Zellen in der Kulturschale hat in den letzten Jahren si-
gnifikante Fortschritte gemacht. Diese eng mit der Stammzellfoschung zusammenhängende
Technologie hat großes Potenzial zur Herstellung von spezialisierten Zellen für die Medi-
kamentenentwicklung, die Modellierung von Krankheiten, sowie die regenerative Medizin.
Ein wichtiger Schritt im Herstellungsprozess der Zellen ist die Qualitätskontrolle, das heißt
die detaillierte Charakterisierung der zellulären Endprodukte, die sicherstellen soll, dass
die generierten Zellen den entsprechenden körpereigenen Zellen möglichst stark ähneln.
Diese Qualitätskontrolle der Zellen kann mit vielen verschiedene Markern und funktionalen
Untersuchungsmethoden bewerkstelligt werden. Die meisten dieser Methoden analysieren
jedoch nur einen relativ beschränkten Bereich der zellulären Eigenschaften und vernach-
lässigen dabei den globalen Vergleich zum angestrebten Zelltyp.
In der vorliegenden Arbeit präsentieren wir einen Ansatz der auf der Analyse der genom-
weiten Genexpression mittels Microarrays basiert und somit komplementäre Informationen
zu den üblicherweise genutzten Einzelgen oder Morphologie-basierten Markern liefert. Da-
zu nutzen wir einen Dimensionsreduktionsansatz um neu generierte Microarray Daten im
eigentlich hochdimensionalen Genexpressionsraum zu lokalisieren. Wir kombinieren dabei
unsupervidierte und supervidierte Dimensionsreduktionsmethoden und etablieren damit
eine zwei-Skalen Landkarte der globalen Genexpression mit der Möglichkeit der direkten
phenotypischen Interpretation der Koordinaten.
Durch die Anwendung dieser zwei-Skalen Landkarte auf in vitro transformierte Zellen kön-
nen wir zeigen, wie nützlich dieser Ansatz zur Generierung komplementärer Informationen
zu den typischen Markern oder morphologischen Informationen ist. In diesem Zusammen-
hang zeigen wir zwei Beispiele in vitro transformierter Zellen, bei denen der Transformati-
onsprozess auf globaler Genexpressionsbasis nicht vollständig abgeschlossen ist. Desweite-
ren können wir zeigen, dass durch die in vitro Differenzierung pluripotenter Stammzellen
meist nicht vollständig ausgereiften Zellen entstehen, die eine hohe Ähnlichkeit zu embryo-
nalen oder fetalen Zellen des entsprechenden Typs aufweisen.
Basierend auf Microarray Daten von künstlichen Mischungen verschiedener Gewebe, be-
obachten wir deutliche nicht-lineare Effekte in den Daten, die gut zum momentanen Ver-
ständnis der Beziehung von RNS Menge und Messsignal passen. Diese nicht-linearen Effek-
te werden aktuell von dem hier vorgestellten linearen Dimensionsreduktionsmodell nicht
berücksichtigt, geben aber wertvolle Hinweise für mögliche zukünftige Verbesserungen des
Modells.
Zusätzlich zur Qualitätskontrolle in vitro transformierter Zellen, könnte der hier entwickelte
zwei-Skalen Ansatz auch für einige andere Anwendungen, wie die Analyse der Medikamen-
tenwirkung auf Zellen oder den Vergleich verschiedener Stadien der Krankheitsentwicklung,
nützlich sein.
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1. Introduction
Embryonic stem cells (ESCs) have been of interest to researchers for many years due to
their ability to differentiate into any cell type of the human body [1]. They can therefore be
used to generate new cells of a specific type for regenerative medicine, disease modelling,
or drug development. However, the ethical issues associated with these cells prevented
intensive research and further use of these cells in many countries.
The discovery of Takahashi, Yamanaka, and colleagues that mouse [2] as well as human
[3] fibroblasts can be reprogrammed into induced pluripotent stem cells (iPSC) by specific
transcription factors, has made pluripotent stem cell research significantly less critical from
an ethical perspective. This led to a sharp increase of research activities in the field, with
many groups working on the improvement of in vitro reprogramming and differentiation
protocols.
However, despite several improvements made in the last years, it is still observed that
especially in vitro differentiated cells do not fully resemble the corresponding cells from
primary tissues [4, 5]. Therefore, it is very important to characterise the transformed cells
appropriately and to compare them to their in vivo counterparts.
Characterisation of cells is classically done by histological analysis, i.e. manual morpho-
logical examination or antibody based staining of specific proteins. Furthermore, several
functional tests are used to check the typical functionalities of a specific cell type. However,
these methods are often either labour intensive, difficult to quantitate, inaccurate, or not
well standardised [6, 7]. Therefore, there is a pressing need to develop well standardised
and quantitative ways to characterise these cells.
In the last years, the way we tackle biological questions started to change. With the advent
of high throughput technologies and systematic storage of omics data, important biological
or medical findings are not only drawn from experiments but also from in silico studies
[8, 9]. Furthermore, significant methodological progress has been made, allowing an inte-
gration of the available data to exploit their full potential. Such an integration of data
from various studies can be used to characterise cells based on a comparison of the new
data with well annotated retrospective data using multivariate statistical methods.
One way to tackle this task is the use of gene expression microarray data, which are abun-
dantly available and give relevant information about the cell type. Existing approaches
use these data to build a multi-class classifier for the diverse human tissue types [10], or
calculate an enrichment score for each tissue [11], aiming to assign the new data to one
specific class, i.e. one specific tissue or cell type. However, this classification into a discrete
set of tissue types is not well suited to characterise cells that deviate from the known in
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vivo tissues or that are mixtures of different cell types. Therefore, it may be better to use
dimension reduction techniques, spanning a low dimensional space with physiologically rel-
evant dimensions to allow a more continuous characterisation of cells in terms of a location
in a well interpretable expression `landscape'.
So far, studies with this aim focused on unsupervised dimension reduction techniques
[11, 12], ending up with a very low dimensional approximation that allows only a very
rough characterisation of cells. We extend this low dimensional space with a residual tis-
sue specific space that is created in a supervised manner. In combination, these two spaces
are referred to as a `two scale map of global gene expression' that can be used to charac-
terise in vitro differentiated cells in comparison to well annotated cell and tissue types.
This introduction gives first some further background information on stem cell research,
its potentials, as well as the need to rigorously classify in vitro transformed cells. It then
describes possibilities of using large sets of publicly available gene expression data for cell
characterisation and motivates the application of dimension reduction methods to deal
with the high dimensionality of these data. The chapter ends with a summary of the main
contributions of this thesis and an outline of its structure and content.
1.1. Reprogramming and differentiation - cellular plasticity
opens new perspectives
Humans are multicellular organisms with trillions of individual cells [13]. These cells can
be classified into hundreds of different cell types [14, 15] with specific characteristics, such
as a specific morphology, functionality, or expression of certain genes. All of these cells
originate from a single cell, the zygote, by replication and differentiation. In this devel-
opmental process, the zygote first self-renews several times before the first differentiation
step occurs, leading to formation of the early blastocyst [16]. The outer part of the early
blastocyst consists of so called trophectoderm cells that become part of the placenta. The
inner part, the so called inner cell mass, consists of pluripotent cells that have the potential
to generate any cell type of the human body [16].
During the next steps of embryonic development, three germ layer (endoderm, mesoderm,
and ectoderm) evolve. These layers were identified as distinct anatomical regions in the
embryo, giving rise to different organs at later stages [17]. This early anatomical division
into different parts led to a hierarchical concept of cell differentiation. According to this
concept, cells take several decision steps during their differentiation. Each decision step
reduces the cellular plasticity, narrowing the set of possible cell types that can evolve from
that cell [18, 19]. This model of differentiation is supported by further experimental evi-
dence, showing that cells that are transplanted from one location to another in the embryo
follow their old differentiation lineage despite of the changed microenvironment [17].
These and other observations [20] indicate that cell type and lineage choices are to some ex-
tent stable with respect to disturbing factors. However, many results from the last decade
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showed that the differentiated cellular states are less restricted, i.e. more plastic, than
previously thought. In 2002, Theise and Krause [17] postulated that "any cell containing
the entire genome, without transpositions, multiplications or deletions, has the potential
to display features of any cell type of the organism from which it was derived". It may
be that only a small part of these transformations are of physiological relevance [17], but
the possibility to transform certain differentiated cells in vitro into any other cell type has
been experimentally validated and is currently shaping research in the fields of stem cells,
regenerative medicine, and disease modelling.
The increasing interest in these fields started with the seminal work of Takahashi and
Yamanaka [2] who reprogrammed mouse fibroblasts into iPSCs by induction of four tran-
scription factors. In 2007, a similar procedure was successfully applied for reprogramming
of human fibroblasts [3, 21, 22, 23]. Since then, many different types of cells have been
reprogrammed to iPSCs with a diverse set of protocols. Starting with the use of retroviral
or lentiviral approaches with genomic integration, more clinically relevant, integration-free
methods, have been developed [24, 25] and various small molecules have been suggested to
increase the usually very low reprogramming efficiency [26]. Furthermore, it was observed
that some cell types, e.g adult neural stem cells, are easier to reprogram than others, re-
quiring the use of only two [27] or even a single [28] instead of the usual four transcription
factors in the case of neural stem cells.
IPSCs are highly similar to ESCs [3], being able to self-renew indefinitely and to differ-
entiate into all three embryonic germ layers [1]. Thus, they serve as a potential source
for all cell types of the human body, including those with low accessibility, e.g. cardiomy-
ocytes or neural cells. In contrast to ESCs, which are derived from the early blastocyst
[1], generation of iPSCs avoids the use of human embryos, resulting in less ethical contro-
versies [29] and reducing political discussions about usage regulations and their impact on
scientific progress [30, 31]. In addition to this ethical advantage, a key promise of iPSCs
is their use for the creation of disease-specific or personalised cells of any type, i.e. with
a disease specific or personalised genome. This may improve in vitro disease models and
reduce rejection reactions in cell therapies, having a great impact for drug development,
and regenerative medicine [32, 33, 34, 35].
For modelling of diseases that are caused by single genetic mutations, the ability to create
disease specific cells, i.e. with a characteristic genetic disorder, is very important. For ex-
ample, many neurodegenerative diseases show a pathological processing of proteins caused
by gene deletions or mutations [36, 37]. One example is the spinal muscular atrophy (SMA)
disease that is caused by a deletion or mutation of the survival of motor neuron 1 (SMN1)
gene resulting in a loss of alpha motor neurons in the spinal cord [38]. SMA has previously
been studied in different animal models or by the analysis of fibroblasts lacking SMN1.
These models have the disadvantages of species specific or cell type specific differences.
However, by reprogramming of the affected fibroblasts to iPSCs and subsequent neuronal
differentiation, one can circumvent both disadvantages as performed in a study by Ebert
and colleagues [38, 39]. A similar procedure may be beneficial in the analysis of cardiac
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dysrhythmia, e.g. in the investigation of the long-QT syndrome [40].
Despite of the promises of iPSC-derived cells for disease modelling and drug development,
the usage of these cells in industrial applications is still comparably low. The reasons for
this are the high costs and time consuming manual processes, as well as a lack of standard-
isation and sometimes insufficient quality of the products, among others [41]. The issues
Figure 1.1.: A picture of the StemCellFactory (www.stemcellfactory.de) which was devel-
oped and build up within the StemCellFactory project. The six meters long
and more than two meters wide machine was constructed at RWTH Aachen
and is now located and maintained at Life & Brain GmbH in Bonn. It was
designed for a fully automatic reprogramming of fibroblasts into iPSCs and a
subsequent differentiation of these into neural cells and cardiomyocytes. One
essential step in the StemCellFactory is the quality control of the end products
in order to assure their usability as an in vitro disease model.
of automation and standardisation are currently tackled by an interdisciplinary research
project building a prototype that performs reprogramming of fibroblasts or mesenchymal
stem cells (MSCs) to iPSCs and subsequent neural or cardiac differentiation [36, 42]. The
StemCellFactory (Figure 1.1) is a novel automatic production unit for reprogramming, cul-
tivation and differentiation of iPSCs, transferring the complex manual laboratory processes
to an automatic production process.
However, the issue of the quality of the cellular end products can not be solved entirely
by automation of the current manual protocols, but requires the improvement of biological
protocols [4]. There are several concerns about the quality of the cells. For instance, muta-
tions may occur during reprogramming as well as during prolonged culturing of pluripotent
stem cells [43, 44, 45]. Another important issue are the relatively strong differences be-
tween in vitro differentiated cells and their in vivo counterparts in their gene expression
status [5]. These differences open the question whether the in vitro generated cells are in
fact of another type than their in vivo counterparts.
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These concerns are also very important for regenerative medicine, where iPSC-derived cell
products present a promising resource for patient specific cells. Despite significant progress
in regenerative medicine in the last years [46], important questions remain regarding the
safety of cell transplants [47], especially due to their observed tumourigenic potential [48].
Perhaps the most dramatic observation in this regard was the formation of a tumour in a
boy that was treated with neural stem cells [49]. This boy with ataxia telangiectasia, an
inherited neurodegenerative disease, developed a glioneuronal neoplasm roughly four years
after treatment and it could be shown that the tumour cells were of non-host origin [49].
Therefore, it is important to develop criteria to control the quality of reprogrammed cells.
These quality criteria should be well standardised, objective and as reliable as possible. One
possibility to characterise cells is through the use of gene expression microarray data. These
data are comparably well standardised and are frequently deposited in public databases, so
that other researchers have access to them. Therefore, it is possible for other researchers to
evaluate the results of a study based on these data. One prominent example where this has
been done led to a retraction of a high profile article [50] and even to some associated legal
issues. In this article, the authors claimed to generate pluripotent stem cells from adult
human testis [50]. However, based on the gene expression data of these cells, another group
of researchers could show that the generated cells are more similar to fibroblasts than to
pluripotent stem cells [51], eventually leading to the retraction of the former article.
The present thesis contributes to this research field by integrating large amounts of pub-
licly available microarray data to characterise in vitro reprogrammed and differentiated
cells according to their large-scale gene expression patterns. This system-wide analysis
complements typical marker-based, genomic, functional or morphological characterisations
of cells.
1.2. Exploiting large public microarray datasets for a global
characterisation of cells
In the last years, the way we tackle biological questions started to change. With the advent
of high throughput sequencing technologies [52] and the increasing amount of datasets that
are available from public databases [53, 54, 55], biology is essentially entering the field of
big data and important biological or medical findings are not only drawn from experiments
but also from in silico studies [8, 9]. These changes in biomedical research pose not only
challenges to bioinformatics for storage and effective handling of the rapidly increasing
amount of data [56], but also require new methods for information extraction and mod-
elling, in order to make sense out of the data and interpret the results appropriately. For
the latter challenge, it is necessary to integrate heterogenous data and to utilise the already
available knowledge for interpretation of new experiments, bringing them into a broader
context [57].
Data integration approaches for microarray gene expression data have been implemented
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at different levels. The classical analyses started with calculation of differential gene ex-
pression between two phenotypes in order to detect genes that are associated with the
phenotypical difference [58, 59]. For the interpretation of the results, knowledge from gene
annotation databases is used, providing information about the genomic location of a single
gene, as well as the structure, functionality, and cellular location of the associated protein
[60, 61].
These analyses were then extended to the level of gene sets. Methods like gene set en-
richment analysis (GSEA) [62, 63, 64] use information from gene ontology [65] or pathway
databases [66] to build gene sets and identify potentially important pathways, processes or
functionalities based on the differential expression of the genes in a predefined set. This
analysis accounts for the fact that most cellular functionalities are accomplished by the
joint action of several proteins making it necessary to study not only a single gene in iso-
lation, but to take a broader view on the expression of a set of genes.
Looking at an even broader scale, it becomes clear that the molecular pathways themselves
also do not act in isolation, but are embedded into a large network [67]. Furthermore, phe-
notypic changes do not only lead to a gene expression change in an individual pathway, but
rather to a global genome-wide change in the expression profile [11]. Consequently, meth-
ods of data integration should also consider this genome-wide scale in order to correctly
interpret system-wide effects that may lead to counterintuitive or misleading results when
interpreted at fine-grained scales only [11, 68]. On such a genome-wide scale, phenotypes
can be compared more directly, e.g. by linkage of gene expression changes in the exper-
iment of interest with gene expression patterns that are associated with specific tissues,
clinical parameters, or changes in the cellular environment [69, 70, 71].
For the focus of the present thesis, the linkage of global gene expression during in vitro
differentiation experiments with tissue specific expression patterns is of high interest [72].
The required comparison of expression patterns from different sources, i.e. primary tis-
sue samples and cultivated cells, faces several challenges due to environmental differences,
biological heterogeneity in clinical samples [73], lab dependent effects, as well as techni-
cal noise. Furthermore, we aim to characterise single samples, i.e. we do not make use
of replicate measurements to reduce the level of noise. Therefore, it is of utmost impor-
tance to utilise the knowledge from retrospective data to distinguish meaningful biological
information from pure measurement errors.
1.3. Locating new samples in reduced dimensional gene
expression spaces
The goal of this thesis is to characterise new samples, especially from in vitro differentiated
cells, by a global gene expression based comparison to well annotated retrospective data.
For this purpose, we use large amounts of publicly available microarray data. Microar-
ray experiments measure the expression of roughly 20,000 genes at the same time in a
6
A Two-Scale Map of Global Gene Expression RWTH Aachen University
high-throughput manner. From a mathematical perspective, this means that one has to
deal with 20,000 variables from which it is initially not known to which extend they are
related to each other. Therefore, any large scale analysis of microarray data must deal
with the `curse of dimensionality' [74] and the associated counterintuitive challenges of
high dimensions [75, 76]. The term `curse of dimensionality' describes some very general
features of high dimensions that are associated, for instance, with the exponential increase
of data points that are necessary to sample spaces of increasing dimensionality with a
sufficient density. This often leads to a prevalence of empty space in high dimensions due
to restricted sample sizes. This prevalence of empty space as well as the other features of
high dimensional spaces impose some problems that affect many data mining and machine
learning techniques, e.g. due to the measure concentration phenomenon [75, 77]. There-
fore, the use of any of these methods must be considered carefully.
The specific challenge in this thesis is to compare the location of new microarray data to
that of retrospective data in the roughly 20,000 dimensional gene expression space. Due to
the high dimensionality of the expression space, it is not possible to directly visualise or to
imagine the location of a sample in the expression space for a direct manual interpretation
of the location. Therefore, several data mining and machine learning tools exist that can
assist in the interpretation of the data.
One possible tool that can be used in this respect is a k-nearest neighbour classifier. This
classifier evaluates the distance of the new sample to all retrospective data and classifies
the new sample based on the annotation of the k nearest neighbours from the retrospective
dataset. A special case of the k-nearest neighbour classifier is the 1-nearest neighbour
classifier, which classifies the new sample according to the annotation of the retrospective
sample with smallest distance.
One problem of the k-nearest neighbour classifier is that it is not well suited for the analy-
sis of high dimensional data. This is due to the measure concentration phenomenon. The
measure concentration phenomenon describes the fact that with increasing dimensionality
the distance of one sample to the nearest and farthest other sample become more and
more similar. That means, that the distance of one sample to all other samples is almost
constant in very high dimensions, making the concept of neighbourhood meaningless.
Another problem that was described for the k-nearest neighbour approach in high dimen-
sions is the `hubness' phenomenon [78]. The hubness phenomenon basically states that
in high dimensions some points eventually become hubs, i.e. these points are very often
among the k-nearest neighbours of all other points, although they are not necessarily sim-
ilar to them from a biological point of view.
Instead of using a k-nearest neighbour approach for classification, several other classifi-
cation algorithms can be applied, e.g. decision trees, neural networks, or support vector
machines. All of these classifiers have different strengths and weaknesses and the best
choice depends always on the particular application [79]. In the case of high dimensional
data, it is important to consider the different pitfalls that are associated with the curse
of dimensionality. The most critical problem for classification in high dimensions is the
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very sparse sampling of the space by the training data, leading to a prevalence of empty
space [80]. This is especially critical for highly flexible non-linear classifiers, e.g. neural
networks, that can easily be overfitted to the training data. Less flexible classifiers that
have more strongly constrained classification boundaries, e.g. linear classification meth-
ods, are usually less effected by the overfitting problem. However, these more constrained
methods may be unable to find a proper boundary for the training data due to inappropri-
ate constraints. Therefore, the best method choice is always a trade-off between flexibility
and the risk of overfitting [79]. Any available information about appropriate constraints
for the classification boundary can help to improve the methods.
The methods described so far focus on a classification of cells into a discrete set of classes,
i.e. they are typically used as multi-class classifiers. However, this approach has a major
drawback, since it does not incorporate the possibility that a new sample is only partially
similar to an existing cell type. This can be critical in cases where tissues are mixtures of
different cell types or when in vitro transformed cells have not fully reached the desired
cell type.
One way to overcome this problem is the use of classifiers that provide probability values
for each class, allowing relatively smooth transitions from one cell type to another [81].
Another approach is the use of dimension reduction techniques that create a space of lower
dimensionality with direct phenotypical interpretation of the coordinates. In this simplified
representation, microarray samples are not restricted to a discrete set of different classes,
i.e. cell types, but can vary continuously on the specified sub-manifold. When such a
reduced dimensional space has been created, new samples can be located in that space,
and the location in the space can be directly used for characterisation of the cells. This is
feasible due to the relatively low dimensionality of the space and the direct phenotypical
interpretability of the coordinates.
Reduction of dimensionality is commonly achieved via unsupervised methods, such as prin-
cipal components analysis (PCA) or non-negative matrix factorisation (NMF). However,
these unsupervised methods do not directly provide an interpretation of the coordinates
in terms of phenotypes. This problem can in principle be solved by supervised dimension
reduction approaches that use the available annotation to determine relevant directions,
e.g. based on regression methods. However, for these methods it is necessary to know the
structure of the low dimensional space in advance and to have appropriate annotations of
the data. Therefore, both kinds of methods have their own advantages and disadvantages
and the specific choice of the method must be carefully done in an application-specific
manner.
The aim of the present thesis is to create a low dimensional representation of the gene
expression space that allows a relatively straightforward characterisation of new data in
terms of their location in the expression space. For the derivation of this low dimensional
space, we compare the strengths and weaknesses of supervised and unsupervised methods
for this particular application. Based on this evaluation, we develop a new workflow that
combines both approaches in order to utilise their complementary strengths.
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1.4. Main contributions of the thesis
A Two-scale map of global gene expression for the characterisation of in vitro
engineered cells
The main contribution of the present thesis is the development of a two-scale gene expres-
sion map that can be used for an absolute characterisation of cells based on gene expression
microarray data. This new method uses a reduced dimensional approximation of the ex-
pression space with physiologically relevant coordinates to improve the interpretability of
the location of these cells in the expression space.
We compare the new method to three existing methods [10, 11, 81] for mRNA-based cell
characterisation that have been published recently and show that it outperforms all of these
methods in some way. In comparison to the `Concordia: Phenotypic concept enrichment'
method of Schmid et al. [11], we can show that our method has a significantly higher ac-
curacy of identifying the correct cell or tissue type. Furthermore, the Concordia method is
only described for a single microarray platform, whereas we show that our method can be
used across different microarray platforms. A further advantage of our method lies in the
above mentioned ability of dimension reduction based methods to characterise cells that
match only partially to a pure tissue, being able to quantify and interpret the differences
in terms of a direction with a phenotypical meaning. This ability is especially important
for the characterisation of in vitro differentiated cells that differ from any in vivo tissue.
In contrast, the method of Schmid et al. provides only a similarity score for each tissue
type, having the associated disadvantages of distance based approaches.
The `Unknown RNA sample annotation' (URSA) method of Lee et al. [10] is applicable
across platforms and can even be used to characterise RNA sequencing data. Furthermore,
it delivers more specific results than the Concordia tool. However, the URSA tool is also
a multi-class classifier that has problems to characterise mixture samples or in vitro differ-
entiated cells that differ from the tissues in the training dataset. Thus, it is not possible,
for instance, to draw appropriate conclusions about the direction of differentiation in time
series experiments or to evaluate the grade of differentiation.
Finally the `CellNet' method of Cahan et al. [81] is well suited for the characterisation
of in vitro differentiated cells. However, it requires relatively large amounts of training
data per tissue type and is therefore currently restricted to a relatively small amount of
tissues. Furthermore, it is retrained for every microarray platform, making it necessary to
have such abundant datasets available for each of the platforms. In contrast, our method
can cope with a relatively small amount of training data per tissue and can be transferred
to other microarray platforms. Therefore, it incorporates many more different tissues and
can also distinguish between subgroups, e.g. between different regions of the brain.
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A workflow for the combination of unsupervised and supervised dimension reduction
techniques
The second contribution of the thesis is the development of a workflow (Fig. 1.2) for the
combination of supervised and unsupervised dimension reduction techniques that combines
the benefits of both individual approaches and that may be of advantage as a general
workflow for other applications as well.
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Figure 1.2.: Workflow of the two-scale map generation and mapping procedure. A large
retrospective microarray dataset incorporating many different tissues and cell
lines is first explored by an unsupervised dimension reduction technique, here
principal components analysis (PCA). The first 3 principal components (PCs)
build the 3-dimensional PCA space. Afterwards, the residual matrix of this
dataset is calculated and used for the supervised dimension reduction using a
fold-change based criterion on each annotated tissue or cell type. New data,
e.g. from in vitro transformed cells, can be mapped to these two spaces by
first mapping the original data to the PCA space, calculation of the residual
matrix, and subsequent mapping to the residual tissue specific space.
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So far, dimension reduction techniques applied to gene expression microarray data were
either purely unsupervised [12], or purely supervised as is the case for the PhysioSpace
method which we developed [72]. The unsupervised PCA based method of Lukk et al.
[12] is not able to find all biologically relevant directions and does not provide biologically
meaningful interpretation for most principal components (except of the first three).
Our own purely supervised method [72] is better in this respect, but suffers a bit from the
shared processes, e.g. proliferation, that lead to high correlations between several different
tissues.
The combined approach developed in this thesis applies unsupervised and supervised di-
mension reduction in a subsequent manner. The unsupervised PCA based dimension re-
duction is applied first, covering mainly shared processes. The supervised methodology
is subsequently applied to the residuals of the PCA, capturing mainly tissue specific in-
formation. Thus, the challenges of the purely supervised method to cope with shared
processes between different tissues were significantly reduced by the PCA based decom-
position, making it possible to dissect general processes that are shared by several tissues
and more tissue specific expression patterns.
Such a two-scale approach may be beneficial for other applications as well. One potential
application is the analysis of disease progression that involves changes in mixture frac-
tions of different cells as well as changes in the gene expression in single cell types. This
combination of two effects could be observed for disease progression in leukaemia [82].
A complementary quality control criterium for in vitro transformed cells
The third contribution is more focused on the biological aspects of the thesis. We describe
and discuss several existing methods for the quality control of in vitro transformed cells and
show that our global gene expression based method can give complementary information
to the commonly used methods. Specific molecular markers or functional assays alone
provide often only relatively narrow information about a specific aspect of the cellular
state, whereas our global comparison provides a broader view. Therefore, it is important
to combine the complementary broad scale and the more detailed information in order
to decide about the quality of the cells. We show examples where the success of the
transformation process is seemingly validated by individual markers in the respective study,
whereas our method hints towards an incomplete transformation of the cells.
Furthermore, due to the general challenge of defining what we mean by a cell type, and
what we mean by good quality, we point out that it is important to interpret the various
quality criteria in an application-specific way. In order to do this, it is very important to
understand how observed differences to the desired cell type can be interpreted and whether
they affect the intended application of the generated cells. The two-scale landscape can
provide an interpretation of observed differences due to the use of reduced dimensional
spaces with directional information that are linked to phenotypes. In contrast, other global
gene expression based methods focus often on a pure comparison of similarity to specific
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cell types or tissues without proper directional information of observed differences.
1.5. Content and structure of the thesis
Chapter 2 of the present thesis focuses on the classification of cells into different types.
It starts with a general introduction of commonly used measurement techniques for the
characterisation of cells. It then focuses on the characterisation of pluripotent stem cells,
discussing and comparing the properties of different methods and pointing out some in-
consistencies that open the question on how cell types can be defined in general. This
question is then discussed from a more theoretical point of view and the concept of cell
types as attractors of dynamical systems is described.
One way to use this concept in a practical setting is to localise cells in the gene expression
space. Therefore, the next section of chapter 2 introduces gene expression microarrays,
which can be used to measure the gene expression of cells on a transcriptome-wide basis.
The specific focus of this section is on the quantitative relationship between the RNA
content and the observed measurement signal, combined with some information about
measurement noise. These information will be important for later parts of the thesis, es-
pecially for the comparison of linear and non-linear mapping methods in chapter 4.
The last part of chapter 2 introduces three existing methods for the RNA based charac-
terisation of cells. These methods will be used in chapter 4 for a comparison to our newly
developed method.
In chapter 3 we focus on the dimension reduction of the high dimensional gene expression
space. To this end, existing approaches for unsupervised and supervised dimension reduc-
tion and especially their application to large gene expression datasets are described. The
strengths and weaknesses of these methods are discussed, using an illustrative statistical
model to clarify the described effects.
After that, the development of the two-scale gene expression map, combining unsupervised
and supervised dimension reduction techniques is described. In order to evaluate the in-
formation content in the low dimensional PCA space and the residual complement, we use
an information ratio criterion [83] that measures the amount of relevant information that
is not captured by the first three principal components.
The mapping of new data onto the two-scale map is described in chapter 4. First, two
different mapping procedures, a linear and a non-linear mapping, as well as the approach
used for cross-platform analyses are described. These procedures are then used to map
various tissues as well as artificial mixtures of different tissues onto the two-scale map for
validation purposes. These data are used to compare the linear and non-linear mapping
as well as to compare the newly developed two-scale map to existing approaches as well as
to a direct supervised dimension reduction approach.
After the validation of the new method, it is applied to the analysis of various human in
vitro transformed cells, namely iPSC derived mesenchymal stromal cells, cardiomyocytes,
neurons, neural stem cells and astrocytes, as well as neural progenitor derived astrocytes
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and neural stem cells that were directly converted from astrocytes.
In chapter 5 we discuss the general idea of using a multi-scale decomposition approach
for the analysis of gene expression microarray data, i.e. to extend the presented two-scale
approach to further scales. Furthermore, we discuss the complementarity of the quality in-
formation that can be received by the two-scale landscape in comparison to commonly used
approaches and propose to combine these information in an application-specific manner to
decide about the quality of the generated cells. Finally, we comment on the relevance of
the presented workflow for other applications in the biomedical area.
Chapter 6 concludes the thesis with a summary of the main insights.
Finally, we present more detailed information on the analysed datasets and utilised software
packages as well as some methodological details in the supplement along with additional
figures and tables supporting the presented results.
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2. Classifying cells into different types
using high-dimensional gene expression
data
The usual goal of in vitro reprogramming or differentiation experiments is the generation
of cells representing a specific cell type, e.g. pluripotent stem cells, neurons or cardiomy-
ocytes. An essential requirement in this context is the assessment of the adopted cell type,
i.e. the proper characterisation of the cells.
In standard biological literature, cells are often assigned to a specific cell type based on
functional assays, marker expression, morphological information or the cellular history
[84]. These possibilities of cell type determination are briefly introduced and discussed
in the first part of this chapter, focussing on the example of characterising pluripotent
stem cells. Assessment of pluripotency is a rather well suited classification problem, due
to its clear functional definition, i.e. the potential to differentiate into derivatives of all
three embryonic germ layers, that can be directly tested by appropriate functional assays.
These functional assays are, however, usually costly, time consuming or critical from an
ethical point of view. Therefore, they are often replaced by surrogate markers that are less
expensive and less critical.
Despite the rather well defined functional definition of pluripotency, researchers often dis-
tinguish between different types of pluripotent stem cells, e.g. depending on the origin
of the cells. While all of these cells are pluripotent, it is not clear whether they differ in
some other properties, e.g. their differentiation efficiency or their tumourigenic potential,
making one cell type more appropriate for specific applications than another.
Thus, despite the joint characteristic of being pluripotent, the cells are not necessarily
equivalent with regard to all their properties. This problem of testing cells for their phe-
notypical equivalence is even more complicated for in vitro differentiated cells compared
to their in vivo counterparts. It motivates the topic of the second part of this chapter,
discussing the question on how a cell type can be defined in a consistent and rigorous
way [85, 86]. This rather theoretical question is not easy to answer. In contrast to e.g.
chemical elements, which can be classified according to their number of protons, cells are
living organisms and there does not seem to exist any essential property that can be used
to classify them in a similar way as the chemical elements [86]. Therefore, the cell type
as attractor concept was introduced [67, 87], which is based on modelling the cell as a
dynamical system.
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Classifying cells based on this concept requires high-throughput measurements such as
gene expression microarrays in order to locate the cells in the high dimensional expression
space. Therefore, we describe the microarray technology in the third part of this chapter.
The focus of this description is on the quantitative relationship between mRNA content
and measurement signal, as well as on the measurement noise. These quantitative proper-
ties are important to consider when models for mRNA-microarray based characterisation
of cells are developed and evaluated.
Three existing models for mRNA based characterisation of cells are introduced in the last
part of this chapter. These models use different methods to reach this aim and have also
quite different characteristics. Two of them are not well suited for the analysis of cells that
fit only partially to an existing cell type, while the third one is limited to a relatively small
amount of different tissues since it requires relatively large amounts of data from each cell
type for the training of the classifiers.
2.1. Assays for the characterisation of in vitro transformed
cells
The discovery of different cell types evolved stepwise during the history of biological re-
search. More and more subtle differences were detected, leading to the definition of various
subtypes, such as the various types of neural cells, ending up with some hundreds of dif-
ferent cell types in the human body that are known to date [15].
Most of these cell types were defined based on specific properties of the cells in the human
body, i.e. in vivo. For example, cardiomyocytes are myocytes that are located in the heart
and motor-, sensory-, and interneurons are distinguished based on their connection to mus-
cles, sensory organs, or other neurons, respectively. When put into culture these cells were
usually still considered to be of the same type as before. While this strategy may be useful
in case of a pure culturing of cells without the intention of changing the cell type, the cel-
lular origin cannot be used to classify in vitro transformed cells anymore. These cells must
therefore be characterised based on molecular, functional, or morphological characteristics
rather than their in vivo origin.
2.1.1. Overview of commonly applied assay types
There is a large variety of different measurement techniques available to characterise cells.
Three main classes of techniques are briefly introduced here, having different strengths
and weaknesses and complementing each other in terms of spatial resolution, molecular
information content, and direct assessment of phenotypic information.
Imaging and immunohistochemistry
The cellular morphology and expression of specific markers that can be stained using
antibodies (immunohistochemical analysis) are frequently used in histological analyses of
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tissue biopsies. Due to their spatial resolution, these methods are very useful for the
analysis of tissues that are mixtures of different cell types. These imaging based methods
can also be used for the analysis of cultured cells and in vitro transformed cells. They are
especially useful for a fast and cheap initial analysis of the cells and are well suited for
automation purposes since they only need liquid handling and microscopy facilities.
One drawback of imaging based methods is the subjectivity due to the usually applied
manual evaluation without proper quantification. This challenge is, however, currently
tackled by image processing approaches trying to create more objective criteria for image
based cell classification [88].
More fundamental disadvantages of these methods concern the information content that
is restricted to morphological information, being hard to directly associate with specific
functionalities or cellular behaviours, or to the expression of individual genes or proteins,
neglecting information about the other molecules that are necessary for a systems-wide
characterisation of the cells.
High-throughput omics measurements
The latter disadvantage is resolved by the use of high-throughput measurement techniques,
which determine the amount of e.g. RNA or proteins on a systems wide level, i.e. they
measure the amounts of ten thousands different genes, proteins, or other molecules simul-
taneously. Furthermore, these measurements are quantitative and usually comparably well
standardised. The quality of different measurement techniques varies, but it is often con-
siderably higher than initially anticipated [89] and initial artefacts and quality issues are
resolved by specific preprocessing and normalisation methods.
One disadvantage of high-throughput measurements are the relatively high costs, com-
pared to imaging or staining techniques. However the costs are rapidly decreasing due to
technical improvements, especially in sequencing methodologies [90].
A further disadvantage is the missing spatial resolution, as well as the measurement of
a pool of thousands of cells, which may consist of an unknown mixture of different cell
types. The latter issue is currently tackled by single cell sequencing technologies [91],
which will probably provide new interesting insights in future studies. Alternatively, de-
convolution approaches can be used to computationally dissect the measured signals into
parts corresponding to specific cell types [92, 93].
Functional assays
Despite the high diversity of functional assays, making it hard to generalise the advantages
and disadvantages of these measurement techniques, some common features can be stated.
Functional assays can provide phenotypical information that, in some cases, directly test
the defining properties of specific cell types, e.g. the pluripotent differentiation potential
of pluripotent stem cells. This is a very valuable information that can be used as gold
standard for the assessment of the corresponding cell type.
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Common disadvantages of functional assays compared to the omics and imaging techniques
are the relatively narrow information content, which is focused on a single functionality,
and often a missing spatial or single cell resolution. Furthermore, some functional assays
are very cost and time intensive as exemplified by the pluripotency assays introduced in
the next section.
2.1.2. Pluripotency assays
Many different assays have been developed to test cells for their pluripotent differentiation
potential, including imaging, molecular and high-throughput based as well as functional
assays. Due to the functional definition of pluripotency, i.e. the ability of a cell to differ-
entiate into derivatives of all three embryonic germ layers, functional assays are a natural
choice for this task. However, due to ethical limitations, high costs, and long durations
of some functional assays, surrogate markers have been developed that have beneficial
properties in these regards (Figure 2.1). The most prominent assays are introduced and
discussed in the following.
Teratoma 
assay 
Immuno-
fluorescence / 
qRT-PCR 
Genexpression 
Microarray 
DNA-Methylation 
(few CpG sites) 
http://www.microarrays.ca/services/Affymetrix_Pric
alpstemcell.chmcres.cchmc.org/files/admin/contrib
 
Embryoid body 
formation + 
analysis 
Costs  
Duration 
Colony 
morphology 
1 hour 
1 day 
1 week 
1 month 
1€ 10€ 100€ 1000€ 
high 
medium 
low 
Reliability: 
1 year 
Figure 2.1.: The choice of specific iPSC characterisation assays is a trade-off between the
cost and duration on one hand and the reliability on the other hand. Several
assays are evaluated here based on approximate values for their costs and
durations [94, 95, 96], as well as a rough rating of their reliability [70, 96, 97].
Exact values of costs and durations depend on the service provider and the
concrete realisation of the assays. The scaling and the tick marks on the
ordinate are therefore rather indicative than mathematically meaningful.
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Tetraploid complementation and chimera assays
The tetraploid complementation assay as well as the chimera assay are regarded as gold
standards for pluripotency assessment in mice. In these tests, pluripotent stem cells are in-
jected into the blastocyst of either a tetraploid embryo, for the tetraploid complementation
assay, or a genetically different embryo with normal chromosome number, for the chimera
assay [98, 99]. In the first case, the tetraploid cells do not contribute to formation of the
mouse fetus, but form the extra-embryonic tissue. Therefore, the whole developing mouse,
if it develops, originates from the injected pluripotent stem cells. This is only possible
if the injected cells were truly pluripotent, and is therefore a very stringent pluripotency
assay.
The chimera assay tests whether the developing mouse consists of a mixture of the two
genetically different cells, i.e. the cells from the initial embryo and the injected pluripon-
tent stem cells. Thus, the injected cells do not have to form the whole mouse, as in the
tetraploid complementation assay, but must still contribute to the formation of tissues
from all three embryonic germ layers to fulfil the criteria of this pluripotency assay.
These two stringent pluripotency assays can not be used to test the potency of human
cells, due to ethical reasons. Therefore, another functional assay, the teratoma assay, is
currently considered as gold standard for pluripotency assessment in human cells.
Teratoma assay
In the teratoma assay, pluripotent stem cells are injected into immunodeficient mice, so
called SCID (severe combined immunodeficiency) mice [96, 6]. After several weeks of in
vivo growth (4 to 15 weeks, depending on the protocol in use [100]) it is checked whether
a benign tumour, consisting of tissues from all three embryonic germ layers, has formed,
validating the pluripotency of the injected cells. Thus, the teratoma assay tests, whether
the injected cells can form tissues of all three germ layers in an in vivo environment, but it
does not check whether the cells can contribute to the development of a full living animal.
Criticism about the teratoma assay includes animal welfare as well as ethical concerns
[6]. Furthermore, the teratoma assay is relatively cost and time intensive (Figure 2.1) and
lacks a proper standardisation [6, 100], although first attempts to standardise the assay
have recently been published [101].
Taking these criticisms and the available alternatives (see below) into account, it is not
recommended to use the teratoma assay as a standard for a pure testing of pluripotency
anymore. However, one may use the teratoma assay for other purposes, especially for
studying the tumourigenic potential of pluripotent cells [6].
Embryoid body formation
An alternative functional assay for pluripotency evaluation is the embryoid body (EB)
assay, which is based on an in vitro stochastic differentiation into cells of all three em-
bryonic germ layers [102]. This assay has many advantages compared to the teratoma
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assay, since it does not use animals, it is cheaper, usually faster and easier to standardise
[102]. Furthermore, EB formation can be used to extract dynamical information of early
differentiation events, which are not accessible from teratomas since the latter are only
evaluated at a single endpoint [6].
The main disadvantage of the EB assay is the in vitro culture environment, which may be
inappropriate for tests of the tumourigenic potential of the studied cells. There may be
many different stimuli or interactions that promote cells to develop a malignant phenotype
and the relevant conditions, whatever they are, may be better represented in an in vivo
mouse model than in vitro. However, it is also not clear how good mouse models represent
the relevant conditions in a human and how reliably results can be transferred between
both species [103].
Molecular markers
Molecular markers can be used as surrogates to the functional assays, and do not directly
test the definition, i.e. the differentiation capacity, of pluripotent stem cells. Therefore,
they need to be validated rigorously with relatively large amounts of cells.
Many different molecular markers have been proposed to characterise pluripotent stem
cells, including the surface markers TRA-1-60 and TRA-1-81 as well as SSEA3 and SSEA4
[104]. Furthermore, several nuclear markers are commonly used to test cells for their
pluripotency, including OCT4 (the corresponding gene is called POU5F1), NANOG, SOX2,
and several others [104]. Many of these markers are, however, not entirely specific to ESCs
and iPSCs, but are also expressed by some cancer stem cells [104]. Apart from that,
systematic evaluations of several pluripotency markers during early differentiating events
indicate differences in the expression dynamics [97].
In an other study, fully reprogrammed cells (SSEA4, TRA1-60, and NANOG positive) were
distinguished from partially reprogrammed cells (SSEA4 positive, TRA1-60 negative, low
expression of NANOG) based on typical pluripotency markers, but established lineages of
both cell types were able to form teratomas [105]. Furthermore, in the same study, TRA1-
60 positive and SSEA4 negative cells occurred during reprogramming. Unfortunately, these
cells could not be established as a cell line in order to check for teratoma formation.
Interestingly, the results of this study are sometimes used to question the gold standard
of the teratoma assay [102, 106]. This is a reasonable debate, since it seems to be clear
that the established partially reprogrammed cells from [105] differ from well known ESCs
in the expression of important pluripotency markers. On the other hand, the established
partially reprogrammed cell line seemed to be able to form tissues derived from all three
embryonic germ layers. Thus, the argumentation on one or the other side depends on
how we define pluripotent stem cells. They can be either defined based on the functional
property, having a pluripotent differentiation capacity, or based on the similarity to the
pluripotent cells in the inner cell mass of the blastocyst.
Summarising the aforementioned results on molecular pluripotency markers, it can be
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stated that most of these markers can nicely distinguish between pluripotent stem cells
and somatic cells (Figure 2.2, right graphic), while there are some conflicting results with
respect to partially reprogrammed cells and some cancer cells. Therefore, it is still un-
der discussion which marker, or which combination of markers is most accurate for the
characterisation of pluripotent stem cells.
Gene expression microarrays - PluriTest
The so called `PluriTest' is a bioinformatics assay that uses two whole genome based gene
expression scores, termed pluripotency score and novelty score, to distinguish pluripotent
stem cells from other cells [70, 107]. PluriTest was trained on a large set of well char-
acterised gene expression microarray data from the Illumina Human HT12 v3 platform
involving 264 pluripotent stem cells (223 ESCs and 41 iPSCs) and 204 somatic cells or
tissues [70, 108]. It uses non-negative matrix factorisation (NMF) [109, 110] for the identi-
fication of pluripotency modules that are the basis of the pluripotency score. The novelty
score is determined as the distance of a sample to a NMF-based convex hull approximation
of the typical pluripotent stem cell location in the high-dimensional gene expression space.
Thus, a high pluripotency score can be regarded as being indicative for the pluripotent
differentiation potential of the analysed cells, while a low novelty score rather indicates
high transcriptomic similarity to the ESCs and iPSCs from the training data.
Therefore, the novelty score is especially useful to detect pluripotent stem cells with ab-
normal or novel (i.e. not present in the training data) transcription patterns. It could be
shown that it is capable of distinguishing germ cell tumors and parthenogenic pluripotent
stem cells from ESCs and iPSCs [70]. This can usually not be accomplished with the single
gene molecular markers that were introduced before (Figure 2.2).
Initially, PluriTest was only developed for one specific microarray platform, the Illu-
mina Human HT12 v3 platform, for which it is available as an online tool (http://www.
pluritest.org/). However, it could be shown that PluriTest can also be used with other
arrays and to some extend also for mouse cells by ortholog probe matching, when an ap-
propriate reference dataset is available [70, 111, 112]. The reference dataset is needed to
define new cutoff values for the pluripotency and novelty score, since the absolute values
of these scores change for different platforms.
Interestingly, while it can be expected that the performance for other platforms is slightly
worse, the PluriTest assay seems still to be capable of distinguishing embryonic carcinoma
(EC) cells from iPSCs and ESCs when it is projected to the Affymetrix Human U133 Plus
2.0 microarray platform (Figure 2.2, left graphic), maintaining its beneficial properties
compared to standard single gene pluripotency markers (Figure 2.2, right graphic). Fur-
thermore, karyotypic abnormal ESCs from the same platform show an increased novelty
score compared to karyotypic normal ESCs.
In summary, PluriTest is a reliable alternative to functional pluripotency assays that is
well standardised, comparably cheap and fast (Figure 2.1), and avoids any kind of animal
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experiments.
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Figure 2.2.: The PluriTest assay (projection to the Affymetrix Human U133 Plus 2.0 ar-
ray) can distinguish between ESC and embryonic carcinoma (EC) cells and
shows an increased novelty score for karyotypic abnormal ESCs (left), whereas
typical pluripotency markers show no clear trend (right). Compared are ESCs
with normal karyotype at passage 11 (green filled dots), ESCs with a simple
karyotypic duplication at passage 53 (black filled dots), ESCs with complex
karyotypic changes at passage 172 (blue filled dots), and EC cells (red filled
dots) retrieved from the Gene Expression Omnibus database (accession num-
ber GSE7234). The red and blue background colours represent a reference
dataset of 368 pluripotent (red) and 1607 somatic (blue) samples smoothed
with a kernel density estimator. Box plots on the top and right side of the
left figure show the corresponding marginal distributions of the novelty score
and pluripotency score. The same colour codes and reference data are used
for the right graphic, showing the log2-expression value of three pluripotency
markers (Nanog, Oct4, and Sox2). The relative large overlap of pluripotent
and somatic samples for Sox2 is mainly due to its high expression in neural
cells.
DNA-Methylation
Another way to assess the pluripotency of cells is through the analysis of epigenetic DNA
modifications. Especially the DNA methylation status of pluripotent stem cells has been
compared to that of several other cell types in various studies [113, 114, 115]. These studies,
however, did not propose a certain marker for evaluation of pluripotency. This has recently
be done by us [116], by a detection of only three CpG sites that are well suited to classify
cells into pluripotent and non-pluripotent. This methylation based evaluation does not
provide the possibility to dissect abnormal pluripotent cells, e.g. EC cells, from normal
pluripotent stem cells, as can be done using PluriTest. However, it represents a cheap and
fast alternative for pluripotency evaluation that is well standardised in contrast to most
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immunofluorescence or qRT-PCR measurements of single marker genes or proteins.
Morphology
Pluripotent stem cells are usually round and small and tend to grow in densely packed
colonies with smooth borders. These morphological characteristics distinguish them from
many other cells, including fibroblasts, which are often used as a source for reprogram-
ming experiments. Therefore, a cheap and fast possibility to get a first impression of the
reprogramming success is phase contrast microscopy (Figure 2.1). However, so far, the
morphological characterisation is rather subjective and neither quantitative nor standard-
ised, and there are only few first attempts to develop quantitative morphological markers
[88]. Furthermore, some partially reprogrammed cells were qualitatively described to have
morphological characteristics that are similar to fully reprogrammed cells. Therefore, it
remains to be evaluated by systematic comparisons how reliably pluripotent stem cells can
be characterised based on morphological criteria. An important first step in this direction
would certainly be a storage of microscopy images in public databases similar to the es-
tablished databases for omics measurements and an evaluation of the preprocessing and
standardisation needs to make images from different microscopes comparable.
2.1.3. Conflicting evidence - comparing EC, ES, and iPS cells
For the characterisation of in vitro transformed cells, it is important to check whether the
generated cells represent the corresponding in vivo cell type in a sufficient manner. In
order to achieve this goal, it would be very helpful to have (in vitro) testable definitions of
cell types that are fully based on the current molecular or phenotypical state of the cells
rather than their history of derivation. This is the case for the definition of pluripotent
stem cells and several assays for pluripotency evaluation were introduced in the previous
section that test the defining property of pluripotent stem cells in a direct or indirect man-
ner. Nevertheless, some differences between some pluripotent stem cells were observed,
e.g. in the expression of certain markers. Furthermore, some pluripotent stem cells are
commonly distinguished based on their origin. ESCs are derived from the preimplantation
or periimplantation embryo [1], EC cells can be isolated from teratocarcinomas [43], and
iPSCs can be reprogrammed from various somatic cells by ectopic expression of usually
four transcription factors [3].
Despite the different origins of these cells, they all express typical pluripotency markers
and it could even be shown for all three of them that they are able to form chimeras or
whole mice by the tetraploid complementation assay [98, 117, 118, 119]. Thus, they fulfil
stringent pluripotency criteria and can thus be considered as pluripotent stem cells.
Taking this result alone, one may argue that EC, ES, and iPS cells should be considered
as equivalent cell types. However, EC cells are derived from malignant and life threatening
germ cell tumors, while ESCs are derived from the embryo and are thus tightly connected
to the formation of new life without a malignant phenotype. Furthermore, EC cells usu-
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ally have chromosomal abnormalities and tend to form malignant teratocarcinomas, while
ESCs usually have a normal karyotype and tend to form benign teratomas when injected
into immunodeficient mice [43, 6, 117, 120, 121]. Yet, there are also reports of ESCs or
ESC derived progenitor cells that form malignant teratocarcinomas [122, 123].
Thus, a pure distinction based on the original location in vivo is problematic. This seems to
be particularly relevant when cells are maintained in vitro for a long time, since prolonged
culturing of ESCs can introduce genomic modifications that are typical for EC cells, leading
to teratocarcinoma formation in immunodeficient mice [43]. However, genomic modifica-
tions can occur frequently and it is not clear which modifications are responsible for a
malignant transformation, and whether the transformation can be explained by genomic
changes alone [123, 124].
The tumourigenic potential is also a major concern for iPSCs, since they can have addi-
tional genomic abnormalities due to mutations in the somatic cells that are used as source
for the reprogramming or due to genomic integrations during the reprogramming process
[124]. Furthermore, single mutated cells, e.g. with a TP53 mutation, may have a selective
advantage during the reprogramming process [125].
In addition, there are many discussions about the similarity or dissimilarity of ESCs and
iPSCs [126]. Newly derived iPSCs with low passage numbers seem to have some epigenetic
memory of the cells that were used as a source for the reprogramming, while this memory
diminishes during prolonged culturing [111, 127]. Furthermore, it is speculated that there
are different steps of reprogramming which are only partially passed by some iPSCs [126],
leading to some variation between different iPS cell lines. However, not only iPSCs, but
also ESCs show considerable variation in their gene expression, epigenetic status as well as
their differentiation propensity [128]. Therefore, one might even ask the question whether
different ES cell lines can be regarded as equivalent.
In summary, conflicting evidence of EC, ES, and iPS cell similarity together with con-
siderable variations between different EC, ES, or iPS cell lines pose the question on how
a cell type can defined in a rigorous way, such that all cells of a specific type have well
defined common properties. This question will be the topic of the next section, showing
that there are many complications that challenge current approaches for defining cell types
in an absolute way.
2.2. The challenge of defining cell types in a rigorous way
Pluripotent stem cells are relatively well defined via their pluripotent differentiation poten-
tial and the ability for prolonged undifferentiated proliferation. Nevertheless, the differen-
tiation efficiency towards various tissues as well as several other properties differ between
different pluripotent stem cells, as indicated in the previous section. Similar problems ap-
ply also for various somatic cell types. Furthermore, many cell types lack a clear testable
definition as it is present for the pluripotent stem cells. Finally, assessing the cell type of
cultured cells is challenged through observations that cultured cells and especially in vitro
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transformed cells have some significantly different properties than their in vivo counter-
parts [12, 5]. Therefore, it is recognised [86] that the question on how to define a cell type
should be tackled in a more systematic way.
2.2.1. The essentialism approach
This question has been recently addressed by Slater [86] who prefers the term "cellular
kind" instead of "cell type". He indicates that there seems to be no essential property
that can be used to define cell types. An essential property in this context is an "intrinsic
property" that is "possessed by all and only the members of a kind", and that explains
"why members of the kind have a series of superficial properties more or less in common"
[86]. A typical example of such an essential property, in a different context, is the number
of protons defining a chemical element. This is an intrinsic property fulfilling the above
criteria, which naturally classifies atoms into a discrete set of different types, while it still
allows differences between two instances of the same kind, e.g. in the number of neutrons
of 12C and 13C atoms. Nevertheless, atoms of one kind have several properties in common
and this can be explained through an intrinsic property, the number of protons, that is
very stable with respect to environmental changes of the atoms.
In the case of cell types, there seems to be no such essential property. While in earlier times,
it was thought that cells selectively loose specific genes during differentiation, suggesting
that the DNA content may be such an essential property [86, 129], we now know that this
does not happen. In fact, for most cell types of an individual, except e.g. mature red blood
cells that do not have a nucleus, the DNA content seems to be the same. Furthermore,
the method of somatic cell nuclear transfer, i.e. the fusion of an enucleated egg cell with a
nucleus from a somatic cell, indicates that no nuclear properties can be regarded as essential
properties, since the fused cells eventually become pluripotent, rather than becoming the
cell type of the somatic cell from which the nucleus was taken [130, 131]. Instead, the
distinction into different cell types may be due to differences in the gene expression, i.e. in
the mRNA and protein content of the cell.
However, using the mRNA or protein content as essential property is problematic as well.
This is due to the fact that cells live, and are therefore not at thermodynamic equilibrium.
The mRNA and proteins are constantly degraded and newly expressed, making the cellular
state dependent on a constant supply from the environment. Furthermore, dynamical
changes such as the cell cycle take place, leading to a dynamic alteration of the mRNA
and protein content, making these properties inappropriate for the essentialism approach
(see [86] for more details).
So, rather than searching for an essential property to define cell types, it may be more
appropriate to account for the dynamic changes and the non-equilibrium state in which
cells live. This is possible through an interpretation of a cell as a dynamical system, with
cell types being (possibly complex) attractor states [67, 87, 132, 133], which is explained
in the following.
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2.2.2. Cell types as attractor states - a dynamical systems view
In the dynamical systems view, the molecular state of a cell is described by a high dimen-
sional state vector, corresponding e.g. to the mRNA content of the cell, where a single
component of the vector corresponds to a single gene. The space spanned by all possible
configurations of this vector is called the state space and a cell is represented by a point
in that state space. Thus, in the case of gene expression data, the state space is approx-
imately 20,000 dimensional, where each dimension specifies the expression status of one
gene.
The possible states that a cell can adopt are restricted due to interactions between different
molecular components of a cell as represented for instance by gene regulatory networks,
imposing certain constraints on the set of possible states. These regulatory networks also
define possible dynamic changes of the molecular state. These dynamic changes can, in
principle, be described by a dynamical model, e.g. a set of differential equations. Ac-
cording to these equations, the cell moves in a coordinated way through the state space,
eventually approaching an attractor state, where it resides. Such an attractor state can be
either a fixed point or, accounting for the cell cycle and other dynamic changes, a dynamic
attractor such as a limit cycle or strange attractor [133, 134].
Many dynamical systems have multiple attractors that are approached depending on the
initial position of the cell in the state space. The set of all initial positions from which
a cell will approach a certain attractor is called the `basin of attraction'. Intuitively, this
can be visualised as an energy-like landscape (sometimes called attractor landscape) with
stationary attractors as local minima [133, 135]. However, this visualisation may be a bit
misleading since the cell lives at a non-equilibrium state and minima in an energy-landscape
usually correspond to equilibrium states.
In the cell type as attractor concept, each attractor in the high dimensional state space
corresponds to a cell type, meaning that a cell that lies in the basin of attraction of one
specific attractor is considered as being of the type that corresponds to this attractor. This
concept leads naturally to a distinction into a certain number of cell types, where all cells
of that type have certain common properties as long as they are not too much disturbed,
i.e. pushed away from the attractor. These properties may change over time, in case of a
dynamic attractor, but will recur after a certain time.
Defining cell types as attractors of a dynamical system is an interesting concept from a
theoretical point of view and there are also some confirmations of the theory from simu-
lations as well as wet lab experiments. Indeed, experimental results show that cells that
are perturbed by different stimuli can eventually approach the same molecular state, in-
dicating that this molecular state may be considered as an attractor state [87]. Another
example is the reprogramming into induced pluripotent stem cells, which can be performed
with different sets of induced transcription factors [136], leading (more or less) to the same
final state. This final state can therefore also be considered as an attractor state. Fur-
thermore, simulations of large random transcriptional networks with boolean approaches
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indicate that the number of cell types in humans corresponds well to the number of ob-
served attractor states in the simulation [67], assuming constant environmental conditions
and model parameters. This makes the cell type as attractor concept plausible.
Thus, there is some experimental evidence for the cell type as attractor concept and the
theoretical implications of this concept are far reaching, including changes in the under-
standing of cancer initiation and progression [134, 137]. However, the concrete implemen-
tation of this concept in terms of a system of differential equations is currently not possible
due to the restricted knowledge of the complicated biological mechanisms. Thus, it is ei-
ther possible to restrict the dynamic analysis to a reasonable subsystem [138, 139], or to
concentrate on specific aspects of the dynamical systems concept.
Therefore, the focus of current research is more on the qualitative description of the at-
tractor landscape. This is done in such a way that the intuitive understanding of the
landscape matches to the observed experimental phenomena. One example is the usually
very low efficacy of the reprogramming to iPSC, which suggests some stochasticity in the
reprogramming process [140]. This rare event of reprogramming may be explained by high
energy barriers in the attractor landscape [141]. Interestingly, it has been reported in a
recent study that this high barrier can be significantly reduced, leading almost to 100%
efficacy of the reprogramming process [142].
Another qualitative behaviour of cells that needs to be explained by a valid theory is the
pluripotency or multipotency of stem cells as opposed to unipotent cells. That means that
the qualitative difference, in terms of the attractor landscape, of the different types of
cells having different potentials to differentiate spontaneously into other cell types has to
be explained. One possible answer would be that stem cells do not lie in a basin of the
attractor landscape, but rather on a saddle point, i.e. a non-stable fix point. However,
this can not explain the potential to maintain pluripotent stem cells for long durations in
culture. Therefore, it is more likely that there is a small local basin on this saddle point,
similar to a mountain lake on the top of a mountain [141].
Another experimental observation that challenges the qualitative understanding of the at-
tractor landscapes is the following interesting behaviour of cell populations that have a
certain heterogeneity with respect to some markers. It was reported that in cultures of
mouse haematopoietic progenitor cells, there are some spontaneous outlier cells with an
extremely high or an extremely low amount of a certain marker protein [143]. Interest-
ingly, when these outlier cells were sorted and cultured separately, the complete evolving
population reconstituted the original population of the system before sorting. This would
indicate that the cells lie in an attractor and are stochastically pushed to some border
from which they return eventually. However, what was a bit surprising is the long time,
i.e. more than one week, these cells needed to relax to the original population [143]. There-
fore, this observation may indicate that there are local sub-attractors within a larger basin
of attraction that lead to a slower recurrence of the disturbed cells[141].
These qualitative refinements of the attractor landscape will probably continue in future
research, incorporating e.g. descriptions about the effects of changes in the environment or
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mutations in the DNA [134]. For the aim of this thesis, mainly the concept of considering
a cell as a point in the high-dimensional gene expression space and a cell type as a specific
region in this space will be utilised, trying to characterise cells based on their location in
this space. For this purpose, we need some measurements of whole genome gene expression,
e.g. gene expression microarrays, which will be introduced in the following.
2.3. Gene expression microarray data
Gene expression microarrays can measure the expression of thousands of genes simultane-
ously. Roughly 20 years ago [144], this initiated a revolution in molecular biology, allowing
to study not only a handful of genes but to look at systems-wide gene expression. Since
then, the number of publicly available microarray data experienced a rapid increase [53]
and the knowledge about the reliability of microarray data [89], common causes and dis-
tributions of measurement errors [145], differences between microarray platforms [146], as
well as appropriate preprocessing strategies [147] has improved. This knowledge is im-
portant for the development of advanced analysis tools that fit well to the properties of
gene expression data. Therefore, a summary of the most relevant characteristics of the
microarray technology is given in the following.
2.3.1. General principles and platform differences
Generally, two types of microarrays are distinguished. Two-colour microarrays measure
the RNA content of two samples simultaneously, focusing on the differential expression
between these samples, while one-colour microarrays measure the expression of a single
sample, providing absolute intensity values [148]. This difference has some impact on
the preprocessing and the statistical design of the experiment. Especially, the integration
of heterogeneous data from different studies and various cell types is easier to manage
with one-colour microarrays, since two-colour microarrays may be hybridised with differ-
ent references across studies. This makes it easier to work with one-colour microarrays
in meta-analyses. Furthermore, it could be shown that the performance of one-colour mi-
croarrays for assessment of differential expression is similar to that of two-colour arrays
[149, 150]. Therefore, we focus on the analysis of the more commonly used single-colour
microarrays in this thesis.
The main steps of a microarray experiment, from RNA extraction to data preprocessing
and normalisation are summarised in Figure 2.3 [151]. These steps can be roughly divided
into three phases. The first phase concerns the sample preparation. It consists of RNA ex-
traction, purification, reverse transcription, amplification, and labelling. The second phase
focuses on the measurement itself, consisting of the hybridisation, washing, and scanning
of the array. The third phase finally deals with data preprocessing and normalisation. In
all of these steps, differences in the protocol, measurement or processing parameters as
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Figure 2.3.: Overview of core steps in a microar-
ray experiment. RNA is extracted
from roughly 105 to 106 cells, puri-
fied, reverse transcribed and labeled
with a fluorescent dye. Additionally,
there is often an amplification step,
which is not depicted in the figure.
The labeled cDNA is then put onto
the array, where it hybridises to com-
plementary oligonucleotide strands
and is thus separated into the differ-
ent genes that are located at differ-
ent spots on the array. Loosely bind-
ing cDNA is washed off from the ar-
ray to minimise cross-hybridisation
of non-specific cDNA. The amount of
RNA that is hybridised to each spot
is then indirectly measured via fluo-
rescence imaging and subsequent im-
age processing of the excited fluores-
cent dye. Subsequent preprocessing
and normalisation steps are finally
used to improve the comparability
between arrays and to remove mea-
surement artefacts. For two-colour
microarrays, a second RNA sample
from reference cells is simultaneously
prepared, labeled with a different
dye and hybridised together with the
first sample.
well as in manual processing can introduce technical noise to the data. This noise can be
tremendously reduced by a high standardisation of chip design, hybridisation, and data
processing protocols [152]. Such highly standardised arrays from commercial companies,
e.g. Affymetrix, Agilent, or Illumina, have only very low between-array variability [89] and
can therefore be reliably used for biological inference.
However, while arrays from one specific microarray platform can be directly compared,
arrays from different platforms are less comparable, sometimes hindering the direct com-
parison of data from two studies of interest. This is due to substantial differences in
absolute expression values between platforms that result from differences in the array de-
sign, as well as differences in hybridisation protocols and scanners, that overall clearly
exceed common batch effects [152]. Parts of the platform dependent differences can be
explained by differences in the lengths and exact sequences of the probes that are attached
to the array. Chips from Affymetrix usually have attached oligonucleotides of 25 bases
length, whereas Illumina probes are 50 bases long and Agilent probes have a length of 60
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bases [146]. Furthermore, arrays from the same company sometimes differ in their probe-
sequences, which may match to different positions within a gene, e.g. close to the 3' end
or equally distributed over the entire gene [153]. Different nucleotide sequences lead to
differences in the binding affinity of probe and target and therefore to different intensity
values, complicating direct comparisons between different arrays.
Overall, there are numerous possible influences on the intensity measurement of a mi-
croarray spot and it is important to study these effects in detail to facilitate a better
understanding and modelling of the data.
2.3.2. From RNA content to measurement signal
The goal of gene expression microarray studies is to measure the mRNA content of cells
for each gene. However, as described in the previous section, the mRNA content is not
measured directly. Instead, a fluorescence intensity is measured for each spot on the array
that is assumed to depend, apart from measurement noise, monotonically on the mRNA
content corresponding to the respective gene. The exact relationship of the measured signal
and the mRNA content is still under investigation [154], but some crucial mechanisms
have already been modelled and some approximations can be made that are very useful
for practical analyses [145, 154, 155, 156].
Notation
Let y be the vector of measured intensity signals from the microarray and let x be the
vector of mRNA concentrations in the target, where each component represents a protein-
coding gene. It is then of interest to determine the function F that relates both vectors,
possibly incorporating an error term 
y = F (x, ). (2.1)
Here, it is assumed for simplicity of the following descriptions that the dimensions of x and
y are equal with a one to one correspondence of the components in x and y. Thus, it is
assumed that probesets were already summarised and that the summarisation only reduces
noise or probe-specific variability, i.e. it only affects  and the probe-specific parameters
of F but not the form of F per se. This is certainly not entirely true, but the detailed
description of the various summarisation methods in combination with platform specific
differences in probeset compositions goes beyond the scope of this thesis.
For a further simplification of the notation, we focus in the following on a single component
yi of y, implying that the form of F is the same for every component, but the parameters can
be probeset-specific. For further notational simplicity, we skip the index i and distinguish
a single component y from the vector y by the missing underline. Also, probeset-specific
parameters are not explicitly indexed with i. The vector x is simplified to a two-component
vector (xS , xN )T , where xS is the amount of specific target, i.e. of the gene that specifically
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binds to the investigated probeset, and xN summarises the non-specific targets into a single
component (it is straightforward to extend the description to the full vector x).
Langmuir model based on physicochemical parameters
We start with neglecting the error terms and describing the relationship of RNA content
and measurement signal in terms of physicochemical parameters, inspired from [157]. First,
the measurement signal y can be described by an affine relationship to the fraction of bound
probe θ:
y = a+ bθ. (2.2)
where a is the background luminescence and b is the slope depending on the scanner settings
(e.g. the exposure time or laser power) and dye properties. The fraction of bound probe
θ can be determined using chemical equilibrium calculations [157]. With some relatively
mild assumptions and some reformulations, this leads to the following expression [157]:
θ =
ωNXN + ωSKS(xS − pθS)
1 +XN +KS(xS − pθS) (2.3)
Here, ωS , ωN ∈ [0, 1] are factors representing the fraction of specific and non-specific target,
respectively, that stays at the probe after the washing steps, and XN = KNxN is the
non-specific binding strengths before washing. KS and KN are equilibrium constants for
specific and non-specific targets, p is the total amount of probe, and θS is the fraction of
bound probe that is bound by a specific target. The term pθS accounts for the depletion
of the specific target due to binding to the probe [157] and can be calculated by solving
the following equation for θS :
θS =
KS(xS − pθS)
1 +XN +KS(xS − pθS) . (2.4)
Plugging equation (2.3) in equation (2.2) and defining the following new constants:
K =
KS
1 +XN
(2.5)
A = a+ bωN
XN
1 +XN
(2.6)
B = b(ωS − ωN XN
1 +XN
) (2.7)
leads to the simplified equation [157]:
y = A+B
K(xS − pθS)
1 +K(xS − pθS) , (2.8)
where we treat XN as a constant, focussing on the relationship between xS and y. For
small values of KxS , θS can be approximated by a linear term cxS for some appropriate
constant c [157]. With this approximation, the previous equation becomes a classical
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Langmuir equation
y = A+B
KˆxS
1 + KˆxS
, (2.9)
where Kˆ = K(1 − pc). The typical shape of such a Langmuir equation can be observed
in microarray spike-in datasets, where the actual amount of RNA for specific genes is
experimentally controlled (Figure 2.4 left). It starts almost linearly with slope Bˆ = BKˆ
for very small values of xS and saturates to its supremum A + B for very large values of
xS .
Gene expression data are typically log2-transformed before analysis. The reasons for this
are twofold. First, for many biological questions the relative change in expression, i.e. the
fold change, is supposed to be of more relevance than the absolute change in expression
and a log transformation allows to use additive models for assessing relative changes.
Second, the technical error in microarray data is mainly multiplicative, i.e. it increases
with increasing RNA concentrations, and it is heavily skewed to the right. Therefore, a
log-transformation results approximately in additive noise with a less skewed distribution,
although the distribution is still not normal and there is still some intensity dependence in
the noise (see paragraph "Noise models" below).
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Figure 2.4.: The RNA content of 42 different genes from spike-in experiments [158] is
plotted against the corresponding signal intensity of the Affymetrix Human
Genome U133A microarray. Each gene is represented by a different colour or
line type (data points are linearly interpolated). The raw intensities (left),
i.e. without log-transformation, have a typical shape corresponding to the
Langmuir equation with varying parameters for the 42 different genes. Log2-
transformation of the concentrations as well as the intensity values (right)
result in a sigmoidal function with three phases: An initial flat phase, a linear
phase with slope close to 1, and a saturation phase which is only slightly visible
in the available spike-in range. Note that the spike-in concentration of 0 was
set to 0.01 for the right graphic to allow log-transformation.
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When we apply a log2-transformation to both xS and y, i.e. we define variables lx =
log2(xS) and ly = log2(y), equation (2.9) becomes
ly = log2(A+ Bˆ
2lx
1 + Kˆ2lx
), (2.10)
which, for appropriate parameters A, Bˆ, and Kˆ, is a sigmoidal function that can be
divided into 3 parts: an initial flat part, a middle part with slope of almost 1, and a
late saturation part. The parameter A determines the initial value, the fraction A
Bˆ
mainly
specifies the length of the initial flat part, and the value of Kˆ determines the beginning of
the saturation part. This characteristic shape can be observed in the spike-in experiment
from [158] (Figure 2.4 right), although the spike-in concentrations are too small in this
experiment to appropriately visualise the saturation phase. It is noticeable that the curves
are fairly similar for the 42 different probes, indicating that the probe-specific parameters
do not vary too much. This seems to be true also for other platforms [159]. These results
will be important for the mapping across microarray platforms, which will be discussed in
section 4.1.2.
Noise models
The development of appropriate noise models for microarray data is important for the
choice of appropriate statistical models for data analysis. However, despite of many inves-
tigations and significant progress, the question about the best model is still not fully solved.
Initial models incorporated an intensity independent, additive error term with normal dis-
tribution [160], or a multiplicative noise term, accounting for the intensity dependence of
the error variance [161]. These models could be refined by a linear combination of an
additive and a multiplicative component [162], providing a reasonably good first order ap-
proximation to the functional dependence of the error on the intensity value. However,
more recent investigations suggest that these models do not suffice to fully describe the
observed error terms, suggesting a very general intensity-dependent noise model without
a specific functional form [163].
The complicated nature of the noise in a microarray study can be partially understood
by the physicochemical model described above. If we assume, for simplicity, that every
parameter in equation (2.9) can vary by an additive term and additionally incorporate
biological noise, we get the following equation:
y = (A+ A) + (B + B)
(Kˆ + Kˆ)(xS + biol)
1 + (Kˆ + Kˆ)(xS + biol)
. (2.11)
Here, the additive noise component A accounts for differences in the background lumines-
cence among other intensity independent effects (equation (2.6)), while the almost mul-
tiplicative noise component B mainly incorporates differences in scanner settings, dye
properties, or washing efficiency. Furthermore, there are two noise terms that can not be
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considered as additive or multiplicative, namely the hybridisation associated error Kˆ as
well as biological noise biol, which have more complicated relationships to the intensity
value due to the saturation effect. Apart from this, Poisson-distributed error terms have
been reported that may occur due to the probabilistic nature of the hybridisation and read
out processes as well as the inverse transcription and amplification processes [145]. Such
Poisson noise can also not be represented by additive or multiplicative terms. Finally,
biological noise is hardly understood and may itself also depend on the mRNA content,
meaning that the additive representation of the biological noise in equation (2.11) may be
inappropriate. Thus, a first order approximation to the intensity dependence of microar-
ray noise may be reasonable in a certain intensity range. However the saturation effect for
high intensity values, affecting mainly prehybridisation and hybridisation noise, as well as
stochastic Poisson distributed effects require second or higher order terms.
These very rough theoretical investigations are further complicated by the different data
preprocessing and normalisation methods that are commonly applied. These methods try
to remove array specific effects and therefore have an additional influence on the noise
distribution and intensity dependence. Many articles discussing the intensity dependence
of microarray noise for Affymetrix data, use the 'Affymetrix Microarray Suite' (MAS) or
'Probe Logarithmic Intensity Error' (Plier) [164] algorithms for data preprocessing. These
algorithms make use of the mismatch (mm) probes on Affymetrix chips and seem to have
higher intensity dependence of the error term after log-transformation than the 'Robust
Multi-array Average' (RMA) [165] algorithm, which uses only positive match (pm) probes
(Figure 2.5). Due to this result, in combination with the fact that newer microarray chips
from Affymetrix, e.g. the Human Gene 1.0 st-v1 chip, do not have any mismatch probes,
the RMA algorithm will be used for data preprocessing of Affymetrix chips in the present
thesis.
Apart from the intensity dependence of the error term, its distribution is also of high inter-
est. It is generally accepted that the noise distribution of non-transformed data is heavily
skewed to the right. Therefore, a log-transformation is usually performed to reduce the
skewness, almost resulting in a normal distribution of the error term. Nevertheless, there
is still some evidence that the distribution is slightly skewed and heavy-tailed [166], which
may be, at least partially, attributed to the remaining intensity dependence of the noise
term after log-transformation [163].
Correlated noise
Many of the above mentioned error sources, e.g. changes in background intensity, scanner
settings or dye properties, as well as hybridisation, washing and amplification processes,
are usually not independent between probes, but affect many, if not all probes, in a similar
way. Furthermore, biological variability is known to result in correlated noise as well.
Only the poisson like stochasticity in the amplification and hybridisation processes can be
assumed to be uncorrelated between different genes.
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Figure 2.5.: The functional dependence of microarray noise on the signal intensity changes
with different preprocessing algorithms. Data preprocessed by the 'Probe Log-
arithmic Intensity Error' (Plier) algorithm have a relatively high intensity de-
pendence after log-transformation (top), while this effect is considerably re-
duced for data that were preprocessed by the 'Robust Multi-array Average'
(RMA) algorithm (bottom). Shown are the mean vs. the difference of two
technical replicates from the T47D human breast carcinoma cell line (dataset
GSE19921 from the Gene expression omnibus database [167]). Red lines in-
dicate the 5% and 95% quantiles calculated on a moving window of 500 data
points width.
Normalisation methods remove parts of the systematic errors that affect all genes in the
same way. However, some between-array differences, like a variability in washing, have
different effects on different probes [156], complicating a removal by normalisation methods.
Furthermore, there is cross hybridisation as well as some spatial bias found in microarray
data, also leading to local rather than global correlations among probes [168, 169]. Overall,
it can be expected that the noise in microarray data is substantially correlated between
different genes and that normalisation methods can only partially remove these correlated
noise terms. Such correlation can severely affect the outcome of data analysis and must
be carefully considered. In the framework of this thesis, this is especially important to
consider when performing principal components analyses or similar unsupervised dimension
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reduction methods that exploit the correlation structure in the data.
2.4. Existing approaches for whole transcriptome based cell
characterisation
The idea to characterise cells based on their global gene expression status is relatively
new due to the restricted availability of appropriate data in earlier times. However, the
acceptance of such methods is increasing due to great success stories, e.g. for the charac-
terisation of pluripotent stem cells [70, 71, 107, 128]. However, these methods were often
restricted to single cell or tissue types. In the recent years, three different methods were
developed that can be used to determine the cell or tissue type of a specific sample, de-
picting a multi-class classifier [10, 11, 81]. These methods are described in the following
and their relevant properties are compared from a theoretical point of view.
2.4.1. Concordia: Phenotypic concept enrichment
The first of these three methods is the Concorida tool, which was published in 2012 [11].
This tool uses a dataset of 3030 microarray samples from the Affymetrix Human U133
Plus 2.0 platform as a reference for the characterisation of new data. These samples
were classified into 1489 anatomy and disease concepts according to the Unified Medical
Language System (UMLS) [170], where each sample can have multiple concept associations
and each concept was represented by at least three samples.
The characterisation of new data is based on an enrichment score for each UMLS concept,
which is calculated as follows. First, the Spearman correlation between the new data and all
of the reference data is calculated. Afterwards, for each concept and each sample of the new
data, an enrichment score is calculated based on a Kolmogorov-Smirnov like test statistic,
comparing the Spearman correlations of the reference samples that are associated with the
concept to those that are not associated with the concept [11]. The enrichment score is
exactly 1, if the correlations to all samples of the respective UMLS concept are consistently
higher than those to all other samples. As a result of the method, the enrichment score is
reported for each UMLS concept, depicting a measure of similarity to each concept.
In the original publication, the Concordia tool is only used for a single microarray platform,
namely the Affymetrix Human U133 Plus 2.0 platform, on which the reference samples were
hybridised. A transformation to other platforms is certainly possible with an appropriate
reference dataset on the respective platform. However, the use of a single reference dataset
for cross platform analyses may reduce the accuracy of the method and needs to be tested.
One disadvantage of the method can be explained with an idealised example. Suppose, for
simplicity, that each sample of the reference dataset is only associated with a single UMLS
concept. Suppose further that there is almost no variation between the reference samples
belonging to a single UMLS concept, i.e. there is no biological or technical variation
between tissues of the same type. Then, if we analyse a new sample that fits to one
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specific concept, e.g. a heart biopsy, the enrichment score for the `heart' concept would
be exactly 1. Now, if we analyse another sample, which does not exactly match to any of
the concepts, but which is partially similar to one concept, e.g. an in vitro differentiated
cardiomyocyte, the enrichment score for the 'heart' concept would be also 1. Essentially,
for any sample that we analyse, there is (almost) necessarily always a concept that is most
similar to this sample, and the enrichment score for this concept is exactly 1, irrespective
of the correlation values themselves, i.e. irrespective on how similar the sample is to the
samples corresponding to this concept. Therefore, if the new cells do not exactly match to
any of the tissues or cell types included in the UMLS concepts from the reference dataset,
this will not be recognised by the enrichment score. Similar effects are true for the concept
with second highest similarity. The value of this concept can always be expected to be
relatively high and it depends only on the sample sizes of the samples that belong to
the first and second concept, e.g. it becomes a little bit lower if there are more samples
corresponding to the best fitting concept.
Thus, the method does not give real information on how similar the new sample is to a
specific concept, but only about the ranking of concepts. This problem is a bit reduced in
the real case, where we have some biological and technical variation in the reference dataset.
However, especially for cases with a relatively high signal-to-noise ratio the problem persists
and it generally prevents the proper characterisation of samples that do not fit exactly to
any of the UMLS concepts.
2.4.2. Unknown RNA Sample Annotation (URSA)
The 'Unknown RNA Sample Annotation' (URSA) tool [10] uses more advanced classifi-
cation techniques to determine the cell or tissue type of new samples. The method was
trained on a large dataset of more than 14,000 samples from the Affymetrix Human U133
Plus 2.0 microarray platform. These samples were manually classified into 244 different
tissue or cell type terms according to the BRENDA Tissue Ontology (BTO) [171].
URSA is a multi-class classifier, which is able to classify unknown samples accurately into
one of the tissue ontologies. This classification is achieved based on a support vector ma-
chine (SVM) classification and a subsequent Bayesian correction utilising the hierarchical
structure in the BTO.
To be more precise, a SVM classifier is trained for each BTO term, with positive labelling
of all samples that correspond to this BTO term or one of its descendants. Samples that
are only annotated to an ancestor of the BTO term are excluded and all other samples are
labeled negative [10]. Thus, the SVM classifier utilises already the tree like structure of
the BTO.
The results of all SVM classifications are then used in a post-processing step to calcu-
late posterior probabilities for each BTO term based on a hierarchical Bayesian correction
method [172] that takes the hierarchical structure of BTO into consideration. This post-
processing step increases the precision and recall of the classifier [10].
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Although the URSA tool was trained on a single microarray platform, it could be shown
that it is applicable for other platforms and even for RNA sequencing data [10]. For cross
platform analyses, the genes were matched according to their Entrez gene identifiers and
the new samples were quantile normalised to adjust their distribution to that of the train-
ing samples. Furthermore, a permutation test is used for post-processing, setting each
non-significant ontology to zero, in order to suppress unspecific associations with tissue
ontology terms [10].
Overall, the URSA tool is a highly accurate and widely applicable tool for RNA based
sample annotation. However, one disadvantage with respect to characterisation of in vitro
differentiated cells is the binary classification for each ontology term, preventing the iden-
tification of partial similarities. Furthermore, the Bayesian correction and the permutation
test used for post-processing may suppress weak signals that can for instance occur due to
a mixture effect in the sample. Therefore, we recommend the tool for a characterisation of
pure tissues, but not for characterisation of samples that may deviate from pure tissues,
e.g. due to mixture effects or incomplete differentiation. Thus, it is also not well suited
for the goal of the present thesis.
2.4.3. CellNet: A Network based classification of cells
CellNet is a very new method published by Cahan et al. in August 2014 [81]. It is spe-
cialised for the characterisation of in vitro transformed cells, providing information about
the global similarity to several different tissues and additionally about possible relevant
transcription factors that may be used to improve the transformation to the desired cell
type.
CellNet was initially developed on the Affymetrix mouse 430.2 and the Affymetrix human
HG U133 Plus 2.0 microarray platforms. It was additionally trained for the Affymetrix
mouse and human Gene 1.0 arrays and for the Illumina Human 8v2 array [81]. However,
for every platform it is retrained based on a platform specific dataset. It uses data from
roughly 20 different tissues with at least 60 (for human) or 100 (for mouse) samples [81].
The training of CellNet starts with the data-based reconstruction of a gene regulatory net-
work (GRN) using the `context likelihood of relatedness' (CLR) algorithm [173]. The CLR
algorithm determines relationships between transcriptional regulators and target genes
based on a correlation measure with a context specific significance cutoff. The method is
used to construct a global GRN with all data as well as additional GRNs for all samples of
"common developmental origin" [81]. These GRNs are then combined to a single GRN per
cell or tissue type which is further processed by applying a cutoff for removing lower per-
forming relationships that is determined by a comparison to a Gold Standard. The Gold
Standard is determined using appropriate data from transcription factor binding measure-
ments, gene expression profiling of mouse ESCs (mESC) modified for inducible expression
of 94 transcription factors, and chromatin immunoprecipitation microarray (ChIP-chip)
and sequencing (ChIP-seq) data of 54 transcription factors in mESC.
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After that, the GRNs are divided into subnetworks of high density interconnection. Each
of the subnetworks is then tested for its tissue specificity by applying a gene set enrichment
analysis that compares the expression of one specific tissue to all others on the gene set
comprising all genes of the subnetwork. All subnetworks that were significant for a specific
tissue are then combined to a single GRN per tissue or cell type [81]. Finally, all genes of
this GRN were used to train a Random Forest classifier [174] for each cell or tissue type,
which can then be used for classification of new samples.
Besides this characterisation of cells using the Random Forest classifier, CellNet incorpo-
rates also a transcription factor focused evaluation of possible ways to improve the cellular
transformation [81]. This aspect is neglected in the present thesis since we focus on the
characterisation of cells.
One major drawback of the CellNet method is the high data requirement for the construc-
tion of the GRNs, preventing the inclusion of more different cell or tissue types due to
limitations of available data. Therefore, it is currently limited to roughly 16 to 20 tis-
sues, depending on the organism, i.e. mouse or human, as well as the specific microarray
platform. Furthermore, the Random Forest classifier is again a binary classifier, with the
disadvantage as discussed for the URSA classifier, although in practice the probability
associated with the classification results gives some indication on how well the respective
tissue is represented in the newly analysed data. This is different in the URSA tool, where
most probabilities are either close to zero or close to one.
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3. A two-scale map of global gene
expression - combining unsupervised
and supervised dimension reduction
techniques
Due to the high dimensionality of gene expression microarray data, it is hard to directly
interpret the data in terms of their location in the expression space. Therefore, dimension
reduction techniques, such as principal components analysis (PCA) [175, 176], can be
used to reduce the expression space to the lower intrinsic dimensionality, by exploiting
correlations between variables. However, finding the biologically relevant dimensions is a
challenge of its own and typical unsupervised methods can suffer from noise and depend
heavily on the choice of samples. Furthermore, the interpretation of dimensions determined
in an unsupervised way is sometimes ambiguous. Supervised dimension reduction methods
can help in this respect, but they have their own disadvantages, associated with incomplete
annotation of important processes, or linear dependencies between the detected directions.
Therefore, we propose a combination of unsupervised and supervised dimension reduction,
in order to join the strengths of both methods.
3.1. An illustrative statistical model for gene expression data
We will use an illustrative statistical model of gene expression to explain some advantages
and disadvantages of unsupervised and supervised dimension reduction techniques in the
following. This statistical model describes the expression measurements yj of sample j, j =
1, . . . , n as a linear combination of two qualitatively different types of biological signal plus
two qualitatively different types of noise.
Among the two types of biological signal, one is always associated with a binary weight,
e.g. describing whether the sample is a heart tissue or not, while the other one is associated
with a continuous weight, e.g. describing the proliferation rate of the sample. Thus, for
db orthogonal biological dimensions ui, i = 1, . . . , db of the first type, the corresponding
term of the model can be described as
∑db
i=1 aijui, where the coefficient aij is a binary
variable stating whether sample j is associated with e.g. the tissue, cell line, or disease
i or not. The term associated with the second type of biological signal can be described
as
∑dc
l=1 cljwl, where dc is the number of orthogonal biological signals of this type, clj is
a continuous variable describing the phenotype, e.g. the proliferation status, of sample j,
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and wl describes the direction of the effect in the expression space.
The noise terms can be distinguished in one term describing correlated noise and one
describing uncorrelated noise. They are described as dn orthogonal noise terms vk, k =
1, . . . , dn, representing noise terms that are correlated between genes, and an independent
identically distributed (i.i.d.) error term j , i.e. without any correlation between genes.
Putting all of these terms together, we arrive at the following linear illustrative model of
gene expression:
yj =
db∑
i=1
aijui +
dc∑
l=1
cljwl +
dn∑
k=1
bkjvk + j ., (3.1)
where all components ui, wl, and vk are assumed to be orthogonal to each other. Here, the
noise coefficient bkj is a random variable with mean 0 and variance 1, the coefficient clj
has also variance 1, and the coefficient aij is a binary variable describing the tissue, cell
line, or disease affiliation. That is, aij is 1 for the ni samples that are affiliated with the
specific phenotype, e.g. for all hematopoietic cells, and 0 for the n − ni samples that are
not affiliated with the phenotype. Each component of the m dimensional vector j of the
noise term is assumed to be normally distributed with mean 0 and standard deviation σ.
Here, m is the length of the vectors in equation (3.1), i.e. the number of genes measured
by the microarray.
This model is certainly very simplistic and does not represent the truth. However, it
can be used to explain some conceptual differences as well as associated advantages and
disadvantages of supervised and unsupervised dimension reduction techniques. The reasons
for the choice of these different terms in the model are the following. First of all, it is
necessary to distinguish between biological variation and measurement noise in order to
separate the effects of interest from disturbing effects. Second, the distinction between the
two types of noise is necessary due to the clearly different statistical behaviour of correlated
and uncorrelated noise terms. In many cases of statistical analyses of microarray data, the
correlated noise is neglected since it is more complicated to model. This can have significant
confounding effects, e.g. for the analysis of gene sets [177]. Third, the separate modelling
of the two biological signal types is mainly due to the availability of annotation. In most
studies that are deposited in public databases only binary phenotypes, e.g. the cell or
tissue type, are annotated. Therefore, this term can be nicely determined by supervised
methods. In contrast, continuous variables, e.g. the proliferation rate, are typically not
annotated and can therefore only be determined by unsupervised methods.
3.2. Exploring gene expression spaces with unsupervised
dimension reduction techniques
Unsupervised dimension reduction methods have the general advantage of being indepen-
dent of available annotations. Therefore, they can be regarded as unbiased with respect to
specific aims of the analysis and do also not suffer directly from any annotation errors. In
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contrast, a common disadvantage of unsupervised methods is the more complicated and
sometimes ambiguous interpretation of the respective dimensions in terms of a biological
meaning, although methods like non-negative matrix factorisation (NMF) [109] have been
designed that usually facilitate a more intuitive interpretation of the detected components.
Apart from these annotation and interpretation related advantages and disadvantages,
there are also more quantitative facts to consider as will be described in the following. For
this analysis, we focus on one of the most simple and most frequently used unsupervised
dimension reduction techniques, namely PCA [175, 176]. We first describe the general
concept of PCA and discuss its optimality for dimension reduction in certain cases. After-
wards, we apply PCA to large gene expression datasets and discuss some general problems
that arise in this analysis.
3.2.1. Principal components analysis - a (sometimes) optimal linear
dimension reduction technique
Concept of principal components analysis
PCA [175, 176] is a technique in multivariate statistics and data mining that is useful when
several variables under investigation are correlated with each other. Due to these correla-
tions, there is some redundant information in the variables which may be problematic for
further analysis, e.g. due to singular matrices in regression analysis, and which may be
exploited to reduce the dimensionality of the variable space.
The concept of PCA is to successively detect orthogonal directions with highest variance
in the data. That means that it first detects the direction with highest variance in the
complete variable space, which is called the first principal component. In a second step, the
analysis is restricted to the orthogonal space to this first principal component and a second
principal component is detected with the highest variance in this space. This procedure
is then continued iteratively, resulting in a new coordinate system with rotated directions
(Fig. 3.1).
The directions detected by this procedure correspond to the eigenvectors of the covariance
matrix of the data. Thus, one procedure to calculate a PCA is an eigendecomposition of
the covariance matrix. However, due to numerical stability reasons a singular value decom-
position (SVD) on the centred data, i.e. with mean 0 for each gene, is usually preferred.
SVD factorises the centred data matrix X ∈ Rm×n into three matrices
X = UΣV T , (3.2)
where U ∈ Rm×m and V ∈ Rn×n are matrices whose columns are orthogonal unit vectors,
called the left and right singular vectors. The matrix Σ ∈ Rm×n is diagonal with positive
numbers on the diagonal which are called the singular values. The right singular vectors,
i.e. the columns of V equal the eigenvectors of the sample covariance matrix of the data,
which are used as new coordinate axes. The multiplication of the two other matrices,
41
A Two-Scale Map of Global Gene Expression RWTH Aachen University
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
ll l
l
l
l
ll
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l ll
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
ll
l
l
l
ll
ll
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
ll
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
ll
l
l l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
ll
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
ll
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
−30 −20 −10 0 10 20 30
−
30
−
20
−
10
0
10
20
30
Variable 1
Va
ria
bl
e 
2
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
ll
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l ll
l
ll
l
l
l
l
ll
l ll
l
ll
l
ll
l
ll
l
l
l l
l
l
l l
l
l
ll
l
l
l
l
l
l
l ll l
l
l l
l
l
l
l ll l
l
l ll
l
l
ll
l
l
l
ll
l
l
l l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l l
l
l
l
l
ll
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
ll l
l
l
l
l l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
ll
l
ll
l
l
l ll
l
l
ll
l l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
lll
l l
ll
l
l
ll l
l l
l
l
l
ll l
l
l
l
l
l
l
l
ll
l
l
l
lll
l
l
l
l
l l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
ll
l
l
l l
l
l
l l
l
l
ll l
l
l
l
l
l
l
ll
ll
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
ll
l
l
l
l l
l
l
l
ll
l
l
l
l l l l
l
l l
l
l
l
l l
l
l
ll l
l
l l
l
l
l
l
l l
l
l
l
l l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
ll
l
l
l
l
l
l
l
l l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
ll
l
lll
l
ll
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l l
l
l ll
l
l
l l
ll
l
l
ll
l
l
l
l l
ll
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l l
l
l l
l
l
l
l
l
l
ll
l
l
−30 −20 −10 0 10 20 30
−
30
−
20
−
10
0
10
20
30
Principal component 1
Pr
in
ci
pa
l c
om
po
ne
nt
 2
Figure 3.1.: Illustration of principal components analysis (PCA). PCA detects successively
the orthogonal directions of highest variance. Here, the two variables (Variable
1 and Variable 2, left graphic) are positively correlated. The first principal
component (PC) has the direction of the longer red arrow. The second PC is
orthogonal to the first PC, showing in the direction of the shorter red arrow.
The right graphic depicts the data in the PCA-rotated coordinate system.
i.e. UΣ are consequently the coordinate values of the data points in this new coordinate
system.
In many practical cases, PCA is used for dimension reduction by keeping only the first p
dimensions of the PCA-rotated coordinate system. These first p dimensions contain large
amounts of the variance in the data due to the variance maximisation criterium used to
determine these principal components. One essential question in this procedure is how to
choose p, i.e. the number of principal components that are kept after dimension reduction.
This can be done, e.g. based on the amount of variation that is explained by the respective
components or based on the relevant information that is captured by the components.
Another question that arises is whether or in which circumstances the PCA provides a
good or even an optimal dimension reduction and how this optimality is measured. This
question will be investigated in the following.
PCA and its optimality for normally distributed data
It is often noted that PCA assumes normally distributed data or is at least optimal for
normally distributed data. However, in many applications such a normal distribution can
not be assumed. Therefore, it is worth to describe, in more detail, the properties of the
PCA in these contexts.
First of all, we would like to note that PCA does not assume any normal distribution.
That means that it is valid also for non-normally distributed data, in contrast to many
parametric statistical tests, e.g. the t-test. Therefore, the main question to address is the
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optimality of PCA and the dependence of this optimality on the distribution of the data.
When we talk about optimality, it is necessary to define some optimality criteria. These
criteria certainly depend on the application of interest. Therefore, we will distinguish three
different cases in the following for which we discuss the optimality of the PCA.
In the first case, we assume that we have an input-output system with p independent
input variables x = (x1, . . . , xp)T that control the system and m output variables y =
(y1, . . . , ym)
T that depend linearly on x:
y = Ax (3.3)
The goal is to determine the values of the p input variables as well as the linear mapping A
given n observations of the m output variables. This problem is well known as the source
separation problem and it amounts to finding p independent components.
PCA can be used to solve this problem under certain assumptions. PCA imposes orthogo-
nality constraints on the detected directions and removes all correlations. This is sufficient
to find independent components when the data follow a multivariate normal distribution,
i.e. x ∼ N(µ,Σ), since the normal distribution is fully characterised by the mean vector
and covariance matrix. Thus, a correlation of zero implies independence of the compo-
nents. However, this is not true for other distributions, for which PCA is not the optimal
choice for source separation. In this case, it is important to use a more general concept of
independence as is done for example in independent component analysis (ICA) [178].
Apart from that, it is important that the linearity assumption is fulfilled, i.e. that the
outputs depend linearly on the inputs. Otherwise, non-linear methods have to be used.
The second case we want to consider involves some noise. Assume again that we have p
input variables and m output variables that are now corrupted by noise:
y = Ax+ , (3.4)
where  is independent of Ax. The goal now is not to detect precisely the values of the p
input variables, but to find a p-dimensional subspace that contains the signal. Thus, we
try to find a reduced dimensional representation that captures the true signal as good as
possible. In the first case described above, the entire signal lies in the p-dimensional PCA-
space in case of a linear model, even if the independent components can not be directly
estimated by the PCA, i.e. even when the data are not normally distributed. This is due
to the reason that we do not have any noise. However, with the presence of noise this may
change.
In fact, PCA minimises the squared error between the data and the reduced dimensional
representation. Hence, given n observations of the output variables, it determines the
matrices Aˆ ∈ Rm×p and Xˆ ∈ Rp×n such that ||Y − AˆXˆ||2 is minimised.
This minimisation of the squared error is equivalent to maximising the likelihood for normal
distributed noise. However, when the noise is not normally distributed, the maximum
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likelihood estimate does not equal the classical PCA solution and some extensions, e.g. to
the exponential family [179], are required.
Thus, in this second case, only the noise term, but not the data themselves need to be
normally distributed in order to receive optimal solutions in terms of a maximisation of
the likelihood.
The third case we consider here is actually the same as the second case, i.e. we aim to
reduce the dimensionality, capturing as much of the relevant signal as possible. However,
we use an information theoretic optimality criterium instead of a likelihood maximisation.
This optimality criterium is related to mutual information I(X,Y ), which is defined for
two random variables X and Y with values in ΩX and ΩY as
I(X,Y ) =
∑
x∈ΩX ,y∈ΩY
p(x, y) log
p(x, y)
p(x)p(y)
. (3.5)
In fact, the optimality criterion that we consider here is the minimisation of the relevant
information loss by the dimensionality reduction. Here, the relevant information loss is
defined as the difference in mutual information of the data and the relevant signal before
and after dimension reduction [180]. In terms of the model in equation (3.4) the relevant
information loss LAX(Y, Yˆp) between the original data Y and the projected data on the
reduced dimensional subspace Yˆp can be expressed as [180]
LAX(Y, Yˆp) = sup (I(AX,Y )− I(AX, Yˆp)), (3.6)
where the supremum is taken over all partitions of the sample space.
Geiger and Kubin [180] show that this information loss is zero when PCA is applied for
dimension reduction and the noise  is independently identically normally distributed with
zero mean. This result does not require any specific distribution of the data themselves,
but only of the noise. This statement can even be extended to non-normally distributed
noise, as long as the noise is independently identically distributed (i.i.d.) and is more
similar to a normal distribution than the signal. Here, the similarity of two distributions
is measured by the Kullback-Leibler divergence [180, 181].
This result is very interesting for our approach since we try to reduce the dimensional-
ity while keeping as much relevant information as possible. Furthermore, the normality
of the noise component is almost fulfilled for logarithmically transformed gene expression
microarray data, while the data themselves are far from being normally distributed. There-
fore, PCA should be well suited with respect to these requirements.
However, there are two problems that cannot be neglected. First, the noise can not be
completely regarded as being independent, i.e. there is correlated noise present in microar-
ray data. Second, there are some additional problems that come along with finite sample
sizes in high dimensions, meaning that the results of PCA depend on the specific choice of
samples. These problems will be further investigated in the next sections.
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3.2.2. Principal components analysis on large microarray datasets
Lukk et al. [12] applied PCA for dimension reduction purposes on a large dataset of 5372
samples from the Affymetrix Human U133 A array, representing 369 different tissues, cell
lines, or disease states. They detected, that the first principal component (PC) of their
analysis separates hematopoietic cells from all other cells, and termed it the hematopoietic
axis (Fig. 3.2 top left). The second PC was associated with malignancy or proliferation,
distinguishing clearly between fast proliferating cell lines and slower proliferating tissues.
Interestingly, this separation on the second component suggests a clustering of all cell lines
into a single cluster, irrespective of and separated from their tissue of origin. This was
also confirmed by a hierarchical cluster analysis applied to the mean expression vectors
for each tissue or cell line [12]. The third PC was associated with neural tissues, and can
therefore be termed the neural axis (Fig. 3.2 top right). Thus, the first three principal
components could be clearly associated with a biological meaning. However, this was not
the case for the fourth component, which correlates with an array quality metric, suggesting
that it represents measurement noise [12]. Therefore, Lukk et al. suggest that the gene
expression space, besides smaller scale differences, has a very low intrinsic dimensionality.
Schmid et al. [11] performed PCA on a different dataset of 3030 samples and achieved
slightly different results. They could confirm a separation of hematopoietic and neural
tissues from all others on their first two principal components, but did not find a separate
clustering of cell lines on the first two components. Unfortunately, they do not show any
results for further components.
In order to evaluate the results of Lukk et al. [12] on an independent dataset, we assembled
our own independent dataset of 7100 samples from the Affymetrix Human U133 Plus 2.0
array and performed PCA on it. The results of this analysis are shown in Fig. 3.2 (bottom),
confirming a separation of neural cells, cell lines, and hematopoietic cells from all other cells
on the first three PCs. However, the order of the separation of these cell types is different
as in the Lukk [12] data set (Fig. 3.2) and the biological interpretation of PC 2 is a bit
ambiguous. Furthermore, the fourth PC is not associated with an array quality metric,
but has a clear biological meaning, separating liver cells (grey dots at the bottom) from all
other cells. This dataset dependent and sometimes uncertain biological interpretability is
a common challenge for unsupervised dimension reduction approaches. Further principal
components of both datasets are depicted in the supplemental Fig. B.1 and B.2.
This visual comparison of the first principal components of both datasets can also be
quantified by statistical analyses. A linear regression model trying to explain each of the
first three PCs of our own dataset using the first three PCs of the Lukk [12] dataset results
in R-squared values of 0.74, 0.66, and 0.70. These are relatively high values, considering
the fact that the comparison of the PCs is also affected by platform specific differences.
In contrast, trying to explain the fourth PC of the own dataset by the first 5 PCs of the
Lukk dataset results in a R-squared value of 0.07, and it increases to a still comparably
low value of 0.50 when the first 10 PCs of the Lukk dataset are used as regressors. Thus,
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this analysis supports the visual observation that the first three PCs of both datasets span
similar spaces, while there are more clear differences in further principal components (this
is true also for other than the fourth PC, data not shown).
Figure 3.2.: PCA applied to the Lukk dataset [12] (top) and the self created dataset (bot-
tom) reveals differences in the tissue associations of the respective PCs. For
the Lukk (own) dataset, PC1 (PC3) is associated with hematopoietic cells (or-
ange), PC2 (partially PC1) is associated with proliferation, and PC3 (partially
PC2) is associated with neural cells (red). PC4 in the Lukk dataset is associ-
ated with an array quality metric [12], while PC4 in the own dataset mainly
distinguishes between liver and liver cancer cells (cyan) and all other cells.
Liver cells are only separately coloured for our own dataset, not for the Lukk
et al. [12] dataset, where they are among the grey dots. For both datasets,
PCs 1 to 3 consistently distinguish mainly between neural cells, hematopoietic
cells, cell lines, and all other cells.
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3.2.3. Effects of sample size and measurement noise on principal
components analysis
There are two interesting observations from the previous section, which we want to inves-
tigate in more detail in terms of the illustrative statistical model described above. First,
the observation by Lukk et al. [12] that the fourth PC of their dataset is correlated with
an array quality metric. This may suggest that the intrinsic dimensionality of the gene
expression space is very low dimensional, at least if only those dimensions are counted that
exceed the level of noise. Second, the observation that principal components differ between
the datasets of Lukk et al. [12] , Schmid et al. [11], and our own dataset. This effect can
be expected to be caused by differences in the sample sizes of the relevant cell types or
tissues.
In order to get a rough understanding of the effects seen in the PCA, it is necessary to de-
termine the eigenvalues of the sample covariance matrix. In the classical statistical setting
of a relatively small number of variables m, and a large number of samples n, approxi-
mated by the limit of n → ∞ for fixed m, the eigenvalues λr of the sample covariance
matrix converge to the eigenvalues of the population covariance matrix [182]. In the illus-
trative statistical model described in section 3.1, we do not have a normal distribution in
all terms. Therefore, it is not straightforward to explicitly determine the population eigen-
values. However, we can state the variability in the direction of the different components
that are included in the illustrative statistical model, which are given by
λ˜r =

ni
n (1− nin )||ui||2 + σ2, r = Idb(i)
||wl||2 + σ2, r = Idc(l)
||vk||2 + σ2, r = Idn(k)
σ2, r > db + dc + dn
, (3.7)
Here, Idb(i) (Idc(l),Idn(k)) is the i-th (l-th, k-th) element of the index set corresponding
to biological components of type one (biological components of type two, correlated noise
components). The components ui, wl, and vk were assumed to be orthogonal to each other.
Although, the λ˜r do not equal the eigenvalues, a higher value of λ˜r means that this com-
ponent of the statistical model will be more strongly represented in the first principal
components. Therefore, the λ˜r are directly associated with the eigenvalues.
The asymptotic convergence of sample eigenvalues to population eigenvalues can only be
reasonably used for the case n  m. For microarray data, in contrast, m is usually at
least in the same order of magnitude as n, often even considerably larger. Therefore, it is
more realistic to consider the asymptotic case of n and m jointly approaching infinity, i.e.
n→∞, m→∞ and mn → γ ∈ (0,∞), resulting in fundamentally different statistics.
In this "large n, large m" case, the sample eigenvalues do not converge to the popula-
tion eigenvalues. Instead, the eigenvalues of the noise term, having population eigenvalues
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λl = σ
2, ∀l, converge to a limiting distribution F, with density [183, 184]:
f(x) = F ′(x) =
 12piγxσ2
√
(b− x)(x− a)1{a≤x≤b}, γ ≤ 1
1
2piγxσ2
√
(b− x)x1{0<x≤b}, γ > 1
, (3.8)
where a = σ2(1−√γ)2, b = σ2(1+√γ)2, and 1 is the indicator function. For γ > 1 there is
an additional point mass 1− 1γ at x = 0. Equation (3.8) specifies the limiting distribution
of all sample eigenvalues. Of special interest is the distribution of the largest eigenvalue
of the noise term, since it is interesting to compare it to the eigenvalues corresponding
to biological components. In [185, 186] it is shown that the largest eigenvalue converges
almost surely to b = σ2(1 +
√
γ)2, i.e. the upper boundary of the support of f, under mild
conditions. Thus, for the Lukk dataset with γ ≈ 4, the largest eigenvalue corresponding
to the independent noise term is 9σ2 instead of σ2. This limited sample size effect is even
considerably stronger for smaller datasets, due to an increased value of γ.
Another sample size associated effect, affecting the eigenvalues of the covariance matrix, is
the decrease of the eigenvalues corresponding to biological signals of type one with more
extreme values of nin , e.g. for the case of fixed ni ≤ n2 and increasing n. To give an example,
consider a typical cell type of the Lukk dataset with roughly ni = 15 samples (5372 samples
divided into 369 distinct tissues or cell types). The λ˜r value corresponding to this tissue
specific component can be calculated according to equation (3.7) to 0.0028||ui||2 +σ2. The
same component on a subset of the data with all 15 samples of this tissue and another 15
samples of other tissues would result in a value of 0.25||ui||2 +σ2 and would thus be almost
100 times higher (assuming that σ2 is negligible). At the same time, the sample variance
corresponding to correlated noise is almost not affected by these sample size differences,
when we assume that it is independent of the sample choice and phenotypes. This may
explain the occurrence of a noise related component already in the fourth PC of the Lukk
dataset. Two examples of the relevance of these sample size effects are shown in Fig. 3.3.
One example shows the first two PCs on a subset of our our own dataset, including all 28
muscle samples, 28 heart samples and 10 further samples, 2 of each of the 5 main classes
distinguished in Fig. 3.2, i.e. brain, cell line, hematopoietic, incompletely differentiated,
and others. Due to the changes in the sample size, the first PC now separates muscle
tissues from all other samples, and the second PC distinguishes between heart and muscle
tissues on one hand, and the other 10 samples on the other hand (Fig. 3.3, left). This
result is of course only a toy example, and the outcome may have been expected by intu-
ition. However, the mathematical principle behind is valid for the complete dataset and
statements about the intrinsic dimensionality based on first occurrences of noise associated
components must be taken with care.
The second example is based on a PCA on the brain tissues from the Lukk dataset (Fig. 3.3,
right), showing that the first PC separates cerebellum and other tissues, whereas the sec-
ond PC separates frontal cortex tissues from more interior brain tissues, i.e. hypothalamus
and caudate nucleus. Thus, for the reduced dataset, these two biologically interpretable
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Figure 3.3.: PCA analyses are severely affected by the number of samples for individual
tissues/cell types (left) and can detect further tissue specific patterns when
applied to subsets of the data (right). On the left, the first and second PCs
of a subset of the own dataset are shown, distinguishing mainly between the
28 heart samples (violet), 28 muscle cells (magenta), and the 10 other sam-
ples. On the right, PCA is applied to the brain tissues of the Lukk dataset,
distinguishing nicely between different brain regions.
directions in the expression space have higher variances than any noise terms, as opposed
to the results from the global analysis. Similar sample size effects are probably responsible
for the differences in the PCs of the Lukk et al. [12], Schmid et al. [11], and our own
dataset. For example, the Schmid et al. [11] dataset contains considerably less cell line
samples than the other two datasets, the Lukk et al. [12] dataset contains a very large
amount of hematopoietic samples, and our own dataset incorporates comparably many
healthy or diseased liver tissues, explaining the direction of the fourth PC.
Beside the sample size dependence, the proper identification of the biological dimensions
depends of course also on the effect size, i.e. the length of the vectors ui or wl, in com-
parison to the strengths of the correlated noise terms as well as the variance σ of the
uncorrelated noise.
Another problem of unsupervised methods is that the interpretation of the detected direc-
tions can be obscured since they may represent a linear combination of biologically relevant
directions. This problem is actually associated with the non-optimality of PCA in detect-
ing independent components when the data are not normally distributed (as discussed in
section 3.2.1).
In summary, the PCA based dimension reduction has especially problems to detect the
phenotypes that are represented by relatively few samples, i.e. the vectors ui with a small
corresponding ni.
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3.3. Supervised dimension reduction of gene expression
spaces
In supervised dimension reduction approaches, some information about the data are used
to find appropriate directions for the reduced coordinate system. Taking the illustrative
statistical model from above as an example, one possibility would be to determine the
coefficients aij or clj based on the information that are a priori available, instead of learning
them from the data. Using these coefficients, supervised dimension reduction approaches
can then determine the reduced coordinate system, i.e. the vectors ui and wl.
3.3.1. Linear regression analysis for supervised dimension reduction
A classical way of doing this is linear regression analysis, which requires the specification
of a statistical model to describe the data. In analogy to the illustrative statistical model
used above (equation (3.1)), a multivariate linear regression model could be specified as
yj =
db∑
i=1
aijui +
dc∑
l=1
cljwl + j , (3.9)
without the explicit incorporation of the correlated noise terms. The choice of the specific
method for calculation of the unknown variables ui and wl depends on the distribution
model for the error term j . In most cases, the error term is assumed to be normally
distributed with mean zero and covariance matrix Σ, i.e. j ∼ N(0,Σ).
In a very general setting without any restrictions to Σ, the correlated noise can be cap-
tured by j . However, for microarray experiments such a general unrestricted setting for
Σ can not be used, since the high dimensionality requires too high sample sizes to allow
an estimation of all parameters. Therefore, many approaches neglect the correlations by
choosing Σ to be diagonal, i.e. with all off-diagonal elements set to zero. More advanced
methods account for the correlated noise terms using a multi-step approach, combining
the regression model with a PCA analysis on the residuals to identify so called `surrogate
variables' that may have confounding effects [187]. Other approaches restrict the flexibility
of Σ even more, by assuming a certain similarity of the diagonal elements in an empirical
Bayes setting [188].
These different methods can have very large effects on the statistical significance assess-
ment, increasing the power of detecting significant differences or reducing bias that can
result from unmodelled correlated noise. However, we are not directly interested in the
statistical significance, but aim to get estimates of the vectors ui and wl. These estimates
are independent of the covariance matrix and are therefore not affected by the specific
structure of the covariance matrix. Therefore, we assume for simplicity a normal distribu-
tion with diagonal covariance matrix Σ and no further constraints. This results essentially
in a linear model for each gene, i.e. it can be evaluated gene wise. The unknown variables
ui and wl can then be determined by an ordinary least squares fitting of the model to the
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data, which is the best linear unbiased estimate according to the Gauss-Markov theorem
[189, 190].
The ability to determine appropriate directions in a supervised manner depends strongly
on the availability and the reliability of a priori phenotypical information. In the following,
we use the cell type annotation in the Lukk et al. [12] dataset for supervised dimension
reduction. Thus, we use a regression model with binary information only, which can be
described by
yj =
db∑
i=1
aijui + j , (3.10)
In this special case the aij have distinct support, meaning that a single sample is always
associated with a single cell type. Therefore, the regression estimates ui equal the mean
values of all samples corresponding to a specific cell type. When we include an intercept
for each gene, ui equal the difference between the mean values of all samples corresponding
to a specific cell type and the overall mean of all samples.
This results in one direction or signature per tissue type or cell line, i.e. in the case
of the Lukk dataset this approach would generate 369 signatures corresponding to the
respectively annotated groups of samples. Geometrically, each of these signatures is the
vector pointing from the overall mean to the mean of the respective tissue or cell type in
the log-transformed expression space.
Due to the use of log-transformed data, the difference between the two mean values equals
the logarithmic fold change. Other approaches, e.g. a (modified) t-test based comparison
[72] or support vector machines, can also be used, but do not have such a straightforward
interpretation in terms of a vector between two well defined points.
The approach described so far does not have any restriction with respect to orthogonality
of the tissue specific vectors. Therefore, it is not surprising that there are relatively strong
correlations between the signatures (Fig. 3.4). These correlations are to a large extent
due to general joint processes like proliferation, or similarities between cells or tissues with
similar functions or cellular compositions, e.g. between hematopoietic cells or different
brain regions, as can be seen in the PCA analysis in section 3.2.2.
3.3.2. Advantages and disadvantages of supervised dimension reduction
The advantages of a supervised dimension reduction in comparison to an unsupervised
dimension reduction are the direct interpretability of the directions due to the direct link
to a phenotypical annotation as well as the ability to detect directions that are represented
by very few samples. Such directions are often not detected by unsupervised methods due
to their sample size dependence as described above.
The main disadvantage of supervised dimension reduction techniques is that the specific
structure in the data must be known beforehand, i.e. it is necessary to specify a precise
statistical model, and all independent variables in this model must be known a priori.
Furthermore, the directions that are found by the supervised method are not necessarily
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Figure 3.4.: Correlation matrix of the 369 tissue specific signatures derived from the Lukk
[12] dataset, showing strong correlations between different signatures. Several
clusters can be identified (boxes and text) that are similar to the main clusters
identified by PCA in Fig. 3.2. The ordering is based on hierarchical clustering
of the columns and rows of the correlation matrix (euclidean distance, complete
linkage).
orthogonal. In fact, these directions can have very high correlations as can be seen in the
example of cell or tissue type based dimension reduction of the Lukk [12] dataset (Fig.
3.4). This complicates a proper projection onto the space spanned by these directions,
especially when singular matrices occur.
The requirement to know all independent variables of the model can be critical when using
retrospective datasets without a standardised annotation.
Furthermore, especially continuous variables that are represented by the coefficients cl in
the illustrative statistical model (equation (3.1)) are often not available at all. A prominent
example is the proliferation rate of the cells, which has a strong effect on the overall gene
expression [68], as can be seen by the PCA analysis (Fig. 3.2). The information on the
proliferation rate of cells is usually not available. Therefore, it is not possible to detect
such directions in a supervised setting.
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The non-orthogonality of the directions is critical for several tissues or cell types. There
are several groups of tissues that have relatively high correlations, such as the brain tissues,
hematopoietic cell types, incompletely differentiated cells, muscle tissues, solid tissues, or
cell lines in general (Fig. 3.4). Together with the finding from the PCA analysis in section
3.2.2, this indicates that there is some tree-like structure in the expression space. According
Overall mean 
Brain Hematopoietic Cell Line … 
Cerebellum 
Frontal cortex 
… T cells 
Macrophages 
… HUVEC 
MDA MB231 
… … 
… 
… 
Figure 3.5.: Illustration of the tree-like structure in the gene expression space. There are
some directions that are shared by several cell types, e.g. by brain tissues
from different regions or by different cell lines. However, at a finer scale these
tissues or cell types are also different from each other. The joint directions of
these more detailed tissue types lead to a relatively strong correlation in their
gene expression.
to this structure, larger groups of different tissues can be first separated from each other
and split into smaller groups afterwards (Fig. 3.5). These joint directions of several cell or
tissue types lead to relatively strong correlations among them. Therefore, the supervised
dimension reduction with vectors pointing directly to the annotated cell or tissue types
leads to relatively large correlations between directions.
Supervised methods that impose a tree structure, e.g. decision trees, use directly the given
variables, i.e. genes, to find an appropriate tree for classification. Therefore, they do not
search for new directions, i.e. combinations of genes, to build up the tree. Thus, as long
as the detailed tree structure is not known, it is not directly possible to account for it by
supervised methods.
Now, one might argue that there is also a tree-like structure in tissue ontologies, which is
also exploited by existing methods, e.g. by the URSA method [10] (section 2.4.2). How-
ever, this does not necessarily fit to the tree-like structure in the data. For example, cell
lines are usually close to their tissue of origin in the BRENDA tissue ontology, e.g. a
breast cancer cell line can be found under breast - breast cancer cell - breast cancer cell
line. However, the data analysis based tree structure suggests that cell lines are relatively
far apart from their tissue of origin and constitute a separate branch in the tree.
One alternative possibility would be to use orthogonalisation strategies in order to reduce
the correlation structure in the tissue specific vectors. While this may be of advantage, it
reduces the interpretability of the directions and it still does not impose a tree-like struc-
ture as depicted in Fig. 3.5. Instead, it keeps one vector as it is, e.g. the vector pointing
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directly to cerebellum tissues, and forces all other vectors to be orthogonal to this vector.
This procedure is then repeated, leading to a subsequent orthogonalisation of all vectors.
Therefore, the vector pointing to cerebellum includes also the general brain expression pat-
tern, while the vectors associated with all other brain regions do not contain this general
expression pattern. This leads to a successively decreased information content and does
not allow a proper comparison of the different brain regions due their unequal treatment.
In summary, unsupervised methods are well suited to detect joint processes, whereas su-
pervised methods are better suited to detect tissue or cell type specific expression patterns.
This complementarity in the strengths of the individual methods is used in the following
to combine them by a subsequent application of the two approaches.
3.4. Combining unsupervised and supervised dimension
reduction techniques
3.4.1. Construction of the two-scale map
As indicated in the previous sections, the unsupervised and supervised methods have com-
plementing strengths and weaknesses with respect to finding biologically relevant directions
in the expression space. Therefore, we will now combine the unsupervised PCA with the
supervised regression-based dimension reduction approach.
To this end, we use the first three PCs of the Lukk [12] dataset to define a principal com-
ponents space (PCA space) and complement it by a supervised tissue specific space. The
PCA space is restricted to the first three PCs since the fourth PC is already associated
with an array quality metric as discussed before. Furthermore, the first three PCs of the
Lukk dataset [12] and our own dataset span similar spaces (see section 3.2.2), being in-
dicative of some robustness of the three dimensional space with respect to differences in
data composition.
The supervised tissue specific space is then determined by the fold change based proce-
dure described above, which is now applied to the PCA residual space, i.e. to the residual
expression which is not captured by the three dimensional PCA. The advantage of such
a decomposition into two different spaces is that much of the correlation is captured in
the orthogonal PCA space. Therefore, correlations in the residual space are significantly
reduced (Fig. 3.6, left).
Lukk et al. [12] hypothesise that the expression space has a very low intrinsic dimension-
ality, apart from more detailed differences. In this respect, we could partly confirm their
results based on the analysis of an alternative large dataset. However, we hypothesise
that there is significant and relevant information in the residual space that should not be
neglected. Hence, we argue that it is worth to extend the analyses of [12].
To argue for the hypothesis of significant and relevant information content in the residual
space, we would first like to hint to the differences between the PCA analyses of the Lukk
dataset [12] and our own dataset, especially on the fourth component. Furthermore, we
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Figure 3.6.: Residual tissue specific signatures after PCA based decomposition show
strongly reduced correlations between each other (left). Only very few clusters
remain in comparison to Fig. 3.6 (the ordering of signatures is kept constant).
In contrast, correlations between samples within a specific tissue or cell line
remain high (right). Shown are the within group correlations of the 96 groups
that contain at least 10 samples before (abscissa) and after (ordinate) PCA
based decomposition.
could show that principle components analysis on subsets of the data is able to find more
detailed structures that fit well to the annotation of cell types. Apart from that, we could
explain the possible reasons for detecting measurement noise already in the fourth princi-
ple component, and showed that different choices of data can reveal other directions that
exceed the noise level (Fig. 3.3, left).
Another validation of our hypothesis is depicted in Fig. 3.6 (right). It shows the cor-
relation of different samples within individual tissue or cell types. According to the low
dimensional hypothesis, one would expect that these correlations within a specific group of
samples would be around zero in the residual space, since almost the entire tissue specific
signal would be captured by the PCA space. However, this is not the case. Indeed, the
within group correlation is only slightly reduced in the residual space (Fig. 3.6, right)
and is significantly larger than zero for all of the 96 cell types with at least 10 samples
that were used for this analysis. Furthermore, a manual investigation of the residual space
vectors suggests that typical tissue or cell type specific genes, e.g. POU5F1, NANOG, or
LIN28A for the ESC signature, are among the genes with highest residual expression for
the respective tissue. Therefore, the residual space still contains important tissue or cell
line specific information.
Similar results can be obtained for our own dataset (Fig. 3.7 and Fig. B.3). Therefore, it
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Figure 3.7.: The tissue or cell line specific signatures derived from our own dataset show
similarly strong correlations as those derived from the Lukk dataset [12] (left).
Correlations diminish strongly after PCA based decomposition (right).
does make sense to extend the three dimensional PCA space by a tissue specific residual
space that is determined by supervised methods as follows.
Two-scale map generation using a reference dataset
Input: Reference dataset X (columns correspond to genes), factor f specifying the
group membership (e.g. according to tissue/cell type)
1. Determine the gene-wise mean µ of the entire reference dataset: µ = 1n
∑n
j=1Xj·
2. Perform a PCA, via a singular value decomposition (svd) on the centered refer-
ence dataset: U ·D · V T = svd(X − µ)
3. Choose the first principal components that have a clear biological meaning (vi-
sual evaluation according to the available annotation, here: first 3 PCs) as PCA
space: PS = (V·i)Ti=1,2,3
4. Determine the residual expression: R = X − µ− (U·i)i=1,2,3 · (Dji)i,j=1,2,3 · PS
5. For each factor level k of f :
a) Determine the gene-wise mean R˜Sk· of all samples corresponding to this
group: R˜Sk· = 1nk
∑
j∈level(k)Rj·
b) Determine the residual tissue specific space RS by a normalisation of the
rows of R˜S to length one: RSk· = R˜Sk·/||R˜Sk·||
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We refer to this combination of the PCA space and the residual tissue specific space
as a two-scale map of gene expression, since the two spaces capture different scales, fit-
ting well to the concept of a tree-like structure in the expression space. The PCA space
captures the joint processes, e.g. proliferation, or joint expression patterns of the brain
and hematopoietic tissues/cell types. Thus, it operates rather on the middle layer in the
tree-like representation (Fig. 3.5). The residual tissue specific space extends this rough
separation then to the more fine-scaled differences in the lower layer of the tree structure.
In the next chapter we will apply the method for the characterisation of several different
microarray samples and compare the two-scale approach to the purely supervised dimen-
sion reduction. We will concentrate on the Lukk dataset [12] for this purpose as its three
leading PCs offer a simpler biological interpretation, but will sometimes switch to our own
dataset, when the cell types included in this dataset fit better to the respective application.
Before doing so, we want to evaluate the relevant information content in the PCA space
and provide further evidence that there is a lot of relevant information not captured by
the PCA.
3.4.2. Estimating the amount of relevant information in the PCA and
residual space via the information ratio
We have described the concept of information loss and the properties of PCA for minimi-
sation of it (see section 3.2.1). In this section we will use a slightly different information
criterion to determine the amount of relevant information that is captured by the three di-
mensional PCA space compared to the information in the other dimensions. The so-called
`information ratio' criterion was introduced by Schneckener et al. [83]. It determines the
ratio of information with respect to a specific phenotypic difference that is contained in
the residual space, i.e. in the space that is not captured by the first three or four PCs.
Here, the information with respect to a phenotypic difference is measured by the negative
logarithmic p-value of a t-test between the samples of two phenotypes. The ratio of infor-
mation in the residual space is determined for each gene and combined as a weighted sum
as described in more detail in the following.
Calculation of the information ratio (IR)
Input: Dataset X (columns correspond to genes), binary factor f specifying the group
membership
1. Determine the gene-wise mean µ of the entire reference dataset: µ = 1n
∑n
j=1Xj·
2. Perform a PCA, via a singular value decomposition (svd) on the centered refer-
ence dataset: U ·D · V T = svd(X − µ)
3. Choose the first k principle components as projection space and determine the
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projected data: P = µ+ (U·i)i=1,...,k · (Dji)i,j=1,...,k · (V·i)Ti=1,...,k
4. Determine the residual expression: R = X − P
5. Calculate for the datasets X, P , and R for each gene the log10 p-values between
the two groups specified in f using a t-test. These log-p-values are named lpX,
lpP, and lpR, respectively.
6. Determine a weight wi = e−λ·lpXi , for each gene i where λ is the slope of the
logarithmic density of the lpX values, which typically follow an exponential
distribution [83].
7. Calculate the information ration IR as
IR =
1∑
iwi
∑
i
wi
lpRi
lpRi + lpPi
One important finding reported by Schneckener et al. [83] is that, in their datasets,
almost all phenotypic information with stable differential gene expression is contained in
the first four PCs. This finding suggests that almost all relevant information content can
be captured by four dimensions. This result would support the finding of Lukk et al. [12],
stating that the overall dimensionality of the gene expression space is very low. Note that
we use only the first three PCs, since the fourth PC of the Lukk dataset [12] represents
noise. Using the first four PCs leads to the same conclusions (data not shown).
In stark contrast to this result, an analysis of the number of controlling nodes in the gene
expression network that are required to fully control the network results in much higher
numbers. In fact, it was estimated that roughly 80% of all nodes must be controlled [191],
which results in a very high number for a network with roughly 20,000 genes. However,
as noted in [192], this analysis does not take into account the co-regulation and feedback
loops that restrict the admissible space to a rather low dimensionality. Furthermore, we can
currently not expect to be able to control any node in a gene regulatory network. Therefore,
we will mainly measure stable states of the gene regulatory network that correspond to
attractors of the regulatory network.
In this context, it is very interesting to investigate in more detail whether we can really find
information beyond the low dimensional PCA space in large gene expression datasets, using
the information ratio criterion. As indicated above, this was not the case for the datasets
investigated in [83]. However, their datasets were usually focused on a more narrow set of
cell types or tissues, e.g. on breast cancers or lung cancers. In contrast, we analyse a very
heterogeneous dataset with hundreds of different cell or tissue types. Therefore, it will be
interesting to see how much relevant information is contained in the first three PCs for the
Lukk et al. [12] dataset.
To this end, we determine the information ratio for comparisons of various different tissues
or cell types. Each of these cell or tissue types has at least 10 samples in the dataset. We
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choose the PCA dimensionality as k = 3, i.e. we determine the amount of information
in the three dimensional PCA space compared to its complement. Some representative
results of this investigation (six comparisons) are depicted in Fig. 3.8, where we compare
the log10 p-values in the PCA space and its complement to those in the original data.
Here, the PCA space is determined based on the full dataset and not only on the set of
tissues/cell types that are compared.
These examples show, that in cases where both groups are in the same large scale group,
e.g. where both are cell lines (pc3 prostate cancer vs. ssMCF7 breast cancer), both are
solid tissues (heart vs. kidney), both are hematopoietic cells (B cells vs. T cells), or both
are brain tissues (cerebellum vs. caudate nucleus), the main information is contained in
the residual space. In contrast, when the compared groups are in different large scale
groups, e.g. cerebellum vs. B cell, or ssMCF7 breast cancer vs. breast cancer, there is
more information in the PCA space. This is due to the large scale differences between these
groups that are captured by the PCA space. Nevertheless, there is still some significant
information also in the residual space, as can be seen by the significant p-values and by the
IR values that are still above 0.3. These results fit very well to our previous results, showing
that the PCA space distinguishes mainly between the 6 large scale groups (hematopoietic,
brain, incompletely differentiated, cell line, muscle, and solid tissue) and finer differences
lie mainly in the residual space.
Furthermore, these results confirm that there is a significant amount of tissue specific
information in the residual space and that at least the linear intrinsic dimensionality of
the gene expression space is clearly higher than 3.
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Figure 3.8.: Information partition between the PCA space and its complement for 6 differ-
ent comparisons. Blue (red) points depict the log10 p-value in the PCA space
(the residual space) in comparison to the log10 p-value in the original dataset.
The corresponding IR values are 0.7436 (pc3 prostate cancer vs. ssMCF7
breast cancer), 0.8887 (heart vs. kidney), 0.8364 (B cell vs. T cell), 0.7188
(cerebellum vs. caudate nucleus), 0.3041 (cerebellum vs. B cell), and 0.3350
(ssMCF7 breast cancer vs. breast cancer).
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4. Using the two-scale map to
characterise new data
4.1. Mapping new data onto the two scale map
4.1.1. Linear mapping
Having constructed the PCA and residual tissue specific spaces, it is now possible to map
new data onto these spaces in order to characterise them in terms of their location relative
to well known tissues or cell lines. Such a mapping can be done in a linear way by the
following two subsequent steps. First, the new data are mapped to the PCA space. This is
done by subtraction of the overall mean vector from the Lukk [12] dataset and subsequent
scalar multiplication with the three principal components from the PCA space. Second,
the residual expression of the new data is determined and scalar multiplied with the nor-
malised (to length one) tissue specific vectors of the residual tissue specific space.
Linear mapping of new data onto the two-scale map
Input: New data Y (columns correspond to genes), PCA space PS, residual tissue
specific space RS
1. Subtract the gene-wise mean µ of the platform specific reference dataset from
the data: Yres = Y − µ
2. Project the data onto the PCA space: PSY = PS · Y ′res
3. Determine the residual expression: R = Yres − PS′Y · PS
4. Project the residuals onto the tissue specific space: RSY = RS ·R′
4.1.2. Mapping to different microarray platforms
This mapping is only directly applicable to new samples from the same microarray platform.
However, there are many different microarray platforms and new samples are usually not
hybridised to the relatively old Affymetrix Human U133A array, which was used to generate
the Lukk [12] dataset. Therefore, it is necessary to transform the two-scale landscape to
other microarray platforms. This can be done by a matching of probe identifiers via their
corresponding genes.
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Figure 4.1.: Illustration of the differences in the expression space for measurement signals
from two different platforms (squares and triangles) compared to the initial
RNA content (circles). Plotted are simulated RNA contents and measurement
signals (both in log2-scale) of two genes (gene A on the abscissa, gene B on the
ordinate) from three different cell types (blue, green, and red). The RNA to
signal intensity transformations (inset) are calculated based on the Langmuir
equation (2.9) with the parameters as specified in the figure. A substantial shift
in the expression values can be immediately observed, while the shortening of
the arrows (due to the flattening of the hybridisation curve at both ends),
as well as the slight change in their directions, is less pronounced. Grey dots
represent the mean values of the RNA content (circle) and the signal intensities
for the two platforms (square and triangle). The black arrow illustrates the
transformation from RNA content to signal intensities via the curves in the
accompanying inset.
However, absolute values are usually not directly comparable between different plat-
forms, since differences in the parameters of the curve describing the relationship of RNA
content and measurement signal (section 2.3.2) often lead to clear shifts in the expression
space (Fig. 4.1). Therefore, it is important to correct for this shift. In the present the-
sis, this is done by exchanging the mean expression value of the Lukk [12] dataset in the
above mapping procedure by the mean value of a reference dataset of the new microarray
62
A Two-Scale Map of Global Gene Expression RWTH Aachen University
platform. Due to the large number of different tissues and cell lines in each of the used
reference datasets, the mean values should not contain large amounts of tissue specific
expression. Therefore, exchanging the mean value of the Lukk dataset by the mean value
of the new reference dataset should remove the platform dependent shift relatively well. A
comparison to the use of the mean from the Lukk dataset showed that using the platform
specific mean gives better results (data not shown). Besides the shift in the expression
space, the lengths of vectors pointing to a specific tissue will also change do to differences
in the RNA to measurement signal curves (Fig. 4.1) as well as differences in the number
of (matching) probes on the array. However, such differences in the lengths of vectors are
not critical since the values are compared to a reference dataset from the same platform
anyways. What is more important is the similarity of directions on both arrays, i.e. that
for a fixed underlying RNA content, the tissue specific vectors on both array types have
similar directions (Fig. 4.1).
This is not critical for the almost linear phase of the log-log curve describing the relation-
ship of RNA content and measurement signal. More critical are both ends of the curves,
where non-linearities occur. However, the non-linearities have a similar shape for all inves-
tigated microarray platforms, resulting in relatively small differences in directions.
Methods for batch effect removal, e.g. using empirical Bayes methods [193], can also be
used for cross-platform normalisation [194]. Such methods usually account for gene wise
additive and multiplicative batch effects and thus concentrate on removal of noise. This
is especially well suited to adjust measurement signals within one specific group of sam-
ples, i.e. from one specific phenotype. That is, they can be nicely used to integrate data
across platforms for determination of differentially expressed genes between two pheno-
types. However, such approaches rely on a relatively well balanced number of samples
for each phenotype and microarray platform. In contrast, the reference datasets which
we consider here may not at all contain a sample of a specific tissue which is present in
the Lukk dataset. Therefore, there is an increased risk of removing valuable biological
information along with the platform differences. Therefore, these methods seem not to be
well suited to remove the non-linear effect seen in the RNA to signal curves.
A first explicit evaluation of the mapping across platforms is shown in Fig. 4.2, projecting
the first three principal components of the Lukk [12] dataset to either the Affymetrix Hu-
man Gene 1.0 st-v1 platform (Fig. 4.2, top) or the previously described own dataset from
the Affymetrix Human U133 Plus 2.0 platform (Fig. 4.2, bottom). Both projections show
very nice results with a very good separation of the hematopoietic cells, brain tissues, and
cell lines from all other samples.
4.1.3. A non-linear rank based mapping method with gene set selection
As an alternative to the linear mapping method, it is also possible to use non-linear map-
ping methods, e.g. in order to increase the influence of specific genes on the mapping or to
account for non-linearities in the data. Here, we describe one non-linear mapping method
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Figure 4.2.: Mapping of the first three principal component of the Lukk [12] dataset
(Affymetrix Human U133A array) to two different Affymetrix platforms,
namely the Affymetrix Human Gene 1.0 st-v1 (top), and Affymetrix Human
U133 Plus 2.0 (bottom) platforms. Both mappings reveal a clear separation
of hematopoietic cells, brain tissues, and cell lines from other samples. This
confirms the possibility to robustly project the three dimensional PCA space
from [12] to other Affymetrix arrays.
with gene set selection that we use as an alternative to the linear mapping.
Non-linear rank based methods with gene selection have been proposed by several groups
[69, 72, 195] for determination of signature associations. These methods are similar to gene
set enrichment analysis (GSEA) [63, 64, 196], but perform gene selection on the microarray
data, rather than using predefined gene sets. The method used in this thesis is similar to
that from Lenz et al. [72], but with a different selection of gene sets. It is implemented
according to the following workflow:
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Non-linear mapping of new data onto the residual tissue specific space
Input: Residuals R from the new data (columns correspond to genes), residual tissue
specific space RS
For each row i of the residual tissue specific space:
1. Determine two gene sets GT and GB consisting of the top and bottom 1% genes
of RSi·, respectively
2. Calculate a Wilcoxon rank sum test between the genes in GT and GB for each
row Ri· in the residuals of the new data
3. Determine the signed log10 p-value of the Wilcoxon test as mapping quantity
The performance of the linear and non-linear mappings will be compared in detail in the
following section. However, some principal advantages of the linear mapping over the non-
linear mapping can already be stated at this point. The linear mapping does not depend
on any cutoff parameters or other choices of methodological details, preventing discussions
about their best choices. Furthermore, the linearity simplifies the relative comparison of
different samples, since the order of operations does not matter. That means, it does not
matter whether the difference building to the other sample or the mapping is performed
first due to the linearity of both operations. This property facilitates an easy comparison
to multiple reference samples without a recalculation of the mapping.
Due to these practical advantages, we will focus on the linear mapping unless the non-
linear mapping turns out to have significant advantages with respect to the accuracy of
the results. Therefore, we will compare both kinds of mapping in the following evaluation
part.
4.2. Evaluation
4.2.1. Mapping various tissues to the two-scale map
For a first evaluation of the two-scale map approach, 24 samples from the Gene expression
omnibus (GEO) dataset GSE18674 are used, consisting of 22 different tissues and 2 cell
lines that were hybridised to the Affymetrix Human U133 Plus 2.0 array. This array has
many probes in common with the Affymetrix Human U133A array. Therefore, platform
specific effects should be relatively small.
Mapping to the PCA space
Mapping of the 24 samples to the three dimensional PCA space leads already to a clear
separation of several tissues. Especially brain tissues (fetal brain, cortex, cerebellum,
and spinal cord) and hematopoietic tissues (bone marrow, spleen, and thymus) as well
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as cell lines (HELA and SHSY5Y) are clearly separated (Fig. 4.3). Furthermore, the
neuroblastoma cell line SHSY5Y reveals a certain similarity to neural tissues on the third
principal component, showing that the tissue of origin has still a certain influence. A
surprising observation is the tendency of the lung sample towards a hematopoietic similarity
(Fig. 4.3). This may be explained by a commonly observed relatively strong immune
activity in the lung [197].
Figure 4.3.: Mapping of 24 tissues or cell lines from GSE18674 to the PCA space.
Hematopoietic tissues (bone marrow, spleen, and thymus) are separated on
the first principal component (PC) and cell lines (HELA, and SHSY5Y) are
separated on the second PC (left). Brain tissues (cortex, cerebellum, fetal
brain, and partially spinal cord) and the neuroblastoma cell line SHSY5Y have
distinct expression on the third PC (right). Background colours correspond
to the samples from Fig. 4.2, i.e. orange: hematopoietic, yellow: hematopoi-
etic cell line, red: brain, green: cell line, magenta: muscle, blue: incompletely
differentiated, grey: other
Mapping to the residual tissue specific space
Among the 22 tissues, several can be expected to have very similar expression values due
to the similar functions of these tissues, e.g. different regions of the brain or tissues from
the colon and the small intestine. It is therefore of special interest how good these tissues
can be separated in the residual tissue specific space. The result of the linear mapping
of the data to the residual tissue specific space is depicted in Fig. 4.4. This mapping
shows a very specific classification into the different tissues. Notably, even different brain
regions, i.e. cerebellum (second column), cortex (fourth column), and spinal cord (15th
column) show clear differences in corresponding signatures of the residual tissue specific
space. The cerebellum sample is specifically associated with the cerebellum signature, the
cortex sample is associated with the brain signature, and the spinal cord sample is most
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strongly associated with the hypothalamus signature.
Sample Two-scale linear One-scale linear Two-scale non-linear
Bone marrow Bone Bone Chronic myeloid leuk.
Cerebellum Cerebellum Cerebellum Cerebellum
Colon Colon mucosa disease Colon mucosa disease Colon mucosa disease
Cortex Brain Brain Brain bipolar disorder
Fetal brain Brain Brain Brain
Heart Heart disease Heart disease Heart disease
Kidney Kidney epithelium Kidney epithelium Kidney epithelium
Liver Cirrhosis Cirrhosis Cirrhosis
Lung Lung Lung Lung
Pancreas Cirrhosis Cirrhosis Kidney
Prostate Prostate gland Prostate gland Prostate gland
Salivary gland Thyroid gland Thyroid gland Oropharynx
Skeletal muscle Skeletal muscle dis. Skeletal muscle dis. Skeletal muscle
Small intestine Small intestine Small intestine Small intestine
Spinal cord Hypothalamus Hypothalamus Hypothalamus
Spleen Lymph node Lymph node Lymph node
Stomach Esophageal adenoc. Lung Bladder mucosa
Testes Testis Testis Testis
Thymus Thymocyte Thymocyte Thymocyte
Thyroid Thyroid adenoc. Thyroid adenoc. Thyroid gland
Trachea Bronchial epithelia Esophagus Barretts Bronchial epithelia
Uterus Myometrium Myometrium Myometrium
HELA HeLa cervical adenoc. HeLa cervical adenoc. HeLa cervical adenoc.
SHSY5Y SK-N-SH neuroblast. SK-N-SH neuroblast. SK-N-SH neuroblast.
Table 4.1.: Tissue signatures with highest values for the 24 different tissues/cell lines from
GSE18674. For several tissues (bone marrow, colon, fetal brain, pancreas,
salivary gland, spinal cord, spleen, stomach, and trachea) there is no directly
matching signature in the tissue specific space. Note that myometrium is the
middle layer of the uterine wall and thus represents a correct identification of
the uterus sample. Furthermore, the SHSY5Y cell line was derived from the
SK-N-SH cell line to which it has the highest association.
The fetal brain sample (5th column) has, besides signals in the brain and cortex sig-
natures, also some association with neuroblastomas, which can be attributed to the more
immature, incompletely differentiated status of fetal brain compared to adult brain.
The SHSY5Y neuroblastoma cell line shows also a specific signal in neuroblastoma sig-
natures, being most strongly associated with the SK-N-SH neuroblastoma cell line, from
which it was originally derived [198].
The other tissues and cell lines can also be correctly identified in many cases (Table 4.1),
but for several tissues there is no matching tissue signature in the Lukk [12] dataset, pre-
venting the possibility of correct identification. This issue can potentially be resolved by
the use of different datasets or by adding further data to the Lukk dataset. For example,
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using the own dataset instead of the Lukk dataset leads to a correct identification of all
22 tissues (Fig. B.4). However, it has to be admitted that the data from GSE18674 are
already part of the own dataset and were therefore used in the generation of this alternative
two-scale map.
Comparison to the one-scale approach
Another interesting point is the comparison of the two-scale and the one-scale approach,
i.e. with and without PCA based decomposition. Use of the one-scale approach on the
Lukk dataset results in a less detailed and specific distinction of different brain regions
(Fig. 4.5, note the different selection and order of the visualised tissue signatures, i.e.
rows), although the top scoring signatures are in most cases the same (Table 4.1). This
less clear distinction reflects the considerably higher correlation in the tissue specific space
without PCA based decomposition observed above (Fig. 3.4). Therefore, we will focus on
the two-scale approach in the remaining part of this chapter.
Linear versus non-linear mapping
The non-linear mapping has similar top scoring signatures as the linear mapping (Table
4.1), with some slight differences mainly for those samples that do not have a directly
matching signature in the two-scale map, e.g. pancreas or stomach. However, a detailed
visual inspection of the heat map depicting the non-linear mapping to the residual tissue
specific space suggests an even clearer distinction of the top scoring signatures from the
less associated ones (Fig. 4.6). This could be interpreted as an advantage of the non-linear
mapping.
A more quantitative investigation of the differences between the linear and the non-linear
mapping reveals interesting insights into their relation. Two different effects can be ob-
served in this quantitative investigation that explain the visual advantages of the non-linear
mapping. First, the score obtained by the non-linear mapping can be nicely represented
by a signed quadratic dependence on the linear mapping in a certain range (Fig. 4.7, Fig.
B.5, appendix A). This can be attributed to the almost quadratic relationship between the
test statistic and the log10 p-value for normally distributed test statistics (appendix A)
and would suggest that there is an almost linear relationship between the Wilcoxon test
statistic and the linear mapping in a certain range. The quadratic relationship leads to a
relative suppression of scores with a lower test statistic compared to those with a higher
test statistic, resulting in a seemingly more specific distinction of the respective signatures.
The second effect, which can be seen in the quantitative investigation, is a saturation effect.
The Wilcoxon test has a certain minimal possible p-value due to the rank based test statis-
tics. This results in a maximum absolute value of roughly 37 for the non-linear mapping in
the present example (horizontal line in Fig. 4.7 and Fig. B.5; appendix A). This saturation
may be interpreted in such a way that the non-linear mapping provides information about
the similarity of directions, neglecting information about the length of the vector showing
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Figure 4.4.: Linear mapping of the 24 tissues or cell lines from GSE18674 (columns) to the
residual tissue specific space of the Lukk [12] dataset (rows). Visualised is a
selection of the 369 tissue specific signatures, including the most significant
ones (see section A). Colours range from blue and green (negative association
with the signature) over yellow (no association) to orange and red (positive
association) as indicated by the colour bar at the top.
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Figure 4.5.: Linear mapping of the 24 tissues or cell lines from GSE18674 (columns) to the
tissue specific space without PCA based decomposition (rows). The heatmap
clearly reveals the higher correlations between different signatures compared
to Fig. 4.4, especially between those corresponding to different brain regions.
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Figure 4.6.: Non-linear mapping of the 24 tissues or cell lines from GSE18674 (columns) to
the residual tissue specific space (rows). The results are more distinct as for
the linear mapping, with a higher difference between best matching signatures
and more weakly associated ones.
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Figure 4.7.: Comparison of the linear and non-linear mapping methods exemplified at a
bone marrow and a liver sample from dataset GSE18674. The non-linear
mapping can in a certain range be approximated by a sign-preserving quadratic
transformation of the linear mapping. However, at higher values a saturation
effect can be observed due to the p-value limitations of the Wilcoxon rank sum
test for fixed sample sizes (here number of probes).
in the respective direction (appendix A). Thus, the maximal value corresponds to an exact
match of the directions, limiting the similarity score to a certain value.
The effect of this limited values on the heat map representation in Fig. 4.6, is that the
maximal values in each column are more similar to each other since they are all limited
by the value of 37. In contrast, for the linear mapping the maximal values of the samples
(columns) differ more strongly, resulting in a less pronounced colouring for some of the
samples. The linear mapping can be adjusted to determine similarity of directions by a
division through the length of the residual data vector. This introduces also a limitation
in the values and leads to more similar maximal values between the columns in the heat
map (Fig. B.6).
In summary, for the 24 tissues and cell lines from dataset GSE18674, the linear and non-
linear mappings result in similar rankings of the tissue signatures and visual advantages of
the non-linear mapping can be removed by non-linear transformations of the linear map-
ping scores. However, this is not generalisable to all data, as can be shown by the examples
in the next section.
4.2.2. Liver and breast cancer mixture data
So far the considered samples had a very clear association with single signatures due to
the purity of the tissues. However, cell preparations may be mixtures of different cell
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or tissue types, or may have only a relatively weak association with a specific signature.
Mixture samples are a good means to check the behaviour of the two-scale map in these
circumstances, since the true composition of the sample is still known, while the association
with a specific tissue may be weak, e.g. due to a relatively low mixture fraction of this
tissue. In the following, two different mixture datasets are discussed. One mixture of liver
and breast cancer tissues which is investigated in the present section and one of heart and
brain tissues, which will be investigated in the next section.
Dataset GSE33116 contains several samples of mixed liver and breast cancer tissues with
mixture fractions of 0%, 5%, 10%, 15%, 20%, 25%, 50%, 75%, 80%, 85%, 90%, 95%, and
100% liver and the reverse amounts of breast cancer tissue. There are several replications
of these mixture fractions in the dataset, but we consider only a single sample per mixture
fraction (see appendix A for more details). The mixed RNA of this dataset has been
hybridised to the Affymetrix Human U133A array, i.e. the same array which was used for
the Lukk [12] dataset. Therefore, the results are not influenced by any platform dependent
effects.
Mapping to the PCA space
Figure 4.8.: The PCA map of the liver and breast cancer mixtures shows slight changes
with changing mixture fractions. Most significant changes can be observed on
the third principal component, where breast cancer samples (0% liver) lie at
relatively extreme values, while liver samples (100%) lie in the middle range.
The mapping of these data to the PCA space shows a monotone curve on the neural
axis (Fig. 4.8), where the breast cancer sample is on the opposite site of the brain tissues
and the liver sample lies in the middle of the non-neural tissues. The extreme value of the
breast cancer sample on the neural axis may indicate that the neural axis does not only
have an association with brain tissues, but also partly with breast cancer tissues, though
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with opposite direction. This is a general disadvantage of unsupervised methods, such as
PCA, that there might be some minor associations to certain tissues or cell types that are
hard to detect. That means, that the principal components may be associated not only
with a single tissue or general process, but with multiple tissue at the same time, where
the association to each individual tissue can be relatively weak. This problem is not very
pronounced in the first three principal components in the present case, but is significantly
more critical in further PCs.
Mapping to the residual tissue specific space
More interesting is the mapping to the residual tissue specific space, since this space con-
tains directions that are directly associated with breast cancer and liver. The linear map-
ping, reveals a clear association of the samples with high liver fraction to the liver, cirrhosis,
and hepatocellular carcinoma signatures, with a monotonously decreasing association for
decreasing liver fractions (Fig. 4.9). The association to the breast cancer signature is
much less clear, but a slightly increasing score with increasing breast cancer fraction can
be observed as well. There may be several reasons for this comparably weak signal, in-
cluding the generally high heterogeneity of cancer tissues or a relatively high similarity of
the breast cancer samples to many other samples in the Lukk [12] dataset, resulting in a
relatively short residual vector to the breast cancer samples. The latter explanation can be
approximately quantified by a determination of the distance of the mean liver and mean
breast cancer samples from the three dimensional PCA space. This distance is five times
higher for the mean liver sample than for the mean breast cancer sample. Therefore, the
linear projection onto the liver signature is substantially higher than for the breast cancer
signature.
Comparison to the one-scale approach
This difference in signal strengths is reduced in the tissue specific space without PCA based
decomposition, where we take the distance to the centre instead of the three dimensional
space. Compared to the previous case with PCA based decomposition, the distance of
the mean liver sample stays almost equal, while the distance of the mean breast cancer
sample doubles. This reflects the observation from above that some breast cancer specific
expression may already be contained in the neural axis of the PCA space, capturing some
of the breast cancer specific expression. Consequently, the breast cancer signal is more
pronounced in the tissue specific space without PCA based decomposition (Fig. B.8),
depicting an advantage of the one-scale approach. However, there are also considerably
higher associations to other cancer signatures in the one-scale approach. Furthermore, the
breast cancer signature is even slightly associated with the 100% liver sample in the one-
scale approach. This association is due to a positive correlation between liver and breast
cancer signatures, which also partially explains the already relatively strong breast cancer
signal for low breast cancer mixture fractions.
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In contrast to that, an opposite effect can be observed in the residual tissue specific space
of the two-scale map (Fig. 4.9), where a slightly negative breast cancer score is present for
the 100% liver sample. Thus, the relative change in the breast cancer score from 100% liver
to 0% liver is similar for both approaches, but the absolute values differ more strongly.
1.0 0.8 0.6 0.4 0.2 0.0
placenta basal plate
liver
cirrhosis
hepatocellular carcinoma
kidney
kidney epithelium
prostate gland
skin
adipose tissue normal
lymph node
bone
heart
skeletal muscle
ligament cell periodontitis
SKMC fetal skeletal muscle myoblast
preadipocytes
primary fibroblast
CCL−153 fetal pulmonary fibroblast
MRC5 fetal fibroblast 
WI38 fetal fibroblast
macrophage
monocyte
brain
frontal cortex Huntingtons
frontal cortex
caudate nucleus
hypothalamus
HCC1500 breast cancer
HCC lung adenocarcinoma
MDA−MB−231 breast cancer
acute myeloid leukemia
cerebellum
breast cancer
lung
B cell
hematopoietic stem cell
embryonic stem cell
universal reference
testis
neuroblastoma
monophasic synovial sarcoma
myometrium
uterine tumor
Jurkat T lymphocyte
T cell
−
88 88
10
0%
 L
ive
r
95
%
 L
ive
r
90
%
 L
ive
r
85
%
 L
ive
r
80
%
 L
ive
r
75
%
 L
ive
r
50
%
 L
ive
r
25
%
 L
ive
r
20
%
 L
ive
r
15
%
 L
ive
r
10
%
 L
ive
r
5%
 L
ive
r
0%
 L
ive
r
Figure 4.9.: Linear mapping of the mixtures of liver and breast cancer tissues (GSE33116)
to the residual tissue specific space. The monotonous decrease of the liver
association is paralleled by a slightly increasing association with the breast
cancer signature.
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Linear versus non-linear mapping
Interestingly, for this mixture example, the non-linear mapping shows a much stronger
association with the breast cancer signature than the linear mapping (Fig. 4.10).
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Figure 4.10.: The non-linear mapping of the liver and breast cancer mixtures to the residual
tissue specific space shows a considerably stronger signal for the breast cancer
signature as the linear mapping (Fig. 4.9).
Furthermore, a very strong association with the liver signature can be already detected
for the sample with only 5% liver RNA. Thus, according to this example, the non-linear
mapping is much better suited to detect very low fractions of specific cell types or tissues.
A similar result can be seen for the non-linear mapping applied to the one-scale tissue
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specific space, i.e. without PCA based decomposition (Fig. B.9). However, as for the
linear mapping, the increased correlations to other tissues leads to a positive signal in
other cancer signatures. Furthermore, an interesting observation is that these associations
to other primary cancer tissues are stronger than the association to breast cancer cell lines
in the one-scale approach, whereas it is the other way around in the two-scale approach.
That means, the second highest association of the 100% breast cancer sample is with
the lung cancer primary tissue in the one-scale approach. In contrast, in the two-scale
approach, the second highest association is with a breast cancer cell line. The reason for
this is the cell line specific expression which is captured in the second principal component.
Therefore, the two-scale map can better detect similarities between cancer cell lines and
their tissue of origin by removing cell line specific effects.
In contrast to the good performance for detection of tissues with small mixture fractions,
the non-linear method is not well suited for the estimation of mixture fractions, especially
for relatively large fractions. This can be exemplified at the example of the liver score,
which does hardly change between the 20% and 100% liver mixture fractions. This is also
reflected in Fig. 4.11, indicating that the liver and breast cancer scores have only slight
non-linear dependence on the mixture fractions for the linear mapping, while there is a
significantly more pronounced non-linearity for the non-linear mapping.
The main reason for these non-linearities is the logarithmic transformation of the mea-
surement signals, leading to sometimes very strong non-linear relationships between the
mixture fraction and the logarithmic measurement signals on which the calculations are
done (Fig. 4.12). This effect is additionally enhanced by the saturation effect in the re-
lationship between RNA content and measurement signal (section 2.3.2). It is generally
stronger for genes with a high fold change between the two mixed tissues than for genes
with a low fold change (Fig. 4.12). Therefore, it is not very surprising that the non-linearity
is considerably stronger for the non-linear mapping, which concentrates on the genes with
highest tissue specific expression. Due to the different strengths of the non-linear effect,
depending on the fold change of the respective gene between the two mixed tissues, there
is some non-linear structure in the residuals after mapping of the mixed samples to both
spaces (Fig. 4.13). That means, that the mixture samples depend non-linearly on the
respective tissue scores. This effect is not present for the pure tissue samples with 100%
liver or 100% breast cancer tissue (Fig. 4.13). Due to this non-linear effect, there are the
observed large differences between the linear and non-linear mapping approaches.
4.2.3. Heart and brain mixture data
Similar to the liver and breast cancer mixture data from the previous section, this section
considers Affymetrix mixture data with RNA of heart and brain samples mixed at different
mixture fractions and subsequently hybridised to a microarray [199]. In contrast to the
previous section, the samples were hybridised to the Affymetrix Human Gene 1.0 st-v1
array. Thus, platform specific differences may obscure the results and it will be interesting
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Figure 4.11.: Comparison of different mapping approaches for the liver and breast cancer
mixture data. The linear mapping with PCA based decomposition is closest
to a linear relationship between the liver (abscissa) and breast cancer (or-
dinate) signatures. The values for both signatures were normalised to have
values between 0 and 1. The maxima of both scores differ strongly for the
linear mapping with PCA (Fig. 4.9), while they are more similar for the other
mappings (Fig. 4.10, B.8, and B.9)
to see whether the mixtures can be identified correctly.
The investigated dataset contains samples with a mixture fraction of 0%, 5%, 10%, 25%,
50%, 75%, 90%, 95%, and 100% brain tissue and the reverse amounts of heart tissue.
Each mixture fraction is available in triplicates, except of the 50% mixture, for which nine
replicate measurements are available.
Mapping to the PCA space
The mapping to the three dimensional PCA space is of high interest for this dataset,
since the third principal component is mainly associated with brain tissues, which are
part of the mixture data. The result of the mapping is depicted in Fig. 4.14, showing a
smooth transition from the magenta area corresponding to heart tissues to the red area
corresponding to brain tissues, with very little variation between replicate measurements.
Furthermore, a slight non-linearity in the distance between different mixture fractions
can be observed on the neural axis, due to the unproportional high change from the 0%
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Figure 4.12.: Explanation of the non-linearity found in the liver and breast cancer mixture
data (Fig. 4.13). Due to the non-linear RNA to measurement signal func-
tions, combined with the applied logarithmic transformation (section 2.3.2),
a linear increase in the RNA of a specific gene leads to a non-linear increase
in the measurement signal. The non-linearity becomes considerably stronger
for genes with a higher fold change between the two mixed tissue types. Solid
lines represent an example of log2-measurement signals for different simulated
genes over the mixture fraction. Dotted lines represent the approximation
made by the linear mapping approach. Differences between solid and dot-
ted lines thus depict the residual value, which increases with increasing fold
change.
to the 5% brain tissue sample. This non-linearity can be explained by the logarithmic
measurement signal as discussed in the previous section. The slight non-linearity on the
malignancy/proliferation axis may have a similar reason.
Mapping to the residual tissue specific space
The linear mapping to the residual tissue specific space also results in a smooth increase
and decrease of the heart and brain signature scores, respectively (Fig. 4.15). The variabil-
ity between replicates is again very small. Similar as for the mapping of the 24 tissues, the
two-scale approach succeeds to distinguish relatively well between different brain regions,
while the one-scale approach suffers from the strong correlations between these regions
(Fig. B.10).
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Figure 4.13.: Non-linear dependence of liver and breast cancer mixture data on correspond-
ing signatures. Depicted is the residual value after projection to both the PCA
and residual tissue specific spaces versus the liver or breast cancer signature
for different mixture fractions. A clear non-linearity can be seen in the 50%
mixture sample, while such an effect is not visible in the pure, i.e. 100% liver
and 100% breast cancer samples.
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Figure 4.14.: Mixtures of brain and heart tissues from the Affymetrix Human Gene 1.0 st
array [199] mapped to the PCA space. The 33 samples with different per-
centages of heart and brain tissue (0%, 5%, 10%, 25%, 50%, 75%, 90%, 95%,
and 100%) describe a nice curve with a monotonously changing projection on
the neural axis.
Furthermore, it can be observed that the heart and brain signatures are negatively corre-
lated, leading to slightly negative values for the pure samples in the opposite signature,
i.e. a negative heart score for the 100% brain sample and a negative brain score for the
100% heart sample.
Linear versus non-linear mapping
This negative correlation is important for the non-linear mapping, since it leads to an
unexpected behaviour in the brain signature (Fig. 4.16, Fig. B.11). In contrast to the
non-linear effects seen in the previous chapter, the brain score shows a relatively sharp
increase for low mixture fractions, stays then almost constant with increasing mixture
fraction and increases again sharply for high mixture fractions (Fig. 4.16, red circles).
This effect can be explained by the negative correlation of the brain and heart scores in
the residual tissue specific space (Fig. 4.17) in combination with the unproportional high
expression of the most prominent heart specific genes due to the non-linear relationship
between the mixture fraction and the logarithmic measurement signal as described in the
previous section (Fig. 4.12 and Fig. 4.13). The unproportional high expression of these
genes prevents an increase in the brain signature score for intermediate fractions of heart
tissue.
Apart from this unexpected phenomenon, the results depicted in Fig. 4.16 resemble those
of the similar Fig. 4.11 from the previous section.
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Figure 4.15.: Linear mapping of the mixtures of brain and heart tissues from Affymetrix
[199] to the residual tissue specific space. A monotonous increasing associa-
tion with brain signatures and a decreasing association with heart signatures
can be observed.
4.3. Comparison to existing approaches
In this section, we compare the two-scale map to two existing approaches for an RNA
microarray based cell characterisation, namely the "Unknown RNA Sample Annotation
(URSA)" [10] and the "Concordia: Phenotypic concept enrichment" [11] tools. The com-
parison to the "CellNet" tool [81] will be shortly described afterwards, within the analysis
of the in vitro differentiated cardiomyocytes. The reason for this is that the tool is cur-
rently restricted to a relatively small number of cell or tissue types, permitting a rigorous
evaluation with the datasets used above.
4.3.1. Unknown RNA Sample Annotation (URSA)
The "Unknown RNA Sample Annotation (URSA)" tool [10] characterises new data based
on a tissue ontology. This characterisation is done based on a support vector machine
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Figure 4.16.: Comparison of different mapping approaches for the brain and heart mixture
data. Plotted is the heart score versus the brain score, each normalised to
values between 0 and 1, for four different mapping procedures, i.e. the linear
and non-linear mappings with and without PCA based decomposition. The
linear mapping is closer to a linear relationship between the heart and brain
score than the non-linear mapping. The non-linear mapping with PCA based
decomposition shows clearly the signed-quadratic relationship discussed in
the previous chapter.
classifier combined with a bayesian approach utilising the tree like structure of the ontology.
The classifier was trained on a very large dataset from the Affymetrix human U133 Plus
2.0 array, but is applicable to data from any platform and even to RNA-seq data [10]. The
URSA tool is accessible via an internet platform (http://ursa.princeton.edu/) and requires
only a ranked list of genes representing the order of expression values from a single sample.
The output of the URSA analysis is a list of tissue ontology terms that are predicted to
be associated with the new data, along with probability values for the association. Thus,
it is essentially a binary classification for each ontology term along with a measure of
confidence. This is a structural difference to the two-scale landscape approach, which
allows an interpretation in terms of a distance between two samples in a certain direction.
This interpretation is especially helpful for mixture data or for the characterisation of
samples that do not exactly fit to a certain tissue. An advantage of the URSA tool is
that it does not require a reference dataset for characterisation of samples from different
platforms.
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Figure 4.17.: The heart and brain signatures in the residual tissue specific space are nega-
tively correlated and several prominent heart specific genes are amongst the
most negative genes in the brain score (left). This negative correlation is not
present in the tissue specific space without PCA based decomposition (right).
The green colour marks all genes that are used for the non-linear mapping to
the brain signature, i.e. the 1% of genes with highest and lowest expression
in the signature.
In the following, the results of the URSA tool applied to the three datasets analysed so far
are discussed.
Expression data from various tissues
We start with the 24 different tissues and cell lines from dataset GSE18674, which do
not contain any mixtures or unknown cell types. These samples are hybridised on the
Affymetrix Human U133 Plus 2.0 microarray. This platform was also used for the devel-
opment of URSA. For these tissue samples, the URSA tool delivers very specific results
and matches quite well to the true tissue type (Fig. 4.18). However, some tissues could
not be identified, i.e. they have very low probability values for all ontology terms that
are included in the URSA tool. These are the lung, salivary gland, and thymus tissues as
well as the SHSY5Y cell line. Furthermore, it has to be noted that some relatively similar
tissues could not be properly distinguished. For example, the colon and small intestine
tissues show almost the same result, being associated with alimentary canal, colon, col-
orectum, gastrointestinal tract, intestine, large intestine, and viscus. The small intestine is
additionally associated with the ontologies digestive gland, endocrine gland, and pancreas,
but not with small intestine. The stomach sample is also similarly classified as the small
intestine sample, without an association to viscus and endocrine gland. Thus, it is also
falsely classified as colon and large intestine.
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Figure 4.18.: Unknown RNA sample annotation (URSA) tool applied to the 24 different
tissues and cell lines from dataset GSE18674. The results are very specific and
most tissues are correctly identified, similar to the two-scale map. However,
several tissues like lung, salivary gland, thymus, and the SHSY5Y neurob-
lastoma cell line are not associated with any ontology at all. Furthermore,
very similar tissues like different brain regions are partly not properly distin-
guished. Colours correspond to probability values ranging from zero (light
yellow) to one (red).
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Another example are the adult cortex and fetal brain samples, having the same match-
ing ontologies, except of an additional similarity of fetal brain to brain cancer. Finally,
spinal cord and cerebellum have exactly the same associations. These small scale differ-
ences between different brain regions could be better resolved by the two-scale landscape
approach.
Liver and breast cancer mixture data
The liver and breast cancer mixture dataset (GSE33116) is more challenging for the URSA
tool for two reasons. First the samples were hybridised on a different microarray platform,
namely the Affymetrix Human U133A array. Second, and more important, the dataset
contains samples that are no pure tissues, but mixtures of two different tissues. Therefore,
it will be interesting to see how the binary classification for each ontology can deal with
such data. The results of this analysis are depicted in Fig. 4.19.
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Figure 4.19.: Results of the URSA tool applied to the liver and breast cancer mixture
data from GSE33116. Neither the pure nor the mixed samples are correctly
classified.
Surprisingly, the URSA tool is not able to correctly identify even the pure samples.
The pure liver sample is falsely characterised as pancreas, whereas the pure breast cancer
sample does not have a clear association to any specific tissue. The most probable reported
associations are endocrine gland (24% probability) and adrenal gland (18% probability).
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Furthermore, the samples with 50% to 100% liver fraction do not show any consistent
differences which may be attributed to different mixing fractions, i.e. they are predicted
to be essentially the same cells. For lower liver fractions the ontology associations stay
similar but with decreasing probability values.
Heart and brain mixture data
The second example of tissue mixtures are the heart and brain mixture data. For these
data, the URSA tool should have less problems to correctly classify the pure samples since
the expression patterns of heart and brain tissues are very distinct from all other tissues.
The relevant tissue ontologies of this analysis are depicted in Fig. 4.20.
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Figure 4.20.: Results of the URSA tool applied to the Affymetrix heart and brain mixture
data. Pure samples are nicely distinguished and correctly classified. However,
no smooth transition can be found for mixed samples. Instead, classifications
change in a binary way. Interestingly, the 25% brain fraction suffices for
a 100% association with heart as well as brain, whereas the opposite 75%
fraction leads to a classification as pure brain tissue without any association
to heart.
Indeed, the URSA tool nicely detects the right tissues, i.e. heart and brain, for the pure
samples. However, it is not really able to identify mixtures of cells, as it either classifies the
samples as pure heart or brain tissue, for the 5%, 10%, 75%, 90%, and 95% brain mixture
fractions, or as 100% of both, brain and heart, as is the case for the mixtures with 25%
and 50% brain RNA. Thus, there is no smooth transition due to the binary classification
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scheme.
Overall, the URSA tool suppresses unspecific tissues much better than the two-scale land-
scape, which suffers a bit from the correlations which are still present between different
tissue signatures. However, due to this suppression, the URSA tool is not able to detect
smaller amounts of mixtures, i.e. it can not nicely detect smooth transitions. This might
be critical for the analysis of in vitro differentiated cells and especially differentiation time
courses, which do not exactly match to one specific tissue. In summary, URSA is a valu-
able and easy to use tool for expression based cell characterisation, but seems not to be
well designed for the analysis of cellular transformations, what is the focus of the present
thesis.
4.3.2. Concordia: Phenotypic Concept Enrichment
The Concordia tool characterises new microarray samples based on their Spearman corre-
lation to a large reference database of annotated samples, combined with an enrichment
score calculated with a Kolmogorov-Smirnov test statistic [11]. The tool was developed on
the Affymetrix Human U133 Plus 2.0 microarray platform and no platform transforma-
tion for cross-platform analyses is described. Therefore, the tool is restricted to a single
microarray platform.
For an evaluation of the tool we use the 24 tissues and cell lines from GSE18674 that
are hybridised on the required microarray platform. Initially, we wanted to use the online
platform (http://concordia.csail.mit.edu) described in [11]. However, the website was not
accessible when we tried to use it (early September 2014). Therefore, we reimplemented the
tool using the own dataset from the Affymetrix Human U133 Plus 2.0 array with manual
annotation of 191 different cell or tissue types. Of these 191 groups, 150 have 3 or more
associated samples and the analyses were restricted to these samples as suggested in [11].
The results of this analysis (Fig. 4.21) are significantly worse than the respective results
of the two-scale map with the same reference dataset (Fig. B.4). Although the correct
concept is in most cases among the top scoring ones, it is very hard to actually identify
the tissue type since there are several enrichment scores with relatively high values which
sometimes do not really fit together. For instance, urethra has the second highest score
for the heart sample. The highest is pericardium and heart itself is only at position three.
Interestingly, the performance measure used in [11] reports results that seem to be quite
good at a first view (e.g. an average "accuracy" of 92.8%). However, this performance
measure evaluates the classification performance of an individual concept over all samples
and averages then over all concepts. That means, it compares the enrichment scores of
all samples for an individual concept and reports the area under the receiver operating
characteristic (ROC) curve. For the own dataset used in the present thesis, this results in
a mean AUC of 97.5%, which is even higher than the 92.8% reported in [11]. The difference
is due to the use of different datasets, and the dataset used here is larger, resulting in better
AUC values [11].
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Figure 4.21.: Results of the Concordia tool applied to the 22 tissues and 2 cell lines of
dataset GSE18674. Plotted is the enrichment score calculated as described
in [11] using the own dataset described in the present thesis as reference. The
results are significantly worse than those of the two-scale landscape.
In contrast, the aim for characterisation of cells is to compare different concepts for a single
sample and to identify the sample using the concepts with highest enrichment scores. For
an evaluation of the performance matching to this aim, one can compare the actual tissue
type of a sample to the concept with highest enrichment score for this sample. This
results in a correct identification of only 20.4% of all samples in the own dataset using
the Concordia tool. For both kinds of evaluation we used a leave-one-out cross validation
scheme as described in [11].
89
A Two-Scale Map of Global Gene Expression RWTH Aachen University
Due to the fact that some concepts are very similar, e.g. liver and fetal liver, it may
happen that some exactly matching concepts have only the second or third highest score.
Therefore, we also checked the fraction of samples where the exact matching concept is
among the top 2 (30.9%), top 3 (39.7%), top 5 (51.4%) or top 10 (73.0%) scores. These
values are still relatively low. So, according to this more strict criterion, the performance
of the Concordia tool is significantly worse than indicated by the AUC criterion. This fits
well to the observations made for the 24 tissues or cell lines from dataset GSE18674 which
are hard to identify (Fig. 4.21).
For a comparison to the two scale map, we did the same leave-one out cross validation
for the two-scale map, using the score of the residual tissue specific space. This results
in a mean AUC of 98.3%, which is slightly higher than the 97.5% of the Concordia tool.
More interesting is the alternative evaluation, comparing the top scoring signatures to the
actual tissue type. This results in a correct identification of 71.4% of the samples, which
is significantly higher than the 20.4% of the Concordia tool. As for the Concordia tool,
this value increases if we check for the top 2 (82.1%), 3 (86.3%), 5 (89.5%) or 10 (92.3%)
scores. All of these results are significantly better than those of the Concordia tool.
In summary, the Concordia tool performs significantly worse than the two-scale map and
seems to be not well suited for characterisation of in-vitro reprogrammed or differentiated
cells.
4.4. Application to in vitro differentiated cells
4.4.1. Mesenchymal stromal cells
Mesenchymal stromal cells (MSCs) isolated from bone marrow of three different donors
were reprogrammed to iPSCs [111] and subsequently redifferentiated back to mesenchymal
stromal cells (iPS-MSC) [200] (Fig. 4.22). The differentiation was accomplished by a simple
exchange of the culture medium to the initial MSC-culture medium. That means, that iPS-
MSCs and MSCs were cultured under the same conditions and are therefore well suited for
an evaluation of the effects of reprogramming and differentiation processes. The redifferen-
reprogramming differentiation 
MSC iPSC iPS-MSC 
Bone marrow 
biopsy  
MSC isolation 
Figure 4.22.: Overview of the mesenchymal stromal cell (MSC) experiment. MSCs iso-
lated from bone marrow of different donors were reprogrammed to induced
pluripotent stem cells (iPSC) and redifferentiated to MSC (iPS-MSC). Gene
expression microarray data were generated from the initial MSCs, the iPSCs,
as well as during the course of differentiation at day 7, 14, 21, 28, and 35.
tiated iPS-MSCs fulfil the "minimal criteria for defining multipotent mesenchymal stromal
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cells" [200, 201], but show some differences in gene expression and methylation compared
to the original MSCs [200]. The expression changes mainly indicate a reduced immune
modulatory function of iPS-MSCs. This could be validated by wet-lab experiments mea-
suring the T cell activation of MSCs [200]. Interestingly, the methylation differences point
towards an epigenetic rejuvenation of iPSCs and iPS-MSCs. That means, two methylation
based markers for age prediction [202, 203] predict that iPSCs are age-reprogrammed to
age zero and redifferentiation towards iPS-MSCs does not lead to an ageing of cells, i.e.
they remain at age zero.
Figure 4.23.: Projection of bone marrow or iPSC derived mesenchymal stromal cells
(MSCs) onto the PCA map. According to the second principal component,
MSCs derived from iPSC (iPS-MSC, blue dots) seem to proliferate faster than
bone marrow derived MSC (black dots). In general, the iPS-MSCs lie on a
path between iPSCs and bone marrow derived MSCs.
Analysis of the expression data with the two-scale landscape also confirms the proper
differentiation towards MSCs (Fig. 4.23 and Fig. 4.24). The main difference between MSCs
and iPS-MSCs in the two scale map is the higher proliferation of the latter as indicated by
a difference on the malignancy/proliferation axis, i.e. PC2 of the PCA space (Fig. 4.23).
This higher proliferation could also be confirmed by wet lab experiments [200]. Similarly
to the epigenetic rejuvenation of the cells, this is indicative of an immature status of the
redifferentiated iPS-MSCs.
On the residual tissue specific space, there are only very tiny differences between MSCs
and iPS-MSCs. For both cell types, several incompletely differentiated signatures, e.g.
associated with MSCs, fibroblasts, or preadipocytes, have a high score. This fits well to
results from the literature, describing the remarkable similarity of MSCs and fibroblasts
[204].
In strong contrast to the MSCs, iPSCs are clearly classified as being similar to ESCs.
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Together with the PluriTest results [200], this confirms the proper reprogramming of iPSCs
and is a further validation of the biological relevance of the two-scale map.
Apart from these two rather pure cell types, i.e. iPSC and MSC, it is interesting to
characterise the cells during the course of differentiation. A first finding from the two-scale
map as well as from other analyses [200] is that the differentiation is already completed
at day 14, showing almost no differences in gene expression and methylation at later
time points (except of slight changes in the proliferation). Thus, the most interesting
intermediate time point between iPSCs and iPS-MSCs is day 7. At this time point, there
is an intermediate signal for both, incompletely differentiated and ESC scores, indicating a
relatively smooth transition from iPSC to MSC without changing to a completely different
cell type in between.
4.4.2. Cardiomyocytes
Analysis with the two-scale landscape
For the analysis of in vitro differentiated cardiomyocytes from human ES cells and iPS
cells we reanalyse data from three studies, which we downloaded from ArrayExpress
(E-MEXP-2654 [5]), or Gene Expression Omnibus (GEO) databases (GSE28191, and
GSE35108 [205]). These studies contain one differentiation time series from day 0 to day
11 (GSE28191), differentiated cardiomyocytes at week 3 and 7 (E-MEXP-2654), as well as
4 weeks differentiated cardiomyocytes from iPSC of healthy people and dilated cardiomy-
opathy (DCM) patients (GSE35108). The DCM samples are "from a three-generation
family of DCM patients carrying a point mutation (R173W) in exon 12 of the TNNT2
gene" [205].
Analysis of these samples with the two-scale gene expression map reveals a continuous
change during differentiation on the proliferation axis (Fig. 4.25), as well as on the embry-
onic stem cell and heart dimensions of the residual tissue specific space (Fig. 4.26). Thus,
in comparison to heart tissues (green points and magenta background on Fig. 4.25), the
in vitro differentiated cardiomyocytes proliferate faster and are not fully differentiated to
heart cells. The latter point is further indicated by a similarity of in vitro differentiated
cardiomyocytes to incompletely differentiated cells, e.g. mesenchymal precursors, embry-
onic myoblasts, or preadipocytes, on the PCA space (Fig. 4.25, blue background), as well
as the residual tissue specific space (Fig. 4.26). In contrast, fetal and adult heart tissues
do not have such a similarity, but are slightly associated with adult adipose tissue (Fig.
4.26). This may hint to an immature status of the differentiating cells.
Having a more detailed look at the ESC and heart scores of the residual tissue specific
space, one can observe a linear relationship between both scores during the course of dif-
ferentiation (Fig. 4.27). That means, that the decrease of the ESC score goes hand in
hand with an increase of the heart score. A deviation from the straight line can only be
observed in the very early differentiation (day 2 and day 5), where almost no increase in
the heart score can be observed, and for the DCM cardiomyocytes, which have already lost
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Figure 4.24.: Linear projection of bone marrow or iPSC derived MSCs onto the residual
map suggests that the differentiation is already completed at day 14. In
general, MSCs and iPS-MSCs have very similar tissue associations with a
dominant association to incompletely differentiated cells. Differentiating cells
at day 7 exhibit similarities to the ESC signature as well as to signatures
associated with incompletely differentiated cells, suggesting a location on the
path between iPSC and MSC.
much of their pluripotency, but have still a comparably low association to heart tissues.
One may ask which kind of transformation the cells undergo and whether the in vitro
differentiated cells are mixtures of heart cells and pluripotent stem cells. To this end, we
investigated the expression of several typical pluripotency markers, i.e. NANOG, POU5F1,
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Figure 4.25.: Projection of heart tissues and differentiated cardiomyocytes onto the PCA
map reveals a decreasing proliferation during differentiation, rendering the
differentiating cells more and more similar to heart tissues. Colour code:
brown: diff. time course day 0, orange: day 2, light orange: day 5, light pur-
ple: day 7, purple: day 9, dark purple: day 11, black: 3 week differentiation,
cyan: 7 week differentiation, red: 4 week differentiation from normal iPSC,
magenta: 4 week differentiation from DCM iPSC, light green: Fetal heart,
dark green: adult heart.
DPPA4, DNMT3B, SOX2, L1TD1, ZSCAN10, LIN28A, and ZFP42. All of these markers
show a sharp early decrease of the expression during the course of differentiation, while
the ESC score decreases only marginally in this time (Fig. 4.28). In contrast, in case of
a mixture effect, one would expect a logarithmic curve with a relatively high expression
for early differentiated cells and a sharper drop down at the very end of the differentiation
(Fig. 4.12). Therefore, the joint similarity to ESCs and heart tissues is not due to a
mixture effect.
Analysis using CellNet
So far, we did not compare the two-scale landscape method to the CellNet tool [81], which
was explicitly designed for the characterisation of in vitro transformed cells. As stated
before, the tool requires relatively large amounts of data for the training and is therefore
currently restricted to relatively few tissues or cell types. Unfortunately, neither neural
tissues, nor mesenchymal stromal cells are part of this set of tissues for the Affymetrix
human gene 1.0 st v1 microarray platform. Therefore, we restrict our analyses to the in
vitro differentiated cardiomyocytes.
Using the CellNet online tool at http://cellnet.hms.harvard.edu, this leads to very
similar results as obtained using the two-scale landscape (Fig. 4.29), albeit with a much
higher training effort of the tool. Therefore, according to this limited analysis, both tools
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Figure 4.26.: Linear projection of heart tissues and differentiated cardiomyocytes onto the
residual map reveals an increasing similarity to heart signatures and a de-
creasing similarity to ESC signatures with prolonged differentiation. Car-
diomyocytes derived from normal iPSCs seem to be more similar to heart
cells than those from dilated cardiomyopathy (DCM) patients. In vitro differ-
entiated cardiomyocytes have some similarities to incompletely differentiated
cell types, in contrast to fetal and adult heart samples.
can be considered as roughly equally good in those cases where the appropriate cell type
is available in the CellNet tool. Certainly, a more detailed comparison of both tools is
necessary to reveal strengths and weaknesses of one or the other tool. However, for most
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Figure 4.27.: Detailed comparison of the heart and ESC scores during cardiomyocyte dif-
ferentiation. An almost linear relationship can be observed with decreasing
ESC score and increasing heart score during differentiation.
of the data analysed here, the CellNet tool does not have appropriate reference data. This
is also the case for the following examples of neurons, astrocytes, and neural stem cells.
4.4.3. Neurons, neural stem cells, and astrocytes
Brain tissue during human development
Many different cell types can be found in the human brain [15], including different types
of neurons, neural progenitors or neural stem cells, as well as glial cells, e.g. astrocytes.
The tissue composition is different in different regions of the brain and it changes strongly
during early brain development [206]. For a detailed investigation of the expression pat-
terns of brain tissue, Kang et al. [206] generated and analysed more than 1300 microarray
samples from embryonic, fetal, and postnatal to adult brain, incorporating data from dif-
ferent brain regions at each developmental status.
The analysis of this large data resource showed that the strongest differences in expression
occur during prenatal brain development [206]. Therefore, it is interesting to map a time
course of brain development to the two-scale map in order to reveal the location of embry-
onic and fetal brain tissues for a comparison to in vitro differentiated cells.
We focused our analysis on samples from the cerebral cortex (or cerebral wall for early
time points) and mapped samples from 15 different age periods [206] to the two-scale land-
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Figure 4.28.: Expression of typical pluripotency markers in the course of differentiation
towards cardiomyocytes. All pluripotency markers show a sharp decrease at
early stages of differentiation, where the overall similarity to ESCs has only
slightly changed. In contrast, when the in vitro differentiated cells would
be mixtures of pluripotent stem cells and heart cells, one would expect a
logarithmic shape of the curve, similar to Fig. 4.12.
scape. In order to do this, we mapped the data that were generated on the Affymetrix
Human Exon 1.0 st-v1 array to the Affymetrix Human Gene 1.0 st-v1 array and quantile
normalised them together, since we do not have an appropriate reference dataset for the
Exon array (see appendix A). This mapping may lead to small differences on the PCA
space compared to the reference dataset used as background for orientation (Fig. 4.30,
Fig. B.13).
The mapping of these samples to the PCA space and residual tissue specific space devel-
oped based on the Lukk dataset are depicted in Fig. B.13 and Fig. B.14. On the residual
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Figure 4.29.: Analysis of the in vitro differentiated cardiomyocytes using CellNet [81].
Shown are all 13 tissue/cell line scores that are currently included in the
CellNet tool for the Affymetrix Human Gene 1.0 st v1 microarray platform.
The results are very similar to those of the two-scale map, showing overall
an increasing similarity to heart and and a decreasing similarity to ESC dur-
ing prolonged differentiation. The values range from 0 (light yellow) to a
maximum of 0.84 (dark red).
tissue specific space (Fig. B.14) a similarity of prenatal brain samples to various brain
cancer and lung cancer tissues or cell lines can be observed. This fits well to the described
similarity of some brain cancer cells to neural progenitors or neural stem cells [207, 208].
Unfortunately, the Lukk dataset does not incorporate samples from fetal brain or neural
progenitors. Therefore, it is not possible to detect similarities to these tissue or cell types.
This is different in the own dataset consisting of 7100 samples from the Affymetrix Human
U133 Plus 2.0 array, which we manually classified into 191 different cell or tissue types.
Therefore, we used this dataset to create an alternative two-scale map.
This two-scale map also consists of the first three PCs (Fig. 3.2 bottom) as PCA map and
a residual tissue specific space that is constructed in the same way as for the Lukk [12]
dataset, incorporating 191 dimensions that correspond to the annotated 191 cell or tissue
types. The map was already shortly mentioned in section 4.2.1, where we showed that it is
capable of correctly identifying all 22 tissues from dataset GSE18674 (Fig. B.4), although
we note that these data are already part of the reference dataset itself.
Due to the neural progenitor and fetal brain samples in the own dataset we use this
alternative two-scale map for the analysis of the brain tissues and in vitro differentiated
neural cell types. Mapping of the 15 samples of the Kang [206] dataset to this two-scale
map reveals an increasing similarity to adult brain tissues on the PCA space over time
(Fig. 4.30). This trend occurs throughout embryonic and fetal development and is almost
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Figure 4.30.: Samples from human cortical development mapped onto the PCA space from
the own dataset. Plotted are cortical brain tissues from embryonic and fe-
tal development (5.7, 9, 12, 13, 16, 21, and 37 post-conceptional weeks) as
well as from youth to adulthood (4 months, 6 months, 1 year, 8 years, 15
years, 36 years, 40 years, and 70 years). During brain development, the ex-
pression patterns get continuously closer to those of adult brain tissue (red
background). Note that the data were generated on the Affymetrix Human
Exon 1.0 st-v1 array, while the reference dataset used for the background
colours was hybridised to the Human Gene 1.0 st-v1 array. This may explain
the slight differences between the adult brain tissues and the red background
on PC2.
completed at birth with only relatively slight differences between newborns and adults on
the PCA space.
On the residual tissue specific space, a similarity of early embryonic cerebral wall tissue
(5.7 post-conceptional week (PCW)) to pluripotent stem cells, neural progenitor cells,
and fetal brain tissue can be observed (Fig. 4.31). The similarity to pluripotent stem
cells decreases very rapidly during development, the similarity to neural progenitor cells
increases first for the sample at PCW 9 and decreases then, while the similarity to fetal
brain tissue increases first and stays high until birth. During late fetal development, the
similarity to adult cerebral cortex and hippocampus increases and stays high throughout
the human life span.
As already observed in previous sections, the two-scale landscape can distinguish between
specific brain regions. Thus, the cerebral cortex samples show high similarities to cerebral
cortex and hippocampus after birth, while samples from the cerebellum show a higher
similarity to cerebellum from 4 months to 36 years after birth (Fig. B.15). The fact that
this similarity decreases again in older aged people is a bit surprising and goes beyond the
scope of the present thesis.
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Figure 4.31.: 15 cortical brain tissue samples from post-conceptional week 5.7 to adulthood
(70 years) mapped to the residual tissue specific space from the own dataset.
The sample from PCW 5.7 has some similarity to fetal brain, as well as to
neural progenitor cells (NPC), and pluripotent stem cells (PSC). The latter
two decrease rapidly during development, while the similarity to fetal brain
increases first and stays high until birth. It then decreases again with the
parallel increase of some adult brain scores, i.e. the cerebral cortex and
hippocampus scores.
In vitro differentiated neurons
In vitro differentiation of pluripotent stem cells into neurons is an interesting topic for
molecular studies of neural development and especially for studying differences in neurons
derived from iPSCs with disease associated genetic defects compared to those derived from
healthy iPSCs. A key requisite for these kinds of studies is a proper differentiation into
neurons that resemble neurons from in vivo brain tissue. Here, we analyse data from two
studies of in vitro neural differentiation.
In the first study (dataset GSE51214) iPSCs are differentiated towards dopaminergic
neurons and either sorted for CORIN positive cells at day 12 or not [209]. CORIN is a floor
plate marker, i.e. it is expressed in the region of the developing plate where dopaminergic
progenitor cells are usually located [209]. Therefore, the CORIN sorted cell preparations
represent a more pure culture, with a higher percentage of midbrain dopaminergic progen-
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Figure 4.32.: In vitro differentiated neurons from datasets GSE51214, and GSE43235
mapped onto the PCA space. The differentiation time course from iPSC
towards dopaminergic neurons (GSE51214, iPSC, Dop. Neuro Day 12, Dop.
Neuro Day 28, and Dop. Neuro Day 42) shows increasing similarity to adult
brain tissue. The samples from the latest differentiation time point (day 42)
lie close to the fetal brain from post-conceptional week 7.5. CORIN sorted
cell preparations (circles) at day 28 and day 42 of differentiation lie closer to
brain tissues than unsorted samples (squares). The neural differentiations in
2D vs. 3D culture conditions from dataset GSE43235 show clear differences.
itor cells and reduced expression of several markers that are typical for other brain regions
[209]. Furthermore, at day 28 of differentiation, the percentage of proliferating cells was
higher in the unsorted samples than in the CORIN sorted samples [209]. Analysis of these
samples with the two scale map reveals a monotonously increasing similarity to brain tissue
over time on the PCA space (Fig. 4.32). Notably, CORIN sorted samples at day 28 and
42 have a higher similarity to brain tissue than unsorted samples. This potentially reflects
the higher number of proliferating cells in the unsorted samples at day 28. On the residual
tissue specific space (Fig. 4.33) the differentiation time course gets increasing similarity
to fetal brain, whereas the similarity to pluripotent stem cells decreases. At day 42 of dif-
ferentiation, the cells are very similar to the fetal mesenchyphalon from post-conceptional
week 7.5 that are also included in the study.
In addition to the difference between CORIN sorted and unsorted cells on the PCA space,
there are also slight differences on the residual tissue specific space. Especially for day 42
of differentiation, there is a notable difference in the hippocampus score, which is higher
for sorted than for unsorted cells.
The second study of in vitro differentiated neurons (dataset GSE43235, no corresponding
article published) investigates differences between in vitro differentiations in a classical 2D
environment versus a 3D environment. They differentiate the cells for 28 days in both en-
vironments. Interestingly, these two differentiations result in very different cells. While the
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Figure 4.33.: Mapping of in vitro differentiated neurons to the residual tissue specific space.
The in vitro differentiation time course from GSE51214 shows increasing sim-
ilarity to fetal brain tissue, ending at similar expression patterns as the fetal
mesenchyphalon from post-conceptional week 7.5 (column 1-20). Differentia-
tion of pluripotent stem cells towards neurons in a 3D culture produces cells
that are more similar to neurons than a similar differentiation in a 2D culture
system (last 5 columns). Both differentiations were accomplished for 28 days
(GSE43235).
3D differentiation produces cells that are similar to the differentiated cells of the previous
study at day 28, the 2D culture system produces cells that have only very slight similarities
to neural cells (Fig. 4.32 and Fig. 4.33).
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Astrocytes and neural progenitors
Two other brain related cell types that receive much interest in studies of in vitro trans-
formed cells are neural stem or progenitor cells and astrocytes, a special form of neuroglia.
In addition to the in vitro differentiated neurons discussed above, we therefore analysed
three further studies. One study investigates the in vitro differentiation of fetal brain
(8 PCW) derived neural progenitor cells (NPCs) towards progenitor derived astrocytes
(GSE43794) [210]. The second study (GSE36145) is concerned with the direct reprogram-
ming of astrocytes to neural stem cells (NSCs). The third study (GSE43382) describes the
reprogramming of fibroblasts to iPSCs and the subsequent differentiation of these towards
NSCs, neurons, and astrocytes [211]. Furthermore, primary astrocytes are included for
comparison purposes.
����������������� ��������
����������
�������������������
� ��
��������
����������� � ������������
Figure 4.34.: In vitro differentiated astrocytes and neural progenitor/stem cells from
datasets GSE43794, GSE36145, and GSE43382 mapped onto the PCA space.
The NPC to astrocyte differentiation (GSE43794) induces almost no changes
on the PCA space and even after 30 days (dark violet points) the NPC derived
astrocytes are still relatively far away from primary astrocytes (blue points).
The iPSC derived astrocytes from GSE43382 (black points) are more simi-
lar to primary astrocytes, although there is still some difference. Similarly,
astrocyte derived NSCs (magenta points) are still very similar to the pri-
mary astrocytes from which they were derived (blue points) and relatively
far apart from fetal brain derived neural progenitor cells (light grey points).
iPSC derived NSCs (cyan point) are more similar to the NPCs.
From the mapping to the PCA space (Fig. 4.34), it was observed that the NPC to
astrocyte differentiation time course (GSE43794) does not show many changes in the global
expression status. Even so the cells at the latest time point (day 30 of differentiation)
tend slightly in the direction were the primary astrocytes lie, they are still relatively far
apart from them. The iPSC-derived astrocytes are more similar to the primary astrocytes,
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although there are still clear differences. Similarly, the astrocyte-derived NSCs are still
very similar to the primary astrocytes themselves and far apart from the fetal brain derived
NPCs. The iPSC-derived NSCs are again more similar to the target cell type.
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Figure 4.35.: In vitro differentiated astrocytes and neural progenitor/stem cells mapped
onto the residual tissue specific space. The differentiation time course from
fetal brain derived neural progenitor cells (NPCs) does not show any signifi-
cant changes on the residual tissue specific space (columns 1 to 19). Astrocyte
derived NSCs are more similar to neural progenitor cells than the astrocytes
from which they were derived. However, a relatively strong similarity to as-
trocytes remains (columns 20 to 25). Reprogramming of fibroblasts to iPSCs
and subsequent differentiation to NSCs, neurons, or astrocytes (GSE43382,
last 7 columns) shows clear differences between the individual cell types. The
respective cell types are nicely recognised by the residual tissue specific space,
indicating a proper reprogramming and differentiation, although some unex-
pected signatures, e.g. fallopian tube for the neural cells, have relatively high
scores.
Similar results can be seen on the residual tissue specific space. Here, it is confirmed that
the NPC to astrocyte differentiation as well as the direct reprogramming of astrocytes to
NSCs lead to suboptimal results, whereas the differentiation from iPSCs shows markedly
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better results. This observation that trans-differentiated cells are less similar to the target
cell type compared to iPSC derived cells was also made using CellNet [81].
These examples show nicely that despite of an activation of specific molecular markers as
well as characteristic changes in the morphology of in vitro transformed cells [210], the
global gene expression may be still clearly distinct from the target cell type. This is a
nice example of complementary information that can be gained using global expression
analyses, such as the mapping onto the two-scale landscape presented here.
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5. Discussion and directions for future
work
The first part of this chapter is concerned with the two-scale map of gene expression.
It discusses the general idea of a two-scale decomposition and comments on a possible
extension to further scales, resulting in a multi-scale decomposition of the gene expression
space.
The second part considers the quality control of in vitro transformed cells. It describes
the different aspects of a good quality that have different relevances for different fields of
application.
In the third part of this chapter, the relevance of the two-scale decomposition approach
for other research fields is described.
5.1. From global to local effects - Using multi-scale
decompositions in gene expression analysis
In this thesis, we have developed a two-scale map of gene expression by a decomposition
into a global scale, capturing common processes of different tissues or cell types and a
finer scale, distinguishing between different tissues or cell types. We could show on the
example of breast cancer samples that such a decomposition is very helpful in order to
preserve an influence of confounding effects, such as a higher proliferation rate or general
culturing associated differences, on tissue specific expression patterns. Similar effects have
also been described for breast cancer outcome, which was supposed to be associated with
an ESC signature [212]. Subsequent analyses could then show that almost all signatures
are significantly associated with breast cancer outcome, since there is an underlying global
effect, namely proliferation, which changes the expression of large amounts of genes [68].
Further details on the confounding influence of variation in large scales are discussed in
[11].
Several methods have been developed so far that are dealing with the problem of confound-
ing, non-phenotype associated variability. Leek et al. [187] propose a multi-step procedure,
called surrogate variable analysis, which learns the main directions of non-phenotype asso-
ciated variability using PCA on the residual vector after excluding phenotype associated
effects. In a recent publication, we have proposed a method that uses a spherical transfor-
mation to reduce variability from rather large-scale non-phenotype associated effects [72].
This method was additionally very useful to generate proper null distributions in sample-
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permutation based approaches for assessment of significant directional associations.
Both of these methods are very useful to account for confounding non-phenotype associated
variability in the data. However, confounding effects, like culturing induced differences,
are not always found as variability in the data under study or cannot be detected by the
above described methods due to improper randomisation, i.e. a perfect correlation of the
confounding variable with the variable of interest. This can be the case, for instance, when
we compare cell line expression data to the expression of various tissues. In these cases,
it is necessary to know the confounding effects a priori in order to be able to account for
them. This can be done by a detection of these effects based on large scale retrospective
data, as was done by Lukk et al [12]. This knowledge can then be used to subtract these
effects from the data before analysing cells for their tissue relationship, as shown with the
two-scale map in this thesis.
So far, we have restricted our analyses to a two-scale decomposition. In general, it would
also be possible to extend the approach to even finer scales, i.e. to make a multi-scale
decomposition. However, there are two reasons why this is not straightforward. First, in
order to do this, it is necessary to have appropriate data with the respective annotation of
the finer scale effects in order to relate these directions to biological knowledge. Second, it
is not clear to which extent finer scales exist, i.e. how large the intrinsic dimensionality of
gene expression data actually is. Third, in the case that finer scales exist, it is questionable
whether they can be appropriately distinguished from noise. In fact, it has been observed
that some biological phenotypes are very hard to detect in gene expression data, irrespec-
tive of the mathematical method applied [213], and that lists of differentially expressed
genes are often very unstable for these phenotypes [83].
One principal possibility to extend the two-scale map by a further scale is to determine the
residuals of the second mapping and to analyse these using gene set enrichment approaches
or to focus on single genes that show a large deviation. This requires the use of the lin-
ear mapping approach, in order to have properly defined residual values. Furthermore, it
requires to use some regularised least squares fitting due to the existing correlation in the
residual space, which leads in practice to an over-fitting of the data (appendix A).
Thus, it is in principle possible to have a third scale and it may make some sense. However,
there are two reasons that prevent a robust application of this approach. The first reason
is that the noise level in the data will be too high in many cases. This is due to relatively
large lab dependent effects, biological heterogeneity, or measurement noise, which in the
past even led to a common belief that different microarray studies can usually not be anal-
ysed together.
A second reason is that the linear model applied is inappropriate in several cases, as we
could show using the mixture data. For these data we calculated the residuals and saw a
clear non-linear effect. This non-linear effect dominates a residual gene ontology analysis
in some cases (Fig. 4.13), detecting gene ontology terms that are related to one of the
mixed tissue types (data not shown). Thus, there will be no important additional biologi-
cal information revealed by this analysis.
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However, as we have shown, a residual analysis can be of high importance to detect non-
linear effects, as we have done, and to improve the model accordingly in the future. This
will be especially important when analysing mixture effects.
5.2. Quality control of in vitro reprogrammed and
differentiated cells
There are many different methods to determine the quality of in vitro transformed cells,
including functional, molecular and morphological criteria. However, as already discussed
in chapter 2, these markers can have conflicting outcomes, leaving some questions about
the actual quality of the cells open.
We introduced a method for the characterisation and quality control of in vitro transformed
cells based on large scale gene expression data, comparing the overall gene expression state
of the transformed cells to that of many different tissues and cell types. This method pro-
vides complementary information to the commonly used single gene or functional assays
as we could show, e.g. at the example of converting neural progenitor cells to astrocytes
(section 4.4.3). While commonly used markers indicate a successful transformation of the
cells [210], our method indicates that the global gene expression status did not change very
strongly and that even after 30 days of differentiation the cells were still very similar to
neural progenitor cells.
This complementary information is very important for judgements about the quality of the
generated cells and it should be part of the standard quality control of in vitro transformed
cells. Despite of this importance of the overall expression of the cells, we want to point
out that other quality criteria are important as well and that information gained from
different criteria should be considered as complementary. For example, information about
mutations at specific disease-relevant genes can usually not be detected using such global
gene expression criteria, unless the mutation leads to a transformation of the cells, e.g. to
a switch from one attractor region to another. However, such mutational information can
be very important especially for safety concerns in regenerative medicine.
Another example of complementary information are DNA methylation profiles. These
profiles could for instance provide information about the cellular age or senescence [200],
which could be very relevant for decisions about the applicability of the cells for modelling
of age-related diseases. Interestingly, in reprogramming and differentiation experiments it
can be observed that epigenetic signs of senescence and ageing are reversed upon repro-
gramming to iPSCs [202, 203, 214] and that re-differentiated cells stay rejuvenated and
acquire epigenetic signs of cellular senescence continuously over time [200].
Apart from these complementary information, it is also important to consider some poten-
tially confounding effects that may influence the interpretation of the results. Such effects
could be the different environmental conditions of cultured cells compared to primary tis-
sues, as well as the mix of different cell types in primary tissues [81]. This has an influence
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on the overall gene expression and should be kept in mind when interpreting the results.
Therefore, it is important to decide about the quality of the generated cells in an application-
dependent manner, using different quality criteria in combination. This will be exemplified
in the following based on two main classes of applications in stem cell research. These are
the use of in vitro transformed cells for regenerative medicine or for disease modelling.
For regenerative medicine, it is of interest whether the in vitro generated cells behave simi-
larly to their in vivo counterparts in the moment they are injected into a human, i.e. when
they are back in the in vivo environment. Cultured human keratinocytes, for instance,
have a different molecular state than their in vivo counterparts but are still successfully
used for burn therapy to regenerate the skin [215]. Thus, it is not of primary interest
whether the cells change their molecular state or their behaviour when they are cultured
in vitro, as long as this change is reversed when they are back in the in vivo environment.
In contrast, for drug screenings and disease models, the in vitro behaviour of the cells
should resemble the in vivo behaviour, in order to get a disease model that is useful for an
accurate prediction of the drug effect. However, the large amounts of failures in clinical
studies that could not be predicted in preclinical research [216] as well as explicit studies
comparing 2D and 3D culture conditions [217, 218, 219, 220] indicate that the environment
strongly effects the cellular behaviour and drug response.
Changes in the genome may occur during reprogramming, especially when vector DNA inte-
grates into chromosomal DNA, and were observed to take place during long term culturing
of pluripotent stem cells [45]. Such changes are not reversed in the in vivo environment
and are therefore a major safety concern in regenerative medicine, potentially promoting
a malignant transformation of the cells. While genomic changes can also have an impact
on disease modelling, concerns about a possible future malignant transformation do not
have any relevance for this application. Thus, as long as a mutation is not associated to
the studied disease, it has usually a rather low impact for disease modelling and may be
neglected in many cases.
Finally, the developmental immaturity that is often observed for in vitro differentiated
cells is mainly a concern for modelling of age-related diseases, while the reprogramming-
associated rejuvenation of cells may be regarded as a positive effect for regeneration of
old-aged and senescent organs or tissues.
Further new technologies will contribute to this field of characterising cells in the near
future. One example are single cell gene expression measurements [221] which became
feasible in the recent years. Especially the possibility of single cell RNA sequencing is very
promising for a whole-transcriptome based characterisation of individual cells, instead of
measuring the expression of thousands of cells simultaneously [221]. These analyses will
probably lead to new insights.
However, so far they are still at their infancy and there exist many problems with the
dynamic changes in expression during the cell cycle, as well as stochastic effects [222, 223].
Furthermore, even if these problems can be solved in the future, a generic problem may
be that the expression of these cells cannot be measured without isolating the cells before.
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Thus, they are put into a different environment, potentially affecting their gene expression.
It remains to be seen how strongly these cells are affected by this procedure. However,
there may be a general problem of changing the objects that we want to measure through
the measurement procedure itself, which is somewhat similar to the uncertainty relation-
ship in physics [224]. This problematic has been described by Theise and Krause already
in 2002 [17] and may introduce another level of complexity when trying to strictly define
what we mean by a cell type and how the quality of transformed cells can be assessed.
5.3. Relevance for other biomedical research fields
In this thesis we focused on the application of the two-scale map to in vitro engineered cells.
However, the map is certainly not restricted to this application field. A proper character-
isation of cells is very important for development of cancer therapies and for optimising
individual therapies in a personalised way. Furthermore, as already indicated above, many
cancer researchers are interested in the differentiation status of cancer cells, and try to find
associations with ESC-like patterns. In this respect, it is of specific interest whether the
similarity to ESCs is specific or whether it is rather a side effect due to correlations with
other phenotypic changes. These two possibilities can be nicely distinguished using the
two-scale map, or even by the direct one-scale approach, as was shown in Lenz et al. [72].
For some types of cancer we could not validate previous findings of ESC similarities [72],
e.g. for prostate cancer [225], as well as for the previously described case of breast cancer
[212]. However, for another kind of cancer, namely Burkitt lymphomas, we could detect an
association to ESCs [226]. Such an effect could also be seen in the PluriTest method, but
it could at the same time be shown that the cells are still far away from being pluripotent
[226].
In the case of comparing cancers from different stages, where we have usually many sam-
ples, it is important to have some significance assessment, which could be achieved using
sample label permutation [72]. For this, it is helpful to use a spherical transformation for
data preprocessing as indicated in section 5.1 [72]. This improves the generation of a null
distribution especially in the case where we have a highly elliptical data distribution [72].
Apart from a direct use of the two-scale map in other research fields, it is also possible to
use the general idea of a multi-scale decomposition for other applications. One example
would be the analysis of stress response data. The response to drugs is to some extend cell
type-specific, i.e. it depends on the cells to which the drug is applied. Therefore, it may be
helpful to make a two-scale decomposition, distinguishing between generic cell type specific
stress responses and drug specific effects. This is especially important since cell lines are
clearly different from real tumor tissues. Thus, it would be highly beneficial to know which
part of the response is drug specific and which depends on the cells to which the drug is
applied. However, these effects have to be studied in more detail in future work, in order
to see whether a two-scale decomposition may be beneficial for this type of application.
Another example is the usage of such an approach in disease progression, e.g. for chronic
110
A Two-Scale Map of Global Gene Expression RWTH Aachen University
myeloid leukaemia, where the mixture fractions of specific cell types change over time and
where these mixture effects dominate changes in individual cells [82].
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6. Summary and conclusion
We created a two-scale map of global gene expression that consists of a PCA based three-
dimensional space and a residual tissue specific space. The PCA space was already de-
scribed by Lukk et al. [12] and distinguishes mainly between hematopoietic tissues, cell
lines, and neural tissues. Accordingly, the first PC is associated with hematopoietic cells,
the second is mainly associated with the proliferation status of the cells, distinguishing
between cell lines and primary tissues, and the third PC separates brain tissues from all
others.
Based on an information theoretic view and utilising the information ratio criterion [83],
we could show that the three dimensional PCA fails to capture a large amount of tissue
specific information. Therefore, we extended this three-dimensional space by a residual
tissue-specific space generated in a supervised manner using the classification of the sam-
ples into 369 different tissues, cell lines, or disease states [12]. Using a relatively simple and
easy to interpret fold-change based method, we defined the 369 coordinates of the residual
tissue specific space as the vectors pointing from the PCA space orthogonally to the mean
of the respective tissue or cell type. This procedure results in 369 directions that are not
necessarily orthogonal to each other. However, we could show that the correlation between
the 369 vectors could be significantly reduced through the PCA based decomposition into
two different spaces.
Using the same method on a dataset we collected independently leads to a similar decom-
position. We could show that the first three PCs of this alternative dataset span a similar
space as the first three PCs of the Lukk [12] dataset. This hints towards a certain stability
of these dimensions. However, we could also show that a PCA-based decomposition is in
general highly dependent on the composition of samples in the dataset. This effect was
particularly pronounced when comparing further PCs of the two datasets as well as by
specific choice of certain subsets of the data.
Apart from this investigation, the second dataset was very useful for the analysis of in vitro
transformed neural cells, since it incorporates samples from neural progenitors as well as
fetal brain, that were highly relevant for this applications but that are not present in the
Lukk [12] dataset.
We described and explained two different methods of mapping new data onto the devel-
oped two-scale map and were able to correctly identify the tissue or cell type of several
samples with these methods. Furthermore, we could show that the two-scale map can
deal with mixture data, being able to identify a smooth transition from one tissue type
to the other in artificial mixture data. While our method outperforms existing methods
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(Concordia [11], URSA [10]) with respect to identification of mixtures, we point out that
the non-linearities in the RNA content to measurement signal and especially the applied
logarithmic transformation lead to a non-linear relationship between the mixture fraction
and the preprocessed microarray data. This non-linearity is not captured by our linear
model, as shown by the remaining non-linear structure in the residuals, and lead to clear
differences between the two proposed mapping procedures. The non-linear mapping is bet-
ter suited to detect low mixture fractions in the data, while the linear mapping is better
suited for an estimation of mixture fractions. However, both mappings do not fully capture
the described non-linearity. Therefore, there is space for improvements in future research
in this direction.
We compared the two-scale landscape method to three existing methods of mRNA-based
cell characterisation and showed that our method has some superior properties. The ex-
isting approaches are either less accurate (Concordia tool [11]), not well suited for char-
acterisation of cells that do not fit exactly to a specific tissue or cell type (Concordia [11]
and URSA [10] tools), or incorporate limited amounts of different cell types due to a high
training data demand (CellNet tool [81]).
Existing dimension reduction approaches for large scale gene expression based cell charac-
terisation focused either on unsupervised methods, i.e. principal components analysis [12],
or on purely supervised methods [72]. We combined here supervised and unsupervised
dimension reduction methods due to their complementary strengths and weaknesses.
With the two-scale map approach, we were able to extend the purely unsupervised approach
by a more fine-scaled residual space, allowing a very detailed investigation of tissue or cell
type similarity. We could also show that the method outperforms the purely supervised
"one-scale" approach due to an increased information content through the decomposition
into joint processes and tissue specific patterns. Furthermore, correlations between differ-
ent tissues could be markedly reduced, making the interpretation of the results easier.
With the example of the breast cancer and liver mixture data, we could show that the PCA
space covers much of the differences between cell lines and primary tissues, such that on
the residual space, there is a relatively increased similarity of cell lines and their respective
tissue of origin. This finding may be very important for drug development processes, where
results from cell line assays are translated to the clinics.
We then applied the two-scale map to several different datasets of in vitro transformed
cells. Using these analyses, we could show that in vitro differentiated cells are in most
cases immature representatives of the desired cell types, having a high similarity to embry-
onic or fetal tissues of the respective type. Furthermore, we showed two examples where
the transformation process was not successful at a global gene expression level, namely
the differentiation of NPCs to astrocytes, as well as the direct reprogramming of astro-
cytes to NSCs. These examples show that the information gained from our global analysis
gives additional complementary insights to the more commonly used single marker based
or morphological information, leading sometimes to contradicting conclusions about the
success of the transformation process.
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Such contradictions lead to the question on how a good quality of the transformed cells can
be defined. We discussed this question in general as well as more specifically for the case
of pluripotent stem cells, coming to the conclusion that there is no single uniform property
that can be used to assess the quality. Instead, the quality criteria should be used in an
application-specific manner and complementary information should be combined to arrive
at a more complete characterisation of the generated cells.
Finally, we propose that a two-scale decomposition of expression data may also be useful
for other applications. Therefore, it will be very interesting to test similar approaches for
drug response data or for the analysis of expression changes during disease progression.
Due to the generality and wide applicability of our method, it is not restricted to the char-
acterisation of engineered cells, but can also be used for characterising naturally occurring
cells with unclear properties and mixture fractions, e.g. cancer cells.
Thus, we describe a general framework for the characterisation of cells that has a wide
applicability and that can easily be extended to focus on specific cell types of interest.
We expect that the proposed method will be extended and refined in the future to tackle
the pressing needs of linking wet lab experiments to clinics and of distinguishing expres-
sion changes in single cells from population effects that are caused by changing mixture
fractions.
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A. Supplemental Materials and Methods
Datasets and software
Software
Almost all analyses were conducted using the statistical software R [227] version 3.0.2
with the Bioconductor software for computational biology and bioinformatics [228] version
2.22.0.
Data preprocessing was performed using the apt-probeset-summarize program of Affymetrix
Power tools (http://www.affymetrix.com/estore/partners_programs/programs/developer/
tools/powertools.affx) with the robust multi array (RMA) [165] normalisation method.
Mappings of genes and probe identifiers between different platforms were performed using
the biomaRt package [229] version 2.18.0 in R.
Datasets
Reference datasets for the two-scale map
Two different versions of the two-scale map were derived that are based on two different
datasets, namely the Lukk dataset [12], and a self assembled dataset from the Affymetrix
Human U133 Plus 2.0 microarray platform. The Lukk [12] dataset was downloaded as
preprocessed dataset from the Array Express database (www.ebi.ac.uk/arrayexpress,
accession number E-MTAB-62). The annotation of tissues, cell lines and disease states are
also available from the Array Express database. Table C.1 provides information about the
sample sizes for each of the 369 different groups.
The own dataset was created based on data from the Gene expression omnibus database
(http://www.ncbi.nlm.nih.gov/geo/), including the studies listed in table C.3. The raw
data from these studies were downloaded and jointly preprocessed with the RMA normal-
isation method. Annotation of different tissues and cell lines was done manually based on
the information provided in the gene expression omnibus database. An overview of the
sample numbers per tissue or cell type is provided in table C.2.
Several analysed datasets were generated on the Affymetrix Human Gene 1.0 st-v1 microar-
ray platform. Therefore, we also created a reference dataset from this platform, which was
used for creation of the background in plots of the PCA space. This dataset consists of the
samples from the following GEO series and Array Express dataset that were jointly prepro-
cessed with RMA: GSE12592, GSE12865, GSE13949, GSE14581, GSE14733, GSE14908,
GSE15163, GSE15791, GSE17504, GSE17757, GSE18072, GSE18171, GSE18296, GSE18376,
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GSE18377, GSE18592, GSE18662, GSE18794, GSE18816, GSE18893, GSE19357, GSE19539,
GSE19719, GSE19736, GSE19846, GSE19976, GSE20546, GSE20549, GSE20581, GSE20631,
GSE20671, GSE20679, GSE20963, GSE21037, GSE21129, GSE21244, GSE21262, GSE21296,
GSE21315, GSE21348, GSE21655, GSE21800, GSE22895, GSE23340, GSE23413, GSE23884,
GSE24434, GSE24533, GSE24621, GSE24997, GSE25557, GSE25673, GSE26250, GSE26336,
GSE26549, GSE26887, GSE26946, GSE27362, GSE27447, GSE27667, GSE28191, GSE28498,
GSE28542, GSE29397, GSE29880, GSE30004, GSE30038, GSE30448, GSE30650, GSE30915,
GSE32527, GSE35108, E-MEXP-2654.
Datasets analysed using the two-scale map
The first dataset that was analysed using the two-scale map (GSE18674) is already con-
tained in the own dataset from the Affymetrix Human U133 Plus 2.0 platform and was
extracted from this dataset for analysis.
The liver and breast cancer mixture data were downloaded as preprocessed data from Gene
expression omnibus (GSE33116). For the analysis, we used the first mixture data, i.e sam-
ples GSM820180 to GSM820192.
The heart and brain mixture data were downloaded as raw data from the Affymetrix web-
site [199] and preprocessed using RMA.
The MSC data were downloaded as raw data from GEO. They consist of the six untreated
samples from GSE46019, i.e. GSM909604 to GSM909609, and all samples from GSE38806
and GSE54766. All data were downloaded as raw data and jointly preprocessed with
RMA.
The cardiomyocyte and heart data were already part of the reference dataset from the
Affymetrix Human Gene 1.0 st-v1 platform and were therefore directly extracted from this
reference dataset. For the analysis, we used all data from GSE28191, all except of the
undifferentiated data from E-MEXP-2654, and the in vitro differentiated cardiomyocytes
from GSE35108.
The brain time course was downloaded from GEO (GSE25219) as preprocessed data and
the probes from this Affymetrix Exon array were matched to the Affymetrix Human Gene
1.0 st-v1 probes via the biomaRt R package. The 15 samples from the cerebral cortex that
were analysed were chosen randomly as follows: GSM708007, GSM708196, GSM708279,
GSM708298, GSM708432, GSM708450, GSM708482, GSM708640, GSM708710, GSM708786,
GSM708896, GSM708926, GSM708955, GSM708987, GSM709315. The 15 cerebellum
samples have accession numbers GSM708006, GSM708137, GSM708201, GSM708297, GSM708431,
GSM708448, GSM708480, GSM708639, GSM708709, GSM708785, GSM708894, GSM708948,
GSM708953, GSM708985, and GSM709313.
The dataset of in vitro differentiated neurons consists of all samples from GSE51214 and
GSE43235 that were downloaded as raw data and jointly preprocessed. The astrocyte and
neural progenitor cells (all data from GSE43794, GSE36145, and GSE43382) were prepro-
cessed in the same way.
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All data were quantile normalised with the reference dataset of the respective platform
before being mapped to the two-scale landscape.
Methodological details
PluriTest analysis
The PluriTest bioinformatics assay was originally developed on the Illumina Human HT12
v3 microarray platform. For a transformation to the Affymetrix Human U133 Plus 2.0
platform, probes were mapped via the biomaRt package. Pluripotency and novelty scores
were calculated based on the NMF-components described in [70]. Due to the platform
transformation, the calculation of the novelty score, is a bit different than in [70]. The
novelty score is basically a distance measure from the NMF space spanned by the pluripo-
tent stem cells in the training dataset. This distance is calculated by the eight-norm in
[70]. Here, we use the squared two-norm instead, resulting in a less strong focus on single
outlier genes.
Relationship between linear and non-linear mapping
We presented and compared two different mapping methods in the present thesis. The
linear mapping method is based on an ordinary linear projection to each coordinate of
the reduced dimensional spaces. The non-linear mapping is only based on a subset of the
genes, namely the 1% of most strongly negatively and positively expressed genes in the
respective signature. The mapping is then accomplished by a comparison of these two sets
of genes via the Wilcoxon rank sum test on the new data.
This non-linear mapping procedure is therefore only based on the ranking of genes, ne-
glecting any information about the effect size, i.e. the length of the vector that is mapped
to the space. This means, that two vectors that have the same direction, but differ in their
lengths, will have exactly the same non-linear mapping result. Therefore, the non-linear
mapping can be considered as comparing only directions, whereas the linear mapping also
considers the length of the vectors. This is one difference between the two mappings that
can be easily removed by a normalisation of the vectors to length one, resulting also in a
comparison of directions for the linear mapping.
Beside this difference between the two mappings, we describe an almost quadratic relation-
ship between the two mappings for some data. This can be explained in the following way.
For sufficiently large and balanced sample sizes, the Wilcoxon rank sum statistic can be
very good approximated by a normal distribution [230]. Furthermore, the value of a nor-
mal distributed random variable has an almost quadratic relationship to the corresponding
logarithmic p-value (Fig. A.1). Therefore, there is an almost quadratic relationship be-
tween the Wilcoxon rank sum statistic and the corresponding logarithmic p-value.
However, the Wilcoxon rank sum statistic is limited by an upper value that is dependent
on the sample size [230]. In the present example this limit is at a log10 p-value of ap-
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Figure A.1.: The value of a standard normal distributed test statistic versus the square root
of the logarithmised p-value shows an almost linear relationship. Therefore,
the log p-value is quadratically dependent on the test statistic.
proximately 37. Therefore, the described quadratic relationship is only valid in a certain
range, which is limited by this upper bound. These two effects together can explain some
of the differences between the linear and non-linear mappings. However, when there are
additional non-linear effects in the data, as described for the mixture data, the relationship
between both mapping procedures is more complex.
According to the above described quadratic relationship, we have fitted a signed quadratic
curve to the data in Fig. 4.7 and Fig. B.5. This fit was accomplished through a fit of
a model of the square root of the non-linear mapping scores depending linearly on the
linear mapping scores. Due to the described saturation effect, the fit is only performed on
those signatures with a linear projection value of at most 50% of the maximal absolute
linear projection value. This avoids the disturbing influence of saturated signatures on the
quadratic fit.
Residual analysis
For the example of mixed brain cancer and liver tissues, we analyse the residuals after
the linear mapping to both reduced dimensional expression spaces, i.e. to the two-scale
map. Such a determination of residuals is straight forward for the PCA space due to
the orthogonality of the coordinates. However, in the residual space there is still some
correlation present, e.g. between the liver and cirrhosis signatures, or between heart and
heart disease. Therefore, the true dimensionality of the residual space is lower than 369.
In fact, the tissue specific signatures in the residual space are not linearly independent, i.e.
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the rank of the matrix of signatures is only 368 and not 369 (according to the rankMatrix
function in R). However, this rank is most probably only that high due to the noise in
the data that artificially increases the rank of the matrix. This has implications for the
mapping of the data to the residual space.
The mapping presented in the thesis is a linear mapping to each signature of the residual
space. However, this cannot be used to calculate the residuals, due to the correlations
mentioned above. To do this, it is necessary to project the data onto the whole space at
once, instead of projecting it onto each coordinate individually. One possibility to do this
is a least squares fitting. However, as indicated above, the true intrinsic dimensionality
of the residual space might be lower than the number of signatures in the residual space.
Therefore, some dimensions may correspond to pure noise. Thus, in order to avoid a fitting
of noise, it is necessary to include some regularisation in the regression model.
In this thesis this is done via the lars regression [231], which constraints the sum of the
absolute regression coefficients. A successive increase of the constraining parameter results
in a stepwise increase of the model size, representing an alternative to the classical forward
selection of regression models [231].
A final choice that has to be made in this procedure is the step at which we stop with
increasing the model, i.e. the choice of the model size. This is usually done based on a
likelihood ratio test, the Akaike information criterion, or similar concepts. For the lars
regression, an other approach, building a trade-off between the squared error and the
degrees of freedom in the model is proposed [231]. However, these concepts usually require
an independence of the repeated measurements in the data. In our case, the repeated
measurements correspond to the different genes, which are certainly not independent (due
to correlated noise terms). Therefore, the classical approaches result in very large models.
Due to the fact that this residual analysis is only a side topic in the present thesis, we
use a rather practical approach to solve this problem, without going into more statistical
details of the best model choice. Thus, we reason that it is unlikely that the analysed
data (especially for the known mixture of two tissues) incorporate more than four different
tissue specific signatures and restrict the model size to four components. Other choices,
i.e. slightly larger or smaller models, do not change the statements made in the thesis
about the residual analysis (data not shown).
Visualisation
All plots were generated with the statistics software R. The background colours in the
PluriTest and PCA space representations were basically done by a kernel density estima-
tion, where the transparency in the colours corresponds to the density of the respective
class at this location. Different classes are represented by different colours. The graphics
of the residual space contain always only a subset of the 369 or 191 signatures. This sub-
set includes always the lowest as well as the five highest scores for each sample. Due to
this choice that depends on the analysed samples, the chosen signatures are different from
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graphic to graphic. Sometimes, some additional fixed signatures were also included.
Implementation of the Concordia tool
The website of the Concordia tool was not accessible at the time we tried to use it. There-
fore, we reimplemented the tool using the own dataset with the 191 different groups as
phenotypic concepts. For the implementation, we strictly followed the methodological de-
scription in [11]. The evaluation of the performance, that even outperforms that of the
original paper, indicates that the implementation was performed correctly.
The evaluation of the tool was performed with a leave-one-out cross validation scheme.
The same scheme was also used for the comparative evaluation of the two-scale map. Only
the PCA space (which was not used for calculation of performance measurements) was not
recalculated at every step of the cross-validation scheme, meaning that it was determined
based on all data. However, due to the large number of samples, the effect on the results
should be negligible.
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B. Supplemental figures
Figure B.1.: Principal components 5 to 12 of the Lukk [12] dataset. PC 5 separates incom-
pletely differentiated and, to a less extent, muscle tissues from the rest. PCs
7 and 8 separate muscle tissues from all others. The separated cluster in PCs
11 and 12 corresponds mainly to CD138 positive plasma cell myelomas. PCs
6, 9, and 10 have unclear or no biological associations.
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Figure B.2.: Principal components 5 to 12 of the own dataset. PC 6, and to some extent
PC8, are specific for muscle tissues. PC7 separates pluripotent stem cells
(green cluster on the left side) from the rest. All other depicted principal
components do not show any clear specificity for a certain tissue or cell type.
139
A Two-Scale Map of Global Gene Expression RWTH Aachen University
l
l
l
l
l
l
ll
l
l l
l
l l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
mean within group correlation − original
m
e
a
n
 w
ith
in
 g
ro
up
 c
or
re
la
tio
n 
− 
re
sid
ua
ls
l
l
l
l
l
l
Brain
Cell Line
Hematopoietic
Incompletely Differentiated
Muscle
other
Figure B.3.: Within group correlations in the own dataset before and after PCA based
decomposition. The within-group correlations in the residual space are all
clearly positive and for several tissues they are similarly high as in the orig-
inal data. This indicates that there is a significant amount of tissue specific
information in the residual space.
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Figure B.4.: Mapping of 24 tissues or cell lines from GSE18674 to the residual space of the
own dataset. All 22 tissues are correctly identified, i.e. the signature with the
highest association matches with the true tissue type. It has to be noted that
the data are part of the own dataset itself.
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Figure B.5.: Comparison of the linear and non-linear mapping methods for all 24 sam-
ple from dataset GSE18674. The non-linear mapping can in a certain range
be approximated by a sign-preserving quadratic transformation of the linear
mapping. However, at higher values a saturation effect can be observed due
to the p-value limitations of the Wilcoxon rank sum test for fixed sample sizes
(here number of probes), leading to a maximal (minimal) value of the 37 (-37)
for the non-linear mapping (dotted lines).
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Figure B.6.: Linear mapping focusing on the directions of the 24 tissues/cell lines from
GSE18674 in the residual space. The residual vectors of the 24 samples were
normalised to length one in order to focus on the similarity of directions,
neglecting the length of the vectors. This introduces an upper bound of 1 to
the depicted values, leading to less differences between the different columns.
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Figure B.7.: Non-linear mapping of the 24 tissues or cell lines from GSE18674 (columns)
to the tissue specific space without PCA based decomposition (rows). The
higher correlations between different signatures compared to the case with
PCA based decomposition (Fig. 4.4) can be especially well seen for those
signatures corresponding to specific brain regions.
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Figure B.8.: Linear mapping of the liver and breast cancer mixtures to the residual space
without PCA based decomposition. The breast cancer signature shows higher
values than for the two-scale approach, but other cancer signatures, e.g. lung
cancer show also relatively high associations, which are better suppressed in
the two-scale approach.
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Figure B.9.: Non-linear mapping of the liver and breast cancer mixtures to the residual
space without PCA based decomposition. The results are clearly less specific
than for the two-scale approach.
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Figure B.10.: Linear mapping of brain and heart mixtures to the tissue specific space with-
out PCA based decomposition. The distinction of different brain regions is
significantly less clear as for the two-scale approach (Fig. 4.15).
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Figure B.11.: Non-linear mapping of brain and heart mixtures to the residual space. The
heart score decreases continuously with increasing fraction of brain tissue,
but the brain specific scores show a relatively sharp increase at very low and
very high brain fractions with a relatively slow increase in-between.
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Figure B.12.: Non-linear mapping of brain and heart mixtures to the tissue specific space
without PCA based decomposition. The results do not show a clear separa-
tion of different brain regions and also no smooth transition for samples with
different mixture fractions.
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Figure B.13.: Samples from human cortical development mapped onto the PCA space from
the Lukk [12] dataset. During brain development, the expression patterns
get continuously closer to those of adult brain tissue (red background). Note
that the data were generated on the Affymetrix Human Exon 1.0 st-v1 array,
while the reference dataset used for the background colours was hybridised
to the Human Gene 1.0 st-v1 array. This may explain the slight differences
between the adult brain tissues and the red background on PC2.
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Figure B.14.: Mapping of 15 cortical brain tissue samples from post-conceptional week 5.7
to adulthood (70 years) onto the residual tissue specific space from the Lukk
[12] dataset. Unfortunately, the Lukk dataset does not contain samples from
fetal brain or neural progenitor cells. Therefore, the highest associations of
developing brain samples is with cancer cell lines. This is the reason, why we
use the own dataset for the analysis of the in vitro transformed neural cells.
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Figure B.15.: 15 samples from the embryonic to adult cerebellum mapped to the residual
tissue specific space of the own dataset. The analysis shows that there is a
clear association with the cerebellum signature from 4 months to 36 years
after birth, indicating that different brain regions can be nicely distinguished.
Surprisingly, this association diminishes in older ages.
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C. Supplemental tables
Table C.1.: Number of samples per group for all 369 groups in the Lukk [12] dataset.
Tissue/cell type Number of samples
293t-tva 1
600MPE breast cancer 1
A549 lung adenocarcinoma 31
A673 Ewing tumor 3
ABC-1 lung adenocarcinoma 1
AMO-1 myeloma 4
AU565 breast carcinoma 1
B cell 11
B-cell lymphoma 213
B-cell lymphoma cell line 4
BT20 breast cancer 1
BT474 breast cancer 10
BT483 breast cancer 1
BT549 breast cancer 1
BeWo choriocarcinoma 4
C2C12 mouse muscle myoblast 3
CAL27 head neck squamous cell carcinoma 2
CAMA1 breast cancer 1
CCL-153 fetal pulmonary fibroblast 3
CD138+ plasma cell 8
CD138+ plasma cell monoclonal gammopathy 8
CD138+ plasma cell myeloma 120
CD33+ cells 1
CD34+ blood cell 8
CD34+ blood cell thymus 1
CMK megakaryoblastic 1
Calu-1 lung epidermoid carcinoma 1
Calu-3 lung adenocarcinoma 16
Calu-6 lung anaplastic carcinoma 1
DU 145 prostate carcinoma 1
EBC-1 lung squamous cell carcinoma 1
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EKVX lung non small cell carcinoma 1
EW24 Ewing sarcoma cell line 4
FM9514 human embryonic myoblast 30
FR4 multiple myeloma 1
H1 mesenchymal precursor 1
H9 mesenchymal precursor 1
HBL 100 breast cancer 1
HCC lung adenocarcinoma 1
HCC-2998 colon cancer 1
HCC1007 breast cancer 2
HCC1171 lung non small cell lung carcinoma 1
HCC1187 breast cancer 1
HCC1195 lung adenocarcinoma 1
HCC1359 lung large cell carcinoma 1
HCC1428 breast cancer 1
HCC15 lung squamous cell carcinoma 1
HCC1500 breast cancer 1
HCC1937 breast cancer 1
HCC2157 breast cancer 1
HCC2185 breast cancer 1
HCC227 lung adenocarcinoma 1
HCC2935 lung non-small cell lung cancer line 1
HCC3153 breast cancer 1
HCC366 non-small cell lung carcinoma 1
HCC38 breast cancer 1
HCC44 non-small cell lung carcinoma 1
HCC515 lung adenocarcinoma 1
HCC70 breast cancer 1
HCC78 lung non-small cell carcinoma 1
HCC827 lung adenocarcinoma 1
HCC95 lung non-small cell carcinoma 1
HCT-15 colorectal adenocarcinoma 1
HCT116 colorectal carcinoma 6
HEK293 embryonic kidney 18
HEK293T embryonic kidney 6
HMEC S1 1
HMEC184 breast cancer 5
HMT3522S1 breast cancer 1
HMT3522S1 breast epithelium 4
HOP 92 non-small cell lung carcinoma 1
HOP-62 lung adenocarcinoma 1
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HS578T breast cancer cell line 1
HeLa cervical adenocarcinoma 32
HeLa cervical adenocarcinoma transfected 10
Hep-2 larynx sqamous cell carcinoma 10
I-6 embryonic stem cell 1
IB3-1 adenovirus transformed bronchial epithelia 11
IGROV1 ovarian cancer 1
JEG3 placental choriocarcinoma 3
Jurkat T lymphocyte 2
KELLY neuroblastoma 1
KM12 colon cancer 1
KM4 multiple myeloma 8
KS Y-1 Kaposis sarcoma AIDS associated 1
KS-IMM Kaposis sarcoma non AIDS associated 1
Kaposi sarcoma 14
LC-1F lung squamous cell 1
LC1/SQ lung squamous cell 1
LC2/AD non-small cell lung adenocarcinoma 1
LK-2 lung squamous cell 1
LNCaP prostate cancer 16
LOXIMVI malignant amelanotic melanoma 1
LU134 lung small cell cancer 1
LU139 lung small cell cancer 1
LU165 lung small cell cancer 1
Lu130 lung small cell cancer 1
Lu65 lung non-small cell adenocarcinoma 1
M14 malignant melanoma 1
M70e hematopoietic 2
MALME-3M malignant melanoma 1
MCF10A breast epithelial fibrocystic disease 2
MCF10A-myc breast epithelial fibrocystic disease 8
MCF12A breast epithelial+M824 1
MCF7 breast epithelial adenocarcinoma 213
MDA-MB-134VI breast cancer 1
MDA-MB-175VII breast cancer 1
MDA-MB-231 breast cancer 26
MDA-MB-361 breast cancer 1
MDA-MB-415 breast cancer 1
MDA-MB-435 melanoma 3
MDA-MB-436 breast cancer 1
MDA-MB-453 breast cancer 1
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MDA468 breast cancer 10
MOLT4 T cell acute lymphoblastic leukemia 18
MRC5 fetal fibroblast 1
MS-1 lung small cell lung cancer 2
NC-NC lymphoblastoid B cell 3
NCI-ADR-RES ovarian cancer 1
NCI-H226 lung squamous cell carcinoma 1
NCI-H322M lung small cell bronchioalveolar carcinoma 1
NCI-H460 lung large cell carcinoma 1
NCI-H522 lung adenocarcinoma 1
NCI-H929 myeloma 1
NCU-MM1 multiple myeloma 1
OVCAR-3 ovarian cancer 1
OVCAR-4 ovarian cancer 1
OVCAR-5 ovarian cancer 1
OVCAR-8 ovarian cancer 1
PC-1 lung squamous cell cancer 1
PC9 lung non-small cell adenocarcinoma 1
QG-56 lung squamous cell cancer 1
RERF-LC-AI lung sqamous cell cancer 1
RERF-LC-KJ lung non-small cell adenocarcinoma 1
RERF-LC-MS lung non-small cell adenocarcinoma 1
RJ2.2.5 Burkitts lymphoma 8
RKO colon carcinoma 24
RXF-393 renal cell carcinoma 1
SBC-5 lung small cell cancer 1
SBC3 lung small cell cancer 1
SF-268 glioblastoma 1
SF-539 glioma 1
SK-N-AS neuroblastoma 1
SK-N-MC neuroblastoma 4
SK-N-SH neuroblastoma cell 4
SKBR3 breast adenocarcinoma 9
SKMC fetal skeletal muscle myoblast 3
SKMM1 multiple myeloma 1
SN12C renal cell carcinoma 1
SNB-19 glioblastoma 1
SNB-75 astrocytoma 1
SQ-5 lung sqamous cell cancer 1
SR lymphoma 1
SUM1315MO2 breast cancer 1
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SUM149PT breast cancer 1
SUM159PT breast cancer 1
SUM185PE breast cancer 1
SUM190PT breast cancer 1
SUM225CWN breast cancer 1
SUM44PE breast cancer 1
SUM52PE breast cancer 1
SW480 colon cancer primary tumor derived 6
Skgt4 esophageal cancer 5
Su-dhl1 anaplastic large cell lymphoma 6
T cell 47
T cell diseased 43
T47D breast ductal carcinoma 11
TERV 7
TK-10 1
U251 glioblastoma 1
U937 lymphoma 1
UACC-257 melanoma 1
UACC-62 melanoma 1
UACC812 breast cancer 1
UO-31 renal cell carcinoma 1
WI38 fetal fibroblast 1
ZR751 breast cancer 1
ZR7530 breast cancer 1
ZR75B breast cancer 1
a498 renal cell carcinoma 1
acute lymphoblastic leukemia 95
acute megakaryoblastic leukaemia 3
acute monoblastic and monocytic leukemia 6
acute myeloid leukemia 295
acute myelomonocytic leukemia 4
acute promyelocytic leukemia 18
acute quadriplegic myopathy 5
adipose tissue normal 8
adipose tissue polycystic ovarian syndrome 9
adipose-derived adult stem cells 6
adipose-derived adult stem cells cultured 3
airway epithelial cell 1
airway epithelial cell cystic fibrosis 5
alveolar rhabdomyosarcoma 9
amygdala 1
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bladder 3
bladder cancer 41
bladder mucosa 4
blood 39
blood transplant rejection 3
bone 7
bone hyperparathyroidis 7
brain 39
brain bipolar disorder 31
brain tumor 82
breast cancer 672
bronchial epithelia 33
bronchoalveolar lavage cell 25
bronchoalveolar lavage cell transplant rejection 4
caco2 colon adenocarcinoma 15
caki-1 renal cell carcinoma 1
caudate nucleus 30
caudate nucleus Huntingtons 38
ccrf-cem T-ALL 1
cerebellum 26
cerebellum Huntingtons 39
chondroblastoma 4
chondromyxoid fibroma 3
chondrosarcoma 6
chordoma 4
chronic myeloid leukemia 44
cirrhosis 5
colo205 colorectal adenocarcinoma 1
colon mucosa bowel disease 8
colorectal cancer 34
conjunctiva 4
connective tissue fibroblast 3
coronary artery smooth muscle cell 9
dedifferentiated chondrosarcoma 2
dendritic cell 1
ea.hy926 cell imortalized endothelial 7
embryonal rhabdomyosarcoma 10
embryonic lung fibroblast 15
embryonic skin fibroblast 23
embryonic stem cell 5
endothelial cell 8
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epidermis 5
epidermis dermatitis 12
erythrocyte 6
esophageal adenocarcinoma 6
esophagus Barretts 7
esophagus epithelium 7
ewings sarcoma 29
fetal lung 1
fetal lung fibroblast 20
fibroblast Cockayne syndrome 8
fibromatosis 3
frontal cortex 27
frontal cortex Huntingtons 36
ganglioneuroblastoma 4
ganglioneuroma 1
germ cell tumor 71
gingiva cell periodontitis 3
glioblastoma 2
glioblastoma cell line 5
granulocyte 6
hI60 promyelocytic leukemia 27
head and neck squamous cell carcinoma 8
heart 36
heart disease 51
hematopoietic stem cell 22
hepatocellular carcinoma 60
hippocampus CA1 5
hippocampus CA1 Alzheimers 8
ht-29 colorectal adenocarcinoma 27
human bronchial epithelial cell line 2
hypopharynx 3
hypothalamus 20
k562 myelogenous leukaemia 48
keratinocyte 8
kidney 29
kidney carcinoma 5
kidney epithelium 9
leiomyosarcoma 7
leukocyte 56
leukocyte multiple organ failure 7
ligament cell periodontitis 3
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lipoma 3
liposarcoma 2
liver 1
lung 5
lung cancer 77
lung emphysema 1
lymph node 10
lymphocyte 80
lymphocyte asthma 3
macrophage 18
malignant peripheral nerve sheath tumor 2
mcf-7aro breast epithelial adenocarcinoma 23
mesangial cell 8
mesenchymal stem cell 25
microvascular endothelial 6
monocyte 21
monocyte familial hypercholesterolemia 4
monocyte multiple organ failure 5
mononuclear cell 143
mononuclear cell infection 314
monophasic synovial sarcoma 7
multiple myeloma 1
multipotent adult progenitor cell 1
myelogenous leukemia 37
myometrium 12
myxoid liposarcoma 6
neuroblastoma 19
neurofibroma 2
oral squamous cell carcinoma 23
oropharynx 1
osteosarcoma 9
ovarian tumor 93
ovary 4
pc-10 lung sqamous cell cancer 1
pc3 prostate cancer 64
pc6 lung small cell cancer 1
pc7 lung non-small cell adenocarcinoma 1
placenta basal plate 21
plasma cell 1
plasma-cell leukemia 6
preadipocytes 24
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precursor T lymphoblastic leukemia 59
prefrontal cortex 2
primary fibroblast 9
primary intervertebral disc 10
progeria syndrome fibroblast 9
prostate cancer 25
prostate gland 11
pterygium 6
regenerating cell periodontitis 3
renal cell carcinoma 11
rpmi-8226 myeloma 1
sarcoma 3
schwannoma 2
sk-mel-28 melanoma 1
skeletal muscle 17
skeletal muscle diseased 50
skeletal muscle muscular dystrophy 33
skin 4
skin basal cell UV treated 3
skmel5 melanoma 21
small intestine 6
smooth muscle 10
spindle cell tumor 5
squamous cell carcinoma of the oral cavity 4
ssMCF7 breast cancer 23
te85 osteosarcoma 8
testis 1
theca 8
theca polycystic ovarian syndrome 5
thymocyte 14
thyrocyte 6
thyroid adenocarcinoma 19
thyroid gland 1
tonsil 10
trabecular meshwork cell 6
ts anaplastic large cell lymphoma 27
u-20s osteosarcoma 2
umbilical vein endothelial cell 42
universal reference 18
unknown gliobastoma 1
unknown lung adenocarcinoma 15
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unknown lung cancer 2
unknown lung cell carcinoma 1
unknown lung large cell carcinoma 3
unknown lung mesothelioma 1
unknown lung neuroendocrine 1
unknown lung non small cell cancer 4
unknown lung small cell cancer 17
unknown lung squamous cell carcinoma 2
unknown small cell lung cancer 1
uterine tumor 23
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Table C.2.: Number of samples per group for all 191 groups in the own dataset.
Tissue/cell type Number of samples
Abdominal _cancer 6
Adipose_stem_cell 5
Adipose_tissue 20
Adrenal Gland _cancer 2
Adrenal_gland 8
Amygdala 16
Appendix _cancer 1
Astrocytes 9
B cells 30
Basal_ganglia 113
Bladder _cancer 32
Bladder or Kidney _cancer 1
Bladder_cancer_cell_line 33
Blood 200
Blood_vessel 20
Bone _cancer 4
Bone_marrow 13
Brain _cancer 33
Brain_cancer_cell_line 56
Breast 20
Breast _cancer 371
Breast_cancer_cell_line 224
Bronchus 6
CD11b+ 3
CD133+ 2
CD235a+ 3
CD34+ 2
CD4+ 2
CD45+ 3
CD8+ 2
CNS_cancer_cell_line 29
Cerebellum 21
Cerebral_cortex 345
Cerebral_cortex_no_astrocyte 3
Cervix 9
Cervix Uteri _cancer 1
Cervix _cancer 36
Cervix_cancer_cell_line 2
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Colon 8
Colon _cancer 358
Colon_cancer_cell_line 174
Common Bile Duct _cancer 1
Corpus_callosum 18
Dorsal_root_ganglia 16
Duodenum _cancer 1
EC 2
Embryo 6
Endometrium _cancer 5
Endometrium_cancer_cell_line 13
Endothelial_cell_line 2
Eosinophils 4
Erythroblasts 8
Esophagus 8
Esophagus _cancer 6
Esophagus_cancer_cell_line 14
Exocrine Pancreas _cancer 1
Fallopian tube _cancer 8
Fallopian_tube 3
Fetal_brain 2
Fetal_liver 1
Fibroblast 68
Fibroblast_cell_line 6
Gallbladder _cancer 2
Gastric _cancer 3
Gastric_cancer_cell_line 24
Glial_progenitor 7
Glioblastoma_neurosphere 8
Granulocytes 2
Granulosa 2
Heart 207
Hematopoietic System_cancer_cell_line 123
Hippocampus 156
Hypothalamus 16
Islets 3
Islets of Langerhans _cancer 1
Keratinocyte 5
Kidney 18
Kidney _cancer 280
Kidney_cancer_cell_line 1
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Larynx_cancer_cell_line 2
Leukemia_cancer_cell_line 18
Liver 150
Liver _cancer 125
Liver_cancer_cell_line 32
Lung 7
Lung _cancer 139
Lung_cancer_cell_line 247
Lymph Node _cancer 17
Lymph_nodes 8
Lymphoblastoid_cell_line 35
Lymphoma_cancer_cell_line 6
MPC 2
MSC 13
Medulla 18
Melanoma_cancer_cell_line 51
Mesenchymal cells 1
Microglia 4
Midbrain 64
Monocytes 55
Motor_neuron 8
Myeloid Dendritic cells 5
Myometrium _cancer 1
NK cells 12
NPC 3
Nasal Septum_cancer_cell_line 2
Nasopharynx_cancer_cell_line 2
Neutrophils 6
Nipple 8
Nodose_nucleus 16
Non-Small Cell Lung_cancer_cell_line 26
Oocyte 3
Oral _cancer 13
Oral cavity_cancer_cell_line 4
Oral_mucosa 8
Ovarian_cancer_cell_line 42
Ovary 27
Ovary _cancer 560
Ovary_cancer_cell_line 17
PBMC 3
PSC 473
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Pancreas 2
Pancreas _cancer 23
Pancreas_cancer_cell_line 41
Parotid gland _cancer 4
Partial iPSC 8
Pelvis _cancer 1
Penis 6
Penis _cancer 1
Pericardium 1
Peritneum 1
Peritoneum _cancer 22
Pharynx 8
Pharynx _cancer 1
Pharynx_cancer_cell_line 6
Pituitary_gland 14
Placenta 1
Plasma cells 2
Plasmacytoid Dendritic cells 5
Pons 15
Prostate 44
Prostate _cancer 88
Prostate_cancer_cell_line 31
Rectosigmoid _cancer 43
Rectum _cancer 41
Renal pelvis _cancer 15
Renal_cancer_cell_line 32
Rib _cancer 1
Salivary Gland _cancer 1
Salivary_gland 10
Skeletal_muscle 28
Skin 41
Skin _cancer 13
Skin_cancer_cell_line 5
Small intestine _cancer 15
Small_intestine 7
Soft tissue _cancer 34
Spinal cord _cancer 1
Spinal_cord 18
Spleen 10
Spleen _cancer 4
Stomach 24
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Stomach (Gastroesophageal junction) _cancer 1
Stomach _cancer 16
Stomach_cancer_cell_line 36
Synovium 14
T cells 95
Testes 10
Testis _cancer 5
Thalamus 24
Thymus 3
Thyroid Gland_cancer_cell_line 4
Thyroid _cancer 36
Thyroid_gland 10
Tongue 18
Tongue _cancer 2
Tongue_cancer_cell_line 12
Tonsil 6
Trachea 8
Trigeminal_ganglia 16
Universal Reference 2
Unknown_cancer_cell_line 5
Ureter _cancer 3
Urethra 8
Uterine Cervix _cancer 1
Uterus 87
Uterus _cancer 231
Vagina 8
Vagina _cancer 1
Vulva 8
Vulva _cancer 11
White_matter 28
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Table C.3.: Number of samples per GEO series for all 108 GEO series in the own dataset.
GEO Series Number of samples
GSE10843 206
GSE1145 37
GSE11882 173
GSE12390 21
GSE12485 10
GSE12486 10
GSE12583 9
GSE13828 10
GSE14711 11
GSE14897 15
GSE14970 12
GSE15175 16
GSE15176 12
GSE15491 3
GSE16093 5
GSE16654 6
GSE16694 8
GSE16963 9
GSE17476 8
GSE18147 10
GSE18180 3
GSE18618 15
GSE18674 24
GSE20033 19
GSE2109 2158
GSE21222 18
GSE21243 4
GSE21610 68
GSE22167 14
GSE22246 13
GSE23402 42
GSE23583 35
GSE23968 14
GSE24223 179
GSE24487 10
GSE24530 8
GSE25090 3
GSE25417 12
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GSE26451 6
GSE26455 6
GSE26672 19
GSE27206 9
GSE27280 12
GSE27924 10
GSE28406 16
GSE28490 47
GSE29115 8
GSE29625 14
GSE29783 10
GSE29819 38
GSE30038 8
GSE32474 174
GSE33025 6
GSE33066 6
GSE33109 39
GSE33325 39
GSE33536 9
GSE33903 22
GSE34211 230
GSE3526 353
GSE35373 6
GSE35603 78
GSE35864 72
GSE36098 9
GSE36609 9
GSE36634 24
GSE36667 2
GSE36754 9
GSE37258 18
GSE37842 4
GSE37896 8
GSE37982 3
GSE38069 2
GSE40438 8
GSE40444 8
GSE40709 9
GSE40751 12
GSE40873 49
GSE41804 40
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GSE42073 6
GSE42114 19
GSE44841 8
GSE45537 135
GSE49541 72
GSE49910 46
GSE5281 161
GSE57083 627
GSE7179 9
GSE7234 4
GSE7307 677
GSE7624 35
GSE8331 8
GSE8590 17
GSE9171 30
GSE9196 53
GSE9440 8
GSE9510 5
GSE9709 10
GSE9770 34
GSE9832 16
GSE9834 6
GSE9835 6
GSE9843 91
GSE9865 13
GSE9891 285
GSE9894 12
GSE9940 18
GSE9941 8
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